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A B S T R A C T
Carrier-free ^ Z n  and ^ G a  produced in the M.K.C. cyclotron 
were used to study the metabolism of zinc and gallium in rats.
The appropriate literature has been reviewed.
Zinc excretion has been studied using a sub-physiological
65tracer dose of ^Zn. In 25 days 80% of the dose was excreted 
in the faeces. The secretions of the pancreas and liver 
contributed approx. 30% of the faecal ^Zn, and it is suggested 
that the origin of approx. 70% of faecal zinc is the secretions 
of the Paneth cells and goblet cells and other gastro-intestinal 
secretions.
Evidence is presented that the zinc secreted in bile is in 
the form of a macromolecular complex.
The distribution and turnover of zinc in a number of soft 
tissues have been studied.
The effect of oral ZnSO^ on the tissue retention of endogenous
65 . ''
.rZn has been studied.
The significance of these results and their relevance to the 
use of radionuclides of zinc as pancreas and prostate gland 
scanning agents have been discussed.
Tissue distribution and excretion of ^ G a  and its localisation 
in transplanted tumours have been studied. Gallium was retained 
in the body due to plasma protein binding and tissue deposition, 
resulting in its slow excretion. ^ G a  .localised mainly in 
viable tumour cells.
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C E A P T E R  I
-GENERAL INTRODUCTION
During the last two decades there has been an 
unprecedented expansion of basic research in nuclear 
science, accompanied by a vast programme of research 
and development in the field of nuclear medicine. The 
tangible effects havejbeen a remarkable increase in the 
kind and the number of radioactive pharmaceuticals available 
for clinical diagnostic and therapeutic use-(Windeyer, 1972).
1-1 Tumour scanning agents
Great interest.has been shown in the development of
compounds for selective concentration in tumours which would
£
be of considerable diagnostic value. An ideal diagnostic 
agent must be able to establish;
(a) The presence of tumours,
(b) The location of• the primary tumour in patients 
with proven cancer,
(c) The metastatic spread of the primary tumour 
and location of secondary lesions,
The presence of the diagnostic agent in the abnormal 
area must be detectable, with relative ease and rapidity.
Such ideal tumour diagnostic agents are non-existent and 
those that fulfil some of the qualities of the hypothetical
-1-
agent are rare. •
Radionuclides with penetrating radiation fulfil the
requirement of ease of detectability. A radionuclide can
indicate the presence of a tumour if it concentrates within
or extraneous to the tumour in relatively high proportions.
Concentration within the tumour in excess of that of
surrounding tissue "shows a "hot-lesion" and the reverse 
%
phenomenon shows a ,fcold-lesionn. In order to be. of value 
in diagnostic applications, a radionuclide should have a 
long physical half-life compared with the duration of the 
investigation in which it is to be used. However, the 
biological half-life should be sufficiently"short for it 
not to constitute a radiation hazard to the recipient. New 
radionuclides which comply with these reqi^rements, and 
also emanate useful radiation required by detection instruments 
are being produced. In the selection of metal nuclides, 
emphasis at the present time has principally been placed 
on the physical characteristics, such as half-life, the 
principal emissions and their energies, the nuclear reactions 
involved in their production and their efficiency of detection. 
The biochemical, physiological and pharmacological 
considerations for the selection and use of these 
radionuclides have been subordinate. Occasionally, some radio­
nuclides have been selected on biologically rational grounds.
aI' \The success of radioiodine for thyroid physiology (Hertz, 1938)
A
nurtured hopes that other elements would be specific for 
certain organs or tumours; nuclides of zinc were proposed 
for the diagnosis of carcinoma of the pancreas (Meschan et al.,
1959)* and the prostate (Johnston et al., 1968) both 
organs with a high affinity for zinc. However the 
success obtained with the artificial element, ^ c  in 
scanning for tumours of the brain, the thyroid, the liver 
and lung (Silver, 1968) justifies the investigation of any 
nuclide for initial test screens to assess its ability to 
concentrate in tumours. "Therefore these elements need not 
necessarily be nuclides of endogenous elements, and can be 
analogues of physiological substances, anutrients or 
antimetabolites.
— ~ 62 6*7 —Currently, the radionuclides Zn and 'Ga are
produced in the M.R.C. cyclotron, and these are screened
in order to evaluate their diagnostic value in tumour
localisation. The availability of these elements in carrier- 
free form permits the study of their metabolic and : 
pharmacokinetic properties at sub-physiological levels , 
which is the subject reported inthis thesis.
1-2 Zinc
% '
1-2-1 Introduction
Zinc is unequivocally required in trace
amounts for the growth and development of plants and animals, 
and is found ubiquitously distributed in the vertebrate 
body (Vallee, 1962). Zinc has been shown to be associated 
with several enzymes (O'Dell & Campbell, 1970). Dietary 
intake of zinc below the normal requirement causes disease 
and the condition can be reversed by dietary supplementation 
or by oral zinc therapy (Prasad, 1966).
-3-
The absorption, tissue distribution and the metabolism 
of zinc have been documented for some eutherian mammals of 
the domestic and laboratory environment (Table 1-1).
Table 1-1 Zinc metabolism studies in mammals
Order Animals Study
Rodentia Mouse
Rat
Sheline et al. 
Gilbert & Taylor
(1943)
(1956)
Lagomorpha Rabbit Cotzias et al. (1961)
Carnivora Dog Sheline et al. 
Robertson & Burns
(1943)
(1963)
Artiodactyla
■s,
Cattle
Sheep
Pig
Miller
McKenney et al. 
Hoekstra et al.
(1963)
(1962)
(1956)
Primates Monkey
Man
Underwood 
Spencer et al.
(1971)
(1965)
1-2-2 Absorption
Since the initial study of Stern et al. (1935) os. the 
zinc requirement of the rat for growth, many studies have 
been reported on zinc absorption.
In an ecperiment in guinea-pigs, Skog et al. (1964)
-4-
found that percutaneous ^ Z n C ^  was very slowly absorbed,
less than 1% of the dose being absorbed over 5 k.
65Subcutaneouslycbposited ^ZnC^ in rats resulted in
approx. 92% absorption in 24h (Khristov, 1970). Absorption 
65of •'Zn from the peritoneum of rats occurred almost com­
pletely'in the first 24 h following injection (Feaster' et al,195 
Ballou and Thompson -(1961) showed that 25% of a dose of 
^ZnClg deposited in the stomach of rats was absorbed from 
the stomach within 24 h. Khristov (1970) stated that other 
soluble compounds of zinc such as zinc acetate, zinc 
citrate and zinc glycine complex are rapidly removed from 
the blood stream and readily absorbed from sites other than 
the surface of the skin.
Sparingly soluble salts of zinc, such as the carbonate 
and the phosphate are only slowly absorbed from subcutaneous 
and intramuscular sites. These compounds and zinc dithizone 
complex are retained in the lungs of rats following intravenous 
injection (Banks et al.,1950). Fhytate^a natural chelating agent 
present in plants, is known to reduce the absorption of 
dietary zinc in animals (O'Dell & Savage, 1960) and man 
(Reinhold et al., 1973).
Dietary zinc is absorbed mainly in the distal portion ' 
of the small intestine. Campen and Mitchell (1965) showed
that in the ligated portions of the small intestine of the 
65rat, ^ZnC^ is absorbed in the duodenal, ileal and the 
jejunal portions to an extent of 5.41%, 2.04%"and 0.66% of 
the dose respectively, in 3 h. ^ZnClg uptake in the everted 
duodenal sacs vas not affected by CN~ or the absence of
-5-
oxygen (Oberleas et al., 1966). Non-radioactive zinc added
to drinking water of rats, containing ^ZnCl^ effectively
reduced ^ Z n  absorption (Avrunina, 1970). By the addition
of 0.04 mg zinc and 2.0 mg zinc as non-radioactive ZnSO^ to
the daily rations which also contained 1.0-jiCi ^Zn, absorption 
65of ^Zn was 5*5% and 2.9% compared with an absorption of
6.4% for the controT~animals. Cotzias et al. (1962)
demonstrated that zinc but not Cu, Ga, Mn ar Cd, when used
as a dietary or intraperitoneal metabolic load, lowered
absorption and enhanced excretion cf ^ Z n  £n mice. With an
increment of ZnSO^ added to the diet from 50 to 500 p.p.m.,
absorption of intraperitoneally administered ^ ^ZnCl2 decreased
from' 34% to 16%. Ballou and Thompson (1961) proposed that
zinc absorption in the gastro-intestinal tract is age-dependent. 
65The amount of ^Zn retained in the body, 24 h after an oral 
dose, decreased from 90% to 15% in the 6 and 26 day old 
Spra^gue-Dawley rats respectively. Suso and Edwards (1968) 
observed recognisable differences in ^^Zn absorption in 
chicken and attributed this to heritable factors.
Duodenal uptake of zinc has been shown to be facilitated 
by the amino acids, glycine and methionine (O'Dell, 1969).
A copper binding protein of approx. mol.wt.10,000, in the 
duodenal mucosal cell supernatant of the chick w^s discovered 
by Starcher (1969). Zinc and cadmium have also been shown 
to associate with this protein. Starcher postulated that 
copper, zinc and cadmium are absorbed in the gut by the same 
mechanism, on the basis of the cytoplasmic protein binding. 
However, there is no evidence to associate cytoplasmic protein
-6-
Table 1-2 Endogenous zinc content in some selected
tissues in* the experimental rats and man
Collip rat August rat Man
Total 
body zinc 
content (pg)
Soft tissue 
content(pg/g)
—  . ■
2930 + 0 0
•
V
1.4-2.3 x 10°
15 - 30 13 - 30 20 - 30
Group Tissue jag zinc / g wet wt.
Liver 30 ± 1.6 30 + 2.8 101 + 13.9
A Pancreas 23 ± 1.0 80 ± 10.4
Kidney — 23 + 3.4
Lung 19 + 1.6 34 + 7.3
B
Spleen ■ — 24 + 3.4 36 + 9*4
Bone 253 + 22 102 + 2.0
Voluntary
C * * *
muscle 13 + 1.0 54
Prostate 180 + 45 220 +16.5
Study (1) (2) (3)
* fug/100 g body weight ** |ug/70 kg body weight
(1) Mawson & Fisher(1951) *** Underwood (1971)
(2) Gilbert & Taylor (1956) (3) Siegel et al.(1961)
-7-
binding with duodenal absorption. Zinc interaction with 
cytoplasmic protein may merely facilitate transport processes 
at thecell membrane. Recently, Campen and Kowalski (1971) 
have reported the.presence of a similar zinc binding 
protein in the duodenal cells of the rat. Thus, zinc 
absorption from the gut does not appear to involve an 
active process, nevertheless, the foregoingevidence indicates 
that it is highly selective.
1-2-3 Tissue distribution of endogenous zinc __
The distribution of endogenous zinc in two strains 
of adult laboratory rat and man are shown in^Table 1-2.
In the body the highest zinc content is found in tie skeleton,
with lower levels in the muscle and liver, the zinc content
being, approx. 26.7%* 17*2% and 4.1%, respectively, of the
total body content, in"' the rat. In humans, in comparison
with the rat, the zinc content is higher in the tissues
studied* This is illustrated by tissues in groups A and
B (Table 1-2) and the prostate, the group A tissues showing
the highest difference. But both species contain about
30 pg zinc per gram body weight. In rats the zinc content
of the skeleton has been found to increase with age (TaylorjlSSX)^
Age Zinc content in bone
(days) . (pg zinc/ g wet wt.)
56 77 + 7
103 104 + 2
513 133 + 8
679 191 + 5
-8-
^ Z n  (ZnC^) has been used, extensively to investigate
tissue distribution of this element, with the assumption 
‘that the tracer seeks the normal■compositional pattern of
by scintillation counting of the gamma radiation present
in. the dissected organs and tissues, withdrawn from the
body at different time intervals after administration.
The findings of Muller (1946), Gunn et al. (1955)> Khristov
(1970) and others have resulted in the following
classification of tissues according to their exchange
65rates for intravenous ^ZnCl^. ^
Group A Tissues
Highest ^ Z n  concentration between 0 to 2 h, 
with subsequent rapid loss:-
_ v
(1) Pancreas
(2) Liver 
(5) Kidney
(4) Duodenum /
Group B Tissues
Intermediate ^ Z n  concentration with 
subsequent rapid loss:-
(1) Spleen -
(2) Lung
(5) Stomach ^
(4) Large intestine
'(5) Heart muscle
65the stable element in the body. . Zn has been assayed
-9-
Group C Tissues
gtr
Initial low ^Zn concentration with subsequent 
increase over a long period (days):-
- (1) Skeleton.
(2), Skin and hair
(3) Testes^
(4) Prostate gland
(5) Voluntary muscle
(6) Erythrocytes >
In the mouse, the rat and the dog the pattern of tissue 
65
distribution of Zn is similar. The peak concentration^
65of ^Zn in group A and B tissues are reached around 
8 h in the dog (Meschan et al.,1959)> around 2 h in 
the rat (Stand et al.,1962), and earlier than 2 h in 
the mouse (Sheline et al., 194-3) after i.v. ^Zn.
Initially, the tissue distribution of ^ Z n  does not follow 
the normal compositional pattern of endogenous zinc. In 
the rat, skeleton and the skeletal muscle contain approx. 
26.7% and 17*2% of the whole body zinc content, but the 
liver with approx. 4.1% zinc content shows an initial 
high concentration of ^^Zn (Gilbert & Taylor, 1956)* At
i
24 h the liver contained 15.7%, the skeleton, 20.7% and
the skeletal muscle, 14.2% of an intravenous dose of ^Zn,
65The rapid release of ^Zn from the liver, its slow release 
from the muscle and its retention in the bone can be seen 
in Table 1-3* Mouse (Sheline et-al* *194-3), rat (Gilbert 
& Taylor, 1956) ,' dog (Meschan et al., 1939), and man 
(Spencer et al., 1965) have been shown to concentrate- 
maximally, about 25%, 35%, 38%,and 64% respectively, of
-10-
65a trace, dose of intravenous ^Zn in the liver.
The initial high concentration of ^ Z n  in the liver
cannot be explained by the^Zn in the blood alone since
a similarly highly vascular tissue, the spleen, contained
less ^ Z n  per gram of tissue at all times (Table 1-4). The
- high concentration in the liver and kidneys is therefore
65
probably due to Zn incorporation into intracellular 
components such as the cellular ma^cromolecules.
Table 1-3 ^ Z n  turnover in the liver, skeleton 
and the voluntary muscle of the rat
N 65Endogenous zinc j Distribution of intravenous ■ Zn
Calculated as:
Percentage of
total body zinc
Percentage of initial dose
Time after injection (days)
0.04.. 1 4  ? 35 100
Liver 4.1
Skeleton 24.7
Muscle 17.2
25 15.7 6.9 4.5
* *
1.6 0.4
20.7 15.0 16.4 11.3 14-.5
14.2 16,9 15.5 9.5* 2.2
Data obtainffrom Gilbert & Taylor (1956)
Other values from Khristov (1970)
-11-
Gilbert and Taylor showed in the rat that group A
tissues all had the same ^Zn/zinc ratios at various
times when the ^ Z n  levels were decreasing. The ratio
in hepatic, renal and duodenal tissues was 0.05 at 3
days and 0.011 at 34 days. This demonstrates that by 3
days there is complete equilibration between the ^ Z n  and
stable endogenous zinc in these tissues. With regard
to ^^Zn kinetics this period will be referred to as the
'equilibrium phase* as opposed to 'pre-equilibrium phase1
which operates from the time of administration until tissue
equilibrium levels are reached.
65Table 1-4 Blood and ^Zn concentration of tissue
Tissue Blood volume 6^Zn concentration
(juL/g tissue) % of i.v. dose/g after
1 h 3 h 6 h 24 h
Liver 178 4.8 3.9
C\J 1.9
Spleen 481 1.9 1.9 1.7 1.4
Kidney 278 4.0 3.3 2.6 1.6
Lewis et al.(1952) Ballou & Thompson (1961)
1-2-5 Cellular and subcellular distribution Of zinc
This aspect has been studied using cytochemical 
staining techniques and autoradiography. Both approaches 
have shown good agreement. Autoradiography following
-12-
intravenous ^ZnClg indicated that in the liver, hepatocytes
65and Kupfferocytes contained yZn (Millar jet al., 1961)•
Mclsaac (1955) examined ^ Z n  localisation in the rat
pancreatic tissue, and reported a high concentration of
^ Z n  in the exocrine tissue, in the first 24 h which then
rapidly decreased. In contrast,,over the four day period
65" of observation ^Zn concentration m  the islet tissue
increased slowly •, and then achieved higher levels than
the exocrine tissue. The intravenous dose of zinc, 900 jug
per 200 g rat, used Ih. this study is far in eccess of the
normal levels of zinc absorbed from the diet. These studies
using the light microscope were unable to demonstrate any
preferential localisation within the cell in either the
pancreas or the liver. In the kidney, ^ Z n  localised more
in the cortex than in the medulla (Meschan et al., 1959)♦
65In the human prostate ^Zn localises in the holocrine as
well as apocrine follicles (Siegel et al., 1961). In the 
65
cat prostate, ^Zn localisation has been demonstrated 
in the apical areas of the acinar cells along the luminal 
border and in the follicular lumen (Elizabeth, 1970).
The fractional centrifugation method has been used 
to Study the distribution of endogenous zinc as well as 
^ Z n  within the cell. Thiers and Yallee (1957) found that 
endogenous zinc was present in all the subcellular fractions 
ofrat liver, with highest amounts in the cytoplasm, 43%, 
and less in nuclei, 37%» microsomes, 12.9%» and mitochondria, 
4.4% ^ Z n  distributes similarly in the rat liver (Cotzias 
& Papavasilow, 1964). Subcellular fractions ofrat and monkey
-13-
prostate gland (Kar & Chowdhry,1966 ) showed similar 
distribution of ^Zn, follov;ing administration of .^ZnClg* 
Suso and Edwards (1971) studying the ^ Z n  distribution in
the subcellular fractions of chicken duodenal mucosal
- • 65cells found a similarity in the distribution of ^Zn after
65oral dosing and when ^ZnC^ is added to the homogenate 
of non-dosed birds.
1-2-6 Zinc in blood
Zinc is a constant constituent of blood and human 
whole blood normally contains 880 + 200 jug zinc/100 ml 
(Valee, 1962). In the rat the normal level is 388 + 22 jug 
zinc/100 ml (Gilbert & Taylor, 1956). In both species 
approx. 12% of the total zinc in blood is found in the
‘s
plasma, while most (79%) is in the erythrocytes. Rabbit
65erythrocytes, labelled in vivo with ^Zn, lost the
radioactivity from the intact cell cytoplasm, when they
were suspended in plasma (Dennes et al., 1962). When
equine erythrocytes \ere incubated in isotonic saline
-solutions also containing ^ Z n C ^ ,  approx. 30% of *^Zn
became localised within the erythrocyte cytoplasm in on©
hour (Sivasarma et al., 1959)." It was not shown whether
65cells suspended in blood plasma containing ^ZnC^ could 
concentrate the isotope to the same extent* Nevertheless, 
reversible exchange of zinc may take place between the 
erythrocytes and plasma under normal circumstances in 
the body.
Gilbert and Taylor (1956), labelled rat serum with
-14-
^ZnClg and administered the serum to rats. The ^ Z n  was 
cleared from the blood stream. The exponential clearance 
curve revealed two components (tq 3*25 h and tQ 203 h). 
Molecular associations between zinc and constituents in 
rabbit plasma have been demonstrated by equilibrium dialysis 
(Dennes et al., 1962). ^ Z n  in blood plasma of chickens 
obtained 2 h after dosage from various routes could not be 
removed by dialysis against distilled water at 3° (Suso & 
Edwards, 1971)* ^ Z n  binding proteins have been examined 
in the rabbit serum by (WH^)S0^ precipitation and low 
temperature Cohn fractionation by Dennes et al. (1962), 
in human serum by starch gel electrophoresis and immuno- 
electrophoresis (Boyett & Sullivan, 1970), and in chicken 
plasma by Sephadex chromatography (Suso & Edwards, 1971)*
Their work has shown that:
(a) Zinc is found in association with a number 
of plasma proteins.
.-(b) Zinc is consistently bound to albumin, 
transferrin and c^-raacroglobulin.
(c) The highest amount of serum zinc is bound 
to albumin, about 60%.
(d) In disease the amount of zinc bound to albumin 
varies, but the fraction bound to transferrin 
and dCr-2macroglobulin remains constant.
The albumin-bound zinc is believed to exchange with tissue zinc. 
At present there is no conclusive evidence for a specific 
transport protein for zinc transport like those for Cu 
and Fe.
-15-
1-2-7 Excretion
65The removal of ^Zn from 1he whole body has been
assessed by monitoring the radioactivity remaining in
65the body at different time intervals after ^Zn injection. 
Ballou and Thompson (1961) determined this for the Sprague- 
Dawley rat after injection of 5pCi of ^ Z n C ^  (= 5 to 10 pg 
zinc), and found that the radioactivity wasremoved from 
the body in an exponential manner. The exponential curve 
was resolved into two components of biological tQ ^=6.28 
and 215 days.
Irrespective of the-route of administration, the 
gastro-intestinal tract acts as the jaajor route for 
zinc excretion (Cotzias et ad., 1962). The amount of 
radioactivity recovered in the excreta after intravenous 
65^Zn administration has been used as a means of indicating 
the gross metabolic turnover of zinc (Sheline et al., 19^3)• 
The excretion of zinc in the faeces with smaller amounts 
in the-urine has been demonstrated after parenteral 
administration of ^ Z n C ^  in mice (Cotzias et al., 1962), 
rats (Mcjsaac, 1955) and in dogs (Montgomery et ad., /!94-3).. 
and the results are given in Table 1-5* The dose levels 
in these studies are not comparable, hence, the results 
cannot be compared accurately._ However,, a marked species 
variation in the faecal secretion of ^ Z n  is evident. This 
may also indicate a higher turnover rate of zinc in the 
lower species.. In Khristov's study on rats, the higher 
faecal secretion (26%) in comparison with Mclsaac's figure 
(16%), may be due to differences in dose levels, variation
-16-
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in dietary zinc or to strain differences.
65The altered faecal excretion of a test dose of ^Zn
^ZnCl^), after the addition of known amounts of unlabelled
zinc to the diet of mice, rats and cattle is shown in
Table 1-6. Addition of added unlabelled zinc to the
diet increased the faecal excretion of orally administered 
65-'Zn in rats and cattle. The study in mice using intra-
65peritoneally administered ^ZnC^ resulted in an
65increase in the faecal excretion of ^Zn. Cotzias et al.
(1962) explained this result, by suggesting the presence
of a homeostatic mechanism controlling both absorption
and excretion of zinc in the gut.
Montgomery et al. (194-3)) studied the secretion of
65intravenously injected ^Zn into the duodenum in dogs.
In the first 23 h duodenal aspirates, free of bile and 
pancreatic juice, obtained from an isolated duodenal loop 
contained 0.2 to 0.4-%, hepatic bile 0.03%) and the pancreatic 
juice 1.2% of the dose. During the seven day period after 
the ^ Z n  injection the following amounts of ^ Z n  were 
recovered
(a) Pancreatic juice, 3 to 7%
(b) Bile, 0.4-%
(c) Duodenal aspirates, 3%
Birnstingl et al. (1937),-in a~ similar study, confirmed
the above findings and also showed that both bile and
63
pancreatic juice contained Zn as early as 15 min following 
injection. '
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1-2-8 Biochemical functions of zinc
The presence of zinc in a variety of metallo- 
proteins with enzyme activity, the requirement of zinc 
for the catalytic action of another group of enzymes and 
the importance of zinc in maintaining the structural 
integrity of certain other macromolecules make this 
element vital for normal ©ell function (Vallee, 1952;
Prasad, 1966; Parisi & Vallee, 1969 and O'Dell & Campbell, 
1970).
Zinc ions are associated with DNA in vivo, and 
are found in stoichiometric ratios with purified DNA 
preparations (Mahler & Cordes,1971 )• It is believed 
that Zn^+and other divalent cations such as Co^+ , Mn^+ ,
p  p
Cu , and Pe + maintain the electrical neutrality of the 
nucleic acids. Nuclear and octra-nuclear ENA also contain 
zinc which is responsible for maintaining the correct 
configuration of the ENA molecule (Wacker & Vallee, 1959)* 
"Glutamate dehydrogenase and malate dehydrogenase, 
two mitochondrial respiratory chain enzymes* are zinc 
,metalioenzymes Glutamate dehydrogenase (mol.wt.1,000,000)
contains 2 to 6 g-atoms of zinc per mol which is essential 
for its activity (Adelstein & Vallee, 1958). Malate 
dehydrogenase (mol.wt.40,000)-*--of bovine cardiac muscle 
contains i g-atom of zinc per mol (Harrison, 1963)*
Dunn et al. (1969) found that horse alcohol dehydrogenase 
(mol.wt. 80,000) contains 3*1 to 4.3 g-atoms of zinc per 
mol and that removal of the zinc causes denaturation. 
Alkaline phosphatase also contains zinc, and is present
-20-
in high levels in bone, intestinal mucosa, kidney- 
(Stadtman, 1961) and most body flucPs. A zinc requiring 
alkaline phosphatase has been found in the ventral lobe 
of the rat prostate (Hopkin & Wakely, 1961)♦ Recently, a 
zinc"containing alkaline phosphatase has been isolated 
from leucocytes (Dechatelet et al., 1971). Carbonic
'n
- ahydrase (mol.wt. 30,000), containing 1 g-atom of zinc 
per mol has been isolated from mammalian erythrocytes 
(Keilin & Mann, 194-0 and Duff & Coleman, 1966). Pancreatic 
carboxypeptidase-A and B, (mol.wt.34-,000) containing 1 g-atom 
of zinc per mol has been isolated from the bovine and porcine 
pancreas (Vallee & Neurath, 1954- and Wintersberger et al.,
3-962).
2+Zn has been shown to activate several other enzymes
s
in vitro such as glycylglycine dipeptidase, arginase, 
histidine deaminase, and oxaloacetate decarboxylase 
(Parisi & Vallee, 1969).
In several of these enzymes zinc is known to function 
the
as a part ofAactive site by linking the substrate and co­
enzyme to the protein. It achieves this by causing alterations 
in the tertiary structure of the protein by bringing the 
groups that constitute the active centre into close proximity. 
This has been demonstrated for carboxypeptidase-A (Vallee,
1964-) and carbonic, anhydrase (Coleman, 1967). The role 
of Zn in carboxypeptidase as postulated by Vallee (1964-) 
is given in Pig. 1. -
Zinc also stabilizes the quarternary structure of 
horse liver alcohol dehydrogenase (Oppenheimer et al., 196?)♦
-21-
Zinc is therefore important in the enzymes concerned with 
digestion, cellular respiration, gaseous transport and 
intracellular energy metabolism. -
Zinc containing metallo-proteins such as metallothionein 
(Pulido et ad;*, 1966) and cytocupreins (Carrico and Deutsch, 
1970) with as yet undefined biochemical functions have been 
isolated and purified.
i
Fig.1. The active centre of carboxypeptidase.
Zn^+ is bound to cysteine sulphur atom (S”) and 
asparagine nitrogen atom (N) of the enzyme. -A and B are 
proton and electron donor groups of the enzyme. The 
binding of a terminal dipeptide to Zm^* and to the protein 
moiety of the enzyme is shown.
Zinc is required for the crystallisation of insulin 
but there is no evidence available to suggest a zinc 
requirement for insulin action. Blundell, Hodgkin et al. 
(1971) noted that insulins from animals other than guinea- 
pig and coypu are stored as zinc-insulin hexamers in the 
granules of the p>-cells of the pancreatic islets. Therefore 
zinc may be required for the polymerisation of the insulin 
molecule for storage.
The high content, of zinc in the cc-cells of duck 
pancreas, and the production of more glucagon in this 
species than in other vertebrates led Weitzel et al.(1956) to 
suggest a zinc-glucagon relationship similar to that 
of zinc and insulin.
Flynn et al. (1972) studying the effect of zinc on 
in vitro corticosterone production by rat adrenal slices 
found that chelation of zinc with dimethyl thiocarbamate 
lowered the production of this hormone. They also showed 
that zinc ions form complexes with ACTH. The requirement 
of zinc in the function of gonadotrophin and growth hormone 
has been proposed. '—
1-2-9 Zinc and the malignant cell
Zinc is essential for the normal proliferative
process (Westmoreland, 1971) and is also required for
tumour growth (Petering et al., 1967). Following injection,
65^Zn accumulates preferentially in spontaneous C^H mammary- 
adenocarcinoma and dibenzanthracene-induced spindle cell 
sarcoma of mice (Heath & Liquier-Milward, 1950). The presence 
of melanoma in mice reduced the loss of intraperitoneally
. -23-
65injected ^Zn from the body. The control animals excreted 
more than 60% of the dose and the tumour bearers .less than 
50%, in 13 days (Prasad et al., 1969). Experimental " zinc 
deficiency in rats caused a marked growth retardation of 
the transplanted Walker carcinosarcoma and increased the 
survival time (HcQuitty et al., 1970).
In humans low serum zinc levels have been reported 
in bronchial carcinoma (Davies et al., 1968), leukemia 
and Hodgkiris disease (Dunn et al., 1969). In benign 
prostatic hyperplasia zinc concentration in the affected 
areas of the prostate gland has been found to be increased 
above the amount of zinc in histologically recognisable 
normal adjacent tissue (Schrodt et al., 1964). Siegel et al*
(1961) showed an increased uptake of ^ Z n  in the benign 
hyperplastic prostate gland in comparison with normal
gland.
Increasedtate of mitosis, and a demand for increased 
protein synthesis, may be the cause of increased zinc 
requirement by the tumour cells.
1-2-10 The use ofradioactive zinc in scanning for 
tumours of the pancreas and prostate gland
Zinc in its radioactive -forms has been utilized
for pancreatic and prostatic scanning by gamma-ray scintigraphy.
62Of the radionuclides of zinc, Zn (tQ ^ = 9*2 h) and
69nwn (t
v 0.3 = 13.8 h) are preferred for clinical use owing 
to their short physical half-lives and suitable gamma-ray v
emissions,
-24-.
^ Z n  with a long physical half-life (265 days) and'a high 
penetrating gamma-radiation O.lliev), presents a health risk 
It was used, however, for clinical trials until the new 
nuclides became available.
The high concentration of *^Zn found in the pancreas 
of several experimental animals after intravenous injection
65
of ZnCl^ kas been the basis for selecting ^ Z n  for
pancreatic scanning. Meschan et al. (1959) using 100 juCi
65of intravenous Z^nO'lg failed to visualise the pancreas
of the dog, although external counting over the pancreatic
area showed 20% of the dose administered. However, biopsy
samples of pancreas contained only 5-6% of the dose,
during 2 to 8 h. This implies that approx. 14-17% of the
radioactivity detected over the pancreatic area originated
in other tissues, principally in the liver. Cottrall
and Taylor (1970) utilised zn, a less penetrating, lower
energy (0.511 MeV) gamma-ray emitter and concluded-that the
levels^of mdioactivity present in the abdomen of humans
621-8 h after 250 juCi of intravenous ZnC^ was so great
_ 62 
as to preclude the use of Zn for pancreatic scanning.
During this period radioactivity in the liver was estimated
to be approx. 44% of the dose. The stimulation of pancreatic
secretion in the rat, by pancreozymin or secretin or the
complexing of zinc by glycine or tryptophan failed to alter
62the pancreas/liver ratio of Zn to an extent sufficient 
for clinical work (Cottrall & Taylor, 1970).
The high levels of zinc detected in the prostate 
gland in normal and hyperplastic conditions have spurred
-25-
the use of radionuclides of zinc for visualisation of 
this gland. In benign prostatic hyperplasia zinc content 
and the ^^Zn uptake by the prostate gland is increased,
but in carcinomatous changes of the prostate, a distinct
— 65fall in the zinc content and reduced uptake of has
been reported (Rossoff & Spencer, 1965 and Gyorkey et al.,
- 1967). On the basis of these observations ^ mZnCl2
(Johnston et al., 1968) has been used to distinguish
carcinoma and other prostatic diseases. High concentrations
of ^ Z n  in the prostate gland of humans following intravenous 
65^Zn has been shown to occur only after about two weeks 
(Spencer et .al., 1965 and 1966), but such time intervals 
are not suitable for scanning with ^ Z n  or with ^ mZn due 
to rapid radioactive decay of these nuclides. Also, a
N
long delay in a diagnostic procedure is not acceptable and 
therefore, methods of augmenting prostatic uptake of nuclides 
of zinc have been attempted. Johnston et al. (1968) 
administered pilocarpine to dogs to induce prostatic fluid 
flow and Prout et al. (195$) treated dogs with testosterone 
propionate and demonstrated^enhanced ^^Zn uptake by the 
prostate gland of the dog. These agents have not been 
reported * to be used in patients. •
Because of the lack of specific tissue localisation, 
nuclides of zinc have noir'been successful as scanning agents 
in clinical diagnosis of pancreatic and prostatic disease.
1-2-11 The use of oral zinc sulphate supplementation 
in medicine
The observation that porcine parakeratosis was induced
-26-
by feeding a low zinc diet (Vallee, 1962) and that a 
skin injury in a zinc-deficient calf failed to heal for 
a long period (Miller et al., 1965) led to further work 
suggesting a role for zinc in wound healing. Savlov et al.
(1962) demonstrated that ^ Z n  accumulated at the site of 
skin and muscle repair and a similar observation for the 
healing of experimental arterial wounds was reported by 
Strain et al. (1968). These observations led to the 
administration of ZnSO^ to assist in wound healing as 
reported by Greaves and Skillen (1970) and Lavy (1972).
Greaves & Skillen (1970) administered 660 mg. ZnSO^.7H^0
orally, per day over a period of months to patients 
with venous leg ulcers and demonstrated satisfactory 
healing. The dose was approx. 60 times the normal daily
N,
zinc intake and plasma zinc levels were 25% above the 
normal in the majority of patients after 16 weeks of 
therapy, but no abnormalities were observed in liver 
function tests. In the study on rats Lavy (1972) administered 
20 mg. ZnSO^E^O orally for 15 days after abdominal surgery 
-.and reported improved wound healing.
Pell et al. (1975) administered ^ Z n  intravenously 
20 days prior to total hip replacement in humans and 
demonstrated increased urinary ^ Z n  and stable zinc excretion 
post-operatively which they claimed was derived from muscle 
tissue. In 1971» Westmoreland showed that connective 
tissue regeneration required zinc.. The increased excretion 
of zinc after trauma or the increased zinc required for 
regenerative processes are possibly compensated for by the
-27-
ZnSO^ therapy. Oral zinc has also been reported to be 
beneficial in cases of zinc malabsorption, growth failure, 
retarded development, *hypogonadal dwarfism* (Prasad, 1966) 
and in porphyria.
-28-
1-5 Gallium
1-5-1 Introduction
Gallium first came to the attention of Mendeleeff 
in 1871, who correctly predicted its occurrence and also 
outlined some of its physical and chemical properties even 
before it was discovered. Gallium was first isolated by 
Boisbaudran from a zinc ore in 1875* It ranks 57th among 
the elements in abundance on the earth’s crust and occurs 
at a concentration of approx. 10“^  per cent. Its presence 
in plants and animals and man has been noted by several 
workers including Belozerov (1965)* Whether trace amounts 
of gallium have a biochemical role or whether it is an 
anutrient has not been reported.
1-5-2 Absorption, tissue distribution and excretion
Enteric absorption of gallium is poor. Dudley and
Levine (194-9) showed this by feeding rats with gallium chloride,
gallium lactate and gallium citrate in the diet at a level of
1000 p.p.m gallium. Only traces of gallium have been detected
in the bone and almost none in Us sues such as the liver kidney
and spleen. In the laboratory rat, tissue distribution studies
72following intravenous injection of stable gallium, ' Ga 
containing stable gallium and carrie r-f re e^Ga have been reported*.
Most inorganic salts of-gallium are known to hydrolyse 
at physiological pH, in aqueous solution. Hence, GaCl^ 
dissolved in 15% to 20% citric acid solution has been used for
tissue distribution studies and clinical trials (Brunner et al.,
a _
1953* &&& Perkinson et al., 1953)* It is believed that a
complex is formed by mixing GaCl^ with citric acid, which. will
be referred to as gallium citrate and this has the following
-29-
properties:
a) The citrate moiety maintains Ga*' in solution,
b) The citrate is metabolisable,
c) The citrate is believed to sustain the release
of Ga^ following administration,
d) The gallium citrate is stable under conditions of
^ sterilisation by autoclaving (120°C at 15 p.s.i.)
Brunner et al. (1953) using ^GaCl^ in 15% citric
acid solution studied the tissue distribution of ^ G a  in
the rat. The 'Ga preparation did not contain stable carrier
gallium above thejlimit of detection (2 x lCT^g gallium/ml).
Following the intravenous administration of trace quantities 
67nearly 45% of 'Ga was retained in the body for 20 days.
At 24 h, 79% of ^ G a  was retained in the body of which approx. 
21% was localised in the liver and 26% in the skeleton.
Over the 20 days no appreciable quantities were lost from 
the skeleton but the liver lost most ^Ga. When stable 
gallium was added to the trace dose of ^ G a  the amount of
^ G a  retained in the body was decreased. For example, 5
67 -3days after an intravenous dose of YGa containing 2.5 x 10 ^g
gallium/kg, 60% of the ^ G a  was retained whereas only 18.5%
was retained when the carrier level was raised to 25 mg
gallium/kg. The decreased retention of ^ G a  was observed in
both liver and skeleton although the effect in the latter
72
was less marked. Similar results were obtained with/ Ga 
indicating that there was~ no discrimination between isotopic 
forms of gallium and that the results were due to the 
different dose levels used.
-30-
The results of these studies are summarised in the 
Table below
Table 1-7 The effect of carrier stable gallium on 
^ G a  citrate and ^ G a  citrate 
distribution in the rat
Gallium concentration
(mg/kg) 26 C.P.* 25
Nuclide ?2Ga 6?Ga 6?Ga
Day of sacrifice
after injection 4 5 5
Number of animals 5 4 4
* *
Tissue radioactivity
Liver 0.91 5.81 0.98
Skeleton 20.9 21.6 15-7
Spleen 0.07 1.66 0.13
Blood 0.14 0.25 0.07
Reference 1 2 2
* Carrier-free . •
** as a.per cent, of injected dose in the whole organ
References:- 1. Brunner et al., 1953 a
2. Brunner et al.,1953b
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Four hours after the intravenous administration of
gallium high concentrations were observed in the kidneys
but the gallium levels decreased rapidly due to urinary
67excretion. With tracer doses of carrier-free 'Ga similar 
amounts of radioactivity were excreted in both urine and 
faeces, but the presence of carrier gallium above 0.25 mg/kg, 
increased the urine/faeces ratio, reaching a value of 10 
at a carrier level of 25-mg gallium/kg.
1-5-3 ^ G a  plasma protein binding
^ G a  binding,by constituents of blood has been 
studied by Hartman Hayes (1969). In an in vitro 
system with rabbit serum labelled with ^ G a  citrate 
containing known amounts of stable gallium varying 
between 1.0 x 10  ^jumol to 10.0 jumol, they established 
the following facts:
67a) The percentage 'Ga citrate bound by rabbit 
serum decreased at concentrations above 3*6 x 10~ 
jumol gallium/10 ml of serum. Below this concentration 
k^Ga was bound to an extent of over 91%.
b) The absolute amount of ^ G a  bound increased 
up to 1.4 jumol gallium/lOml, after which ^ G a  
binding was lowered.'
c) ^ G a  binding was not affected by citrate up 
to a concentration of 6.6 pmol citrate/10 ml 
serum.
67d) The percentage of 'Ga bound, was not affected-
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between pH 7*5 and 8.0 but below pH 7«4 binding 
decreased.
e) The gallium binding components in plasma at
^ a concentration of 1.0 x 10~^ jumol gallium/lOml 
serum are not ultrafiltrable through a membrane 
with a mol.wt. cut-off of 10,000.
f) ^ G a  was eluted in association with 280nm 
absorbing molecules excluded from Sephadex 
G-25 gel.
g) The percentage binding obtained by gel-filtration 
(approx* 60%) was lower than that obtained by 
equilibrium dialysis (90%).
Ito et alv (197Q) using Sephadex G-75 gels chromato­
graphed blood sera obtained from rabbits following intravenous 
^ G a  citrate and found also that ^ G a  was eluted in association 
with proteins. Although these studies indicate that gallium 
interacts with serum proteins, the binding proteins were 
not identified.
1-3-4 Subcellular I ocalisation of ^ G a
Ito et al. (1970) and Becker et al. (1972)
studied the distribution of ^ G a  in the cell organelles 0f
rabbit and rat'.liver following intravenous injection of
^ G a  citrate. The soluble as well as particulate fractions
contained gallium with the highest amount found in the
soluble and nuclear fractions. Light microscopic autoradio-
67graphy showed a high -Ga localisation in macrophages of
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the lymphoreticular tissue and also Kupffer cells and 
polygonal cells in the liver of rats (Swartzendrub^er 
et al., 1970). Electron microscopic autoradiography 
showed ^ G a  localisation in lysosomes, in lysosome-rich 
cells such as the macrophages, hepatocytes and the proximal 
convoluted tubular cells of the irat kidney (Swartzendrubller,
et al.(1972)•
\
1-3-5 The affinity of cancer cell for gallium
^ G a  localisation in a number of transplantable
tumours in mice andjrats (Hayes et al., 1970) aad rabbits
(Ito et al., 1971) have been reported. Hayes et al. (1970)
reported ^ G a  localisation in spontaneous mammary tumours
of C^H mice and in hyperplastic thymus of the AKR/J mice
which became spontaneously leukemic. Ito et al. (1971)
67
showed that more Ga was located in the nuclear fraction 
than in the soluble fraction of tumour cells from VX-2 
epidermoid carcinoma of rabbit. Similar results were 
obtained by Bickel and Hanson (1972) with JBI plasmocytoma 
ascites, cells of nts and they also demonstrated that these 
cells concentrated gallium during the rapid growth phase.
This is in agreement with the findings of Hayes et al. (1970) 
and Nash ejb al.(l972) that Ga concentrates mainly in 
viable tumour cells rather than in necrotic zones. The 
suppression of tumor growth by radiotherapy (Yaidya et al., 
1970) and chemotherapy (Heidenreich et al., 1972) decreased 
the uptake of ^ G a  by the tumour. The affinity of the 
tumour cell for gallium was also shown by Hart et al. (1972)
-34-
who observed an antitumour effect of GaCNO^^.QI^O in 
a number of solid tumours grown in mice and rats.
67
1-3-6 The use of Ga as a tumour scanning 
agent
Compounds of gallium have rarely been considered
in diagnostic or therapeutic medicine but Dudley and Kaddox
(194-9) envisaged its application in the form of ^ G a
citrate as a radio-therapeutic agent in the suppression
of osseous tumours in the bone. In clinical trials Edwards
& Hayes (1969 & 1970) used cyclotron-produced ^ G a  citrate
and showed an affinity of gallium for soft tissue tumours.
In later trials a variety of tumours including bronchial
carcinoma, gastric carcinoma and malignant melanoma have
67been shown to concentrate 'Ga (Ito et al., 1971? Lavender
et al., 1971 and Langhammer et al.) 197 2 ) In Hodgkin's
disease ^ G a  accumulated in the lymph nodes (Edwards &
Hayes'^ 1970). ^ G a  Localisation in inflammatory lesions
was initially reported by Lavender et al. (1971)* Recently,
Blair et al. (1973) observed gallium localisation in
experimental staphylococcal abscesses in the rat and suggested
that ^ G a  citrate may be of use in locating deep seated
67abscesses in man. 'Ga. citrate is not therefore specific
67for tumours only. The mechanism of 'Ga localisation in 
tumours or abscesses is not known.
1-3-7 Toxicity of gallium
Dudley et al. (1950) gave the following results,-
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for the ten day DD^q , following subcutaneous gallium 
citrate.
Species LD^(mg Ga/kg body weight)
Mouse 600
Rat 100
Rabbit 4-5
Dog 15
These results show that gallium toxicity is 
species dependent with a higher toxicity in the higher 
animals. Gallium chloride and gallium lactate in the diet
N
of rats at a level of 15 to 20 mg gallium per day up to 
26 weeks failed to manifest any toxic symptoms and Dudley 
and Levine (194-9) concluded that gallium compounds such 
as the chloride, lactate and citrate offer little hazard 
as an ingested poison. Intravenous gallium lactate, at 
a dose level of 20 mg Ga/kg body weight produced toxic 
symptoms in the rat. In this species toxicity of gallium 
citrate is less than gallium lactate as shown by the ten 
day 220mg Ga/kg body weight for gallium citrate and
4-6 mg Ga/kg body weight for gallium lactate (Brunner 
et al., 1933)•
Acute intravenous dosing of gallium citrate in 
rats (220 mg Ga/kg), in dogs (35 mg Ga/kg) and chronic 
dosing (2.5-lag Ga/kg) twice a week in the rat for a long
-56-
period produced lesions in the kidney, lymph nodes and
spleen in both species. Polymorphonuclear lymphocyte
infiltration in the lymph nodes was pronounced (Brunner 
b
et al., 1953)* Areas of high lymphocyte .infiltration 
contained little gallium. Symptoms like those due to 
common metal poisoning such as diarrhoea, albuminuria, 
anorexia have been noticed in experimental gallium 
poisoning in the above studies. Although a knowledge 
of gallium poisoning is of interest, toxicity due to 
carrier-free doses of ^Ga, 4 x lCT1^ jumol ^Ga/human, 
used in tumour scanning, is unlikely to occur.
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1-4 Aims of the present work
From the review given in this Chapter, it is clear 
that the basic outlines of the metabolism of zinc have been 
worked out. The accumulated evidence in this field is now 
sufficient to allow one to seek more precise information 
on the metabolism of this trace element at the cellular 
level, with a clearer insight into the absorption, 
transformation (i.e. incorporation into other molecules) 
and removal from the cell. It is believed that such 
investigations should throw light on its role in life-processes 
in health and disease. A thorough understanding of the 
behaviour of zinc may be of importance in the development 
of radio-zinc-pharmaceuticals, whose differential absorption 
would enable scanning of organs and tissues with increasing 
accuracy- and precision.
65Initial studies utilised the then available 'Zn 
preparations which in most instances contained a high level 
of stable carrier zinc. It appears that the doses of zinc 
used in experiments with small animals were in excess of 
physiological amounts, and hence the stable carrier zinc
would have influenced the observed behaviour of ^Zn.
65Therefore, a high specific activity 'Zn preparation was 
utilised to obtain sub-physiological zinc.doses, which 
were used to investigate further the tissue distribution, 
metabolism and excretion of zinc.
^ G a  is a new radio-diagnostic agent which is used
in clinical trials for tumour scanning. Knowledge of the
behaviour of gallium in the body is scant and therefore the 
tissue distribution and excretion of gallium have been invest­
igated.
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C H A P T E R  2
EXCRETION OF ZINC
2-1 Introduction
The pharmacokinetic aspects of ^ Z n  have been
reviewed in Chapter 1. Most of these studies by other
workers have utilised high levels of non-radioactive
65zinc accompanying the trace dose of 'Zn. It is conceivable
that the carrier zinc influenced the observed behaviour
of ^ Z n  which therefore may not have behaved physiologically. 
65'Zn doses in this study contained minute amounts of carrier 
zinc and can be considered as sub-physiological amounts.
N
This study was conducted to reveal the excretion of
65sub-physiological doses of ^Zn and consisted of five 
fundamental investigations:- 
Whole body counting,
Faecal accretion,
Urinary excretion,
65Faecal and urinary excretion of 'Zn when 
Additional oral ZnSO^ is given ~
Biliary and pancreatic excretion.
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2-2. Animal experimentation
2-2-1 * Animal maintenance
Male Wistar strain rats were used and were obtained 
from"the Royal Postgraduate Medical School animal house, 
four weeks prior to their use. Normal healthy tats were 
selected of weight 2350 + 25 g at 11 - 12 weeks of age.
During the four weeks in the laboratory the rats 
were kept in a small room with adequate ventilation 
at a temperature of 70 - 72°F. Although the humidity was 
not controlled, occasional checks showed that the relative 
humidity was about 50%. Rats were exposed to 12 h light 
periods (9 a.m. - ^ p.m.).
During the pre-experimental period the mtsvere
N.
housed in plastic cages (NKP Gages, Kent). The cages 
had stainless steel roofs and wire floors which, were 
elevated to prevent rbody contamination of mdioactive 
excreta after dosing.
Groups of four animals were trained for a period 
of four weeks to semi-restrained conditions in metabolism 
cages, which were made of perspex and contained a cylindrical 
living compartment of dimensions 20 x 30 cm, with a perspex 
lid. The floor was made ofstainless steel wire coated with 
perspex. A removable perspex separator was fitted to allow 
separation of solid and liquid excreta.
During the ^ Z n  studies the cages were cleaned and 
decontaminated by washing the whole cage in tap water. The 
separators were treated with 1% EDTA solution and subsequently 
dipped in 1% ZnSO^ solution. This procedureras adopted to 
minimise ^ Z n  contamination.
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Other animals were trained to acute restraint, 
four weeks prior to bile duct cannulation. The standard 
restraining cages were constructed out of perspex with 
perspex coated wire floors and roofs.
Animals in all restraining cages were removed 
from the cage once a day, during the pre-experimental 
- as well as the experimental period, and allowed to clean 
themselves.
Rats were given a pellet diet 41B ( Dixon & Son 
Ltd., Herts. ). The food hoppers were filled at 7 p*m. and 
the remaining food was removed at 9 a.m. next day. The 
diet was cited by the manufacturer to contain the following 
mineral composition
Element Composition
( pg/kg diet )
6.1 x 106 
1.7 x 106
e.-Tx 10^
6 x 10^
15 x 105 
55 x 105 
73
The daily consumption of solid food in a group of 
six rats weighing 230 + 5 S was checked. These consumed 
24 - 30 g of food per night which represents a daily 
intake of zinc of 350 - 450 jpg .
Ca
Mg
Fe
Cu
Zn
Mn
Co
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2-2-2 Anaesthesia
Anaesthesia was performed using diethyl ether,
—4cotaining 3 x 10 % pyrogallol as an antioxidant ( Hospital
Pharmaceutical Dept. ). Hats were made to. inhale ether 
vapour by keeping them in a stream of air bubbled through 
ether. Isotope injection was carried out under light 
ether anaesthesia, indicated by a respiratory rate of 
100 - 110 per min. In bile duct cannulation, an operation 
which takes approx. 45 min, rats were kept under fairly 
deep anaesthesia, and a respiratory rate of 90 - 100 
per min was maintained by 1 - 2  min exposure to ether at 
approx. 10 min intervals. In tissue distribution studies 
animals were deeply anaesthetised, with a respiratory 
rate of less than 70 per min prior to sacrifice. Wherever 
possible ether inhalation was kept to a minimum.
2«2-*3 Cannulation of the bile duct
In Wistar rats visual examination shows that 
a
the bile duct is embeded in the distal four fifths of
A
the pancreatic tissue.In this study, the anatomy of the 
pancreatic ducts with regard to the opening into the 
common bile duct was ascertained as follows:-
(a) The bile duct was ligated about half a 
centimetre below the hilus of the liver, at a point where 
the pancreatic tissue no longer surrounds the bile duct.
(b) Indian-ink was gently injected from the 
duodenal end of the common bile duct.
(c) Pancreatic tissue was carefully excised from 
the omentum and freed from the overlying adipose tissue
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by immersing the preparation in a mixture of acetone: 
ether (1:1).
(d)* The fat-free preparation was stained with 
1% eosin solution and flattened out on a glass plate.
The ink entered the pancreatic tissue through 
at least two large ducts and a number of csmall ducts 
(see Fig. 2.1). Fig* 2.2. shows the positions where 
cannulae were inserted in the bile duct for the collection 
of either bile or bile and pancreatic fluid.
Cannulations were performed between 8 - 10 a.m. 
on animals starved for 24- h before the operation. A 
polythene cannula of i.d. 0.028 cm and o.d. 0.061 cm 
(Portex, Kent), cleaned free of foreign particles with 
95% ethanol, was bevelled and smoothed by heat at one
v
end. An grea on the right ventro-lateral aspect, below 
the rib-cage of the animal was closely clipped and cleaned 
with cotton wool soaked with methanol. An oblique 
incision 2.5 - 5*0 cm, long was made from the xiphisternum 
towards the lateral line. The duodenal loop was moved 
posteriorly to/visualise thejbile duct. The bile duct 
was held anterior to the pancreatic tissue with thin 
silk thread (Mersilk) and the duct gently pulled back 
with the free ends of the thread. While holding it 
in position, an incision "was made on the bile duct and 
the beVelled end of the cannula was guided into it 
with the aid of fine foreeps. The cannula was secured 
in position with two knots on either side of the 
incision. For the collection of combined bile and
-45-
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(position B) in the common bile duct of the 
Wistar rat.
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pancreatic fluid, the bile duct was ligated at a point 
very near the duodenum. The cannula was guided about half 
a centimetre along the bile duct and secured.
For both procedures, the free end of the cannula 
was^guided to the exterior through the lumen of a gauge 19 
injection needle introduced into the peritoneal cavity 
from a mid-dorsal position of the animal. The pancreatic 
tissue was irrigated with sterile, 0.9% NaCl solution at 
37; The surplus solution was later removed by tilting 
the animal to its right side. This procedure was adopted 
to wash bile and pancreatic fluid from the areas contaminated ~ 
with' these fluids,which happened when the bile duct was 
incised. opening of the abdomen was sutured in
three layers and the area was sealed with a surgical 
spray, Nobecutane ( B.D.H. ).
A supplement of 2.3% glucose and 0.9% NaCl was 
added to the drinking water of the cannulated animals.
Pellet food was given in the normal manner.
^ During the operative procedure care was 
taken to: -
, (a) Avoid handling the liver, the pancreas and
duodenum.
(b) Avoid application of undue pressure on these 
organs due to excess leverage-on the bile duct.
This procedure prevented exposure of abdominal 
viscera. The post-surgical recovery appeared to be very 
satisfactory. At the termination of the study, four days 
later, histological sections of the liver showed bile duct
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proliferation, but no signs of ascending infection or 
inflammatory reactions of the liver w e r e  recorded.
The rats were allowed to recover for 24 h before 
experimentation.
2-2-4 Iiethod of injection
'The test compounds were injected into the right 
lateral caudal vein ( i.v. ) using a gauge 20 needle. The 
radioactive solution was gently forced into the vein 
over a period of 2 min. A volume of blood equal to the 
total injectate was withdrawn, and slowly fed back into 
the vein. The injection area was washed to remove any
Tf
radioactivity. If extravasation occurAed, as indicated by 
poor blood flow into and out of the syringe, the animals 
were not used for further experimentation. Failures due 
to imperfect injections were about 10%.
2-2-3 Sample collection
Faeces and urine were obtained from the animals 
kept in metabolism cages, the daily faecal samples being 
collected in polythene bags. Faeces were then dried in an 
oven at 120°C for 24 h on a watch glass. These were 
transferred in one gram amounts into counting vials.
Urine samples were collected directly into weighed 
counting .vials and at the end of each 24 h period 
the vials were reweighed, and one gram amounts v/ere placed 
into separate vials for radioactivity measurements.
File, and bile and pancreatic fluid samples were 
collected hourly in weighed polythene containers
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in an automatic fraction collector. Precautions were 
taken to minimise evaporational losses from the containers 
by using caps perforated in two places to introduce the 
bile duct cannula and to allow the passage of air.
2-3 " Radioactivity measurement
2-3-1 Ionisation chamber
A high pressure ionisation chamber (Twentieth
Century Electronics Ltd., Surrey) was used to measure the
radioactivity of stock solutions, in order to ascertain
the specific dilutions required for the calibration of
the more sensitive whole body counter and the highly 
a
sensitive gamra^ -ray spectrometer as well as for determining 
the dilutions for biological work. The ionisation current 
produced by 1 - 2 mCi of ^ Z n  and ^ G a  contained in 
gravimetrically known quantities of solution were measured 
and the radioactivity in juCi was obtained from the following 
equation:-
^ x  " bV  K,
x — a * 1000 = pCi
( i R a " b )  . . .  K*
Where, i = ionisation current in pA due to nclide x,X . A
i^a= ionisation current in pA due to 1.0 to mCi of 226ga
b = background current in pA,
K = specific ionisation constant of nuclide x 
in R/h/mCi
KE a / 226Ea> = '
KZn/65zn> - 2-7
KGa,(67Ga) -1.55
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2-3-2 Animal whole body counter
This instrument consists of eight Geiger-Miiller
f
tubes, a probe unit and a scaler. The Geiger tubes are
arranged in a circle surrounding a central perspex
platform, on which is placed the radioactive source*
The animals following radioactive dosing, were
restrained in a 400 cur polythene box and placed in
the centre of the platform.The probe unit was set to
impose a paralysis time of 200 ps. The observed counting
rates were corrected for the counts lost during the
imposed paralysis time, using a chart constructed according 
*
to the formula:-
1 - V
where,
N = observed count rate,o ’
N = corrected count rate,
t = paralysis time.
The true counting rate of the source wa3 obtained by the 
subtraction of the background counting rate. The instrument
was calibrated using standard quantities of the appropriate
radionuclide, and was used to record counting rates between 
100 - 500 c.p.s. The stability and the performance of the 
counter was checked daily using a sealed source of 20 pCi 
of 65Zn.
2-3-5 Gamma-ray spectrometer
The radioactivity of tissues and other biological 
extracts were assayed in a gamma-ray spectrometer ( Nuclear 
Enterprises, Edinburgh ). The gamma counting system
-49-
consists of a cylindrical Nal crystal viewed by two photo­
multiplier tubes in summation.
Prior to use in each series of measurements the 
instrument was calibrated as follows:-
^ (a) The full gamma-ray spectrum was obtained for
the nuclide.
(b) The countingmte of a sample of known
radioactivity was obtained using a suitable, 
area of the spectrum.
The background radioactivity was checked using 
empty vials under similar counting conditions. Although
the instrument was later modified to provide adequate
/
shielding around the detector, when ^ Z n  was counted for the
experiments described here the background count rate
increased owing to other samples in the magazine. This was
minimised by keeping a blank between each vial containing a
67radioactive sample. For Ga, a lower energy gamma-ray 
emitter, blank vials were kept only at the begining and at 
the end of the magazine. Routinely* samples of approx. 1 g 
-were counted, but on occasions where larger samples were 
used the counting rates were corrected for the change in 
geometry. ^
Counting times of 100 s were adequate for tissue 
counting, at the activity"levels used, at all times. 
Biological extracts were counted for periods of 100 - 1000s 
and the background was counted for a similar length 
of time. Paralysis time corrections were not applied in 
all these estimations as the counting rates were low.
The instrument was calibrated using standard quantities
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of the appropriate radionuclide. Wherever applicable 
radioactive decay was taken into consideration and the 
appropriate- corrections were made using decay charts.
- 51-
2-4- Materials
65zn
^Zn was produced in the M.E.C. cyclotron 
according to the nuclear reaction:-
65Cu + 2t> 65Zn + 2 V
29 1 30 0
(Clark et al., 1957) .
The activated Cu target was processed by the Radiochemical 
Centre (Amersham), to recover ^Zn. ^Zn, with a specific^ 
activity better than 100 mCi/mg zinc, was supplied in glass 
bottles, each containing 5 mCi of ^ZnCl^ in 10 ml of 
0.1M-HC1.
A dose of 20 juCi was used in all experiments.
The stodk solutions were diluted by the addition of the 
required volume of 0.1M-HCI to contain 20 pCi ^ Z n  in 
0.2 ml. '
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2-5 Experimental results
2-5-1 Whole body counting
Three rats were injected i.v. with a dose of
20 fuCi of ^ZnC^ ( = 0*2 jag zinc). Upon recovery from
anaesthesia, the rats were transferred to polythene
boxes for radioactivity counting and were later housed 
in metabolism cages. Radioactivity in the animals was 
counted individually, in the whole body counter, each 
morning for a period of 5 weeks. The contamination of 
polythene boxes was prevented by polythene sheets which 
were replaced daily.
Table 2-1 ^ Z n  retention in the body
Day % 65Zn
s
retention in rat
1 2 3 4 5 6
*
0 100 100 100 100 100 100
•1 84.0 84.5 85.7 88.0 84.8 85.3
— 2 79.5 73.6 73.7 77.9 74.2 75.7
3 71.0 68.3 67.4 72.0 70.7 71.8
4 68.2 65.3 64.0 67.5 64.0 66.3
5 66.9 63.2 62.0 64.6 62.2 63.9
6 62.5 58.1" 56.3 60.5 58.0 60.6
*the initial count rate was assumed - to be 100%
The radioactive counting was done for a period 
of 100 s and was repeated five times for each animal.
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The counting rate observed for each animal immediately 
after the injection was considered as 100%, and the 
subsequent estimates were expressed as a percentage of 
this value.
This experiment was repeated using a second
65group of three rats. The amounts of yZn retained m  
the body of .individual rats during the first 6 days are 
shown in Table 2-1. The six animals in this study retained 
somewhat similar amounts of ^Zn, i.e., individual variations 
were small.
These estimations were combined for a total of 
36 days and the mean values obtained from the six animals 
are represented graphically in Fig. 2.3* The whole body 
retention curve was analysed to reveal two exponential
s
components, one of tQ ^ » 2.3 days and the other ^q .5 =
73 days (see Fig. 2.4). These results indicated that 
the i.v. tracer dose of ^ZnCl2 was eliminated from the 
body initially by a rapid process, and finally by a 
slow process.
,2-5-2 Faecal excretion -
The faeces were collected from the six animals 
used in the experiment for whole body counting. The ^ Z n  
radioactivity in the faeces was assayed by gamma-ray 
spectrometry and the amount of 6^Zn was calculated as 
a percentage of the injected ^Zn. The mean results are 
expressed graphically in Fig.2.5.
It is clear that the i.v. trace dose was 
largely removed by faecal excretion. During the first 
6 days approx. half the dose of ^ Z n  was recovered
001
^unoo ip i^ iu j sm; Jo %so Xpoq,aqj. uj u o i^ u a ^ y
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in the faeces, this was followed by a much slower excretion 
and more than 80% of ^Zn was excreted in 25 days. Larger 
individual variations between animals occurred in the slow 
excretion period*
( ^ 0 ‘Z S  ~ 3 6  d a y s )
IS  ... »1 JL 1 ■ i I i t .  .
O  4 8  12 ID 2 0  2 4  2 8  3 ‘A 3 6  
Time after in jection-*^nC^2^a^
Fig.2,4* Analysis of the whole body retention curve of ^Zn.
2-5-3 Urinary excretion
The urine was collected from the six animals 
used in the experiment for whole body counting. The 
amount of'^Zn recovered in urine, expressed as a mean 
for the six animals, and calculated as a percentage of 
the injected dose of ^ Z n  is shown in Fig.2.5*
The results clearly show that only small 
amounts of ^ Z n  was excreted in the urine. During the 
first 3 days after injection approx. 1% of the dose was 
excreted in urine and following this only trace amounts 
of6^Zn were detected in the daily collections. At least 
a part of this could be due to 6^Zn contamination from
faecal matter, hair and other exudates.
-36-
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Analysis of ^ Z n  clearance from the body.
65Whole body ^Zn calculated as:-
Whole body ^^Zn = (100%) - (% cumulative faecal ^Zn)
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65The elimination of ^Zn in the urine was not related 
to the volume of urine. However, for a given animal the 
ratio of daily faecal ^ Z n  to daily urinary ^ Z n  was 
approx. constant and was of the order of 100 for most 
rats.
Assuming that the faeces and urine were the
65only routes of excretion of ^Zn from the animal, the 
65^Zn retained in the body was calculated. The average
65results for the ^Zn retained in the six rats are 
presented graphically in Pig.2.6. Analysis of this 
curve revealed two exponential components, an initial 
rapid process ( tq 1.3 days ) and a slower process
( to.5= ^  days
V
2-5 - A The effect of additional oral ZnSO^ on the excretion 
Of 6^Zn
In a group of four rats, two were force-fed 
with 1.0 ml of a solution containing 2.0 mg ZnSO^^^O 
in de-ionised water, by gastric intubation. The other 
two served as controls, and were given 1.0 ml of 
de-ionised water by intubation. Doses were given daily 
for 30 days, between 4.30 - 3 P*m. • These animals had 
free access to water and solid food was offered in the 
night. During this period, no noticeable signs such as 
poor feeding, poor growth or any other symptoms due to 
intubation of ZnSO^ were observed other than increased 
epilation in the ZnSO^ treated rats. At the termination 
of the study the oesophagus and the stomach were opened 
and no visible damage was apparent. On the 31st day the
-59-
65rats were injected i.v. with 20 {uCi of ^ZnC^. Daily 
faecal and urine samples were collected from these 
animals for 7 days. This experiment was repeated twice more 
under identical conditions.
65The radioactivity due to ^Zn in faeces was
65calculated as a percentage of the injected ^Zn dose. The
ZnSO^ group received 0.453 mg zinc ( = 2 mg ZnS0^.7H20 )
daily, until the termination of the faecal collection.
Both groups, the treated and controls received the normal
65dietary zinc. The amounts of ^Zn recovered in the faeces 
are shown in Table 2-2.
Table 2-2 Faecal excretion <of i.v. 65Zn (6^ZnCl„) after
oral ZnS0„—  — 4 v
Time after ^ Z n Cumulative faecal 65^Zn content
injection (% of dose)
Tdays)
ZnSO^ group Control group
Mean + s.d. Mean + s.d.
1 12.59 2.56 16.57 3.42
2 . 22.11' 2.87 32.07 3.46
3 26.02 3.14 38.97 3*72
4 30.52 3.28 46.57 4.52
5 33.36 3.57 48.02 4.04
6 33.32 3.92 53.56 4.06
7 37.18 3.86 56.26 4.43
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The results of the control group in this study
a 65compared favourably with the previous fecal ^Zn study 
(2-5-2), for cumulative faecal ^ Z n  content in the 
first seven days:
" Previous study - 55*60 + 3*09%
Control group in this study - 56.19 + 3*91 %
No significant difference waS noted, (P = 0.7)*
However, the ZnSO^ treated rats showed decreased excretion
65of i.v. yZn (see table 2^ -2) and the difference shown
by this small group of six rats was highly significant. .
1
It thus appears that an increased intake of zinc oraly
resulted in the prolonged retention of an intravenously
65
administered trace dose of ^ZnCl^*
The urine of the oral ZnSO^ treated animals 
did not show any appreciable difference in ^^Zn content 
over the period of seven days:
Control group - 1.27%
v.
^ ZnSO^ group - 1.38%
2-5-5 ^ Z n  excretion in pancreatic fluid and bile
Cannulated animals were injected i.v. with 
65approx. 20 juCi of ^ZnCl^ except for one animal given
6540 juCi. The total amounts of ^Zn recovered in bile and 
the external secretions of the__ pancreas were estimated. 
Bile and bile and pancreatic fluid were collected hourly 
from a group of ten rats, five rats donating bile and the 
other five rats donating the combined secretions. ^ Z n  
radioactivity was calculated as a percentage of the dose 
received by each animal. Results of this experiment are
-61-
shown in Table 2-3. The bile contained approx. 2% of the.
dose of injected ^Zn, during 0-48 h, and approx. equal 
65amount of ^Zn was recovered each day. The combined
65secretions contained 4-5 times more ^Zn in comparison
with "the bile. More ^ Z n  was detected in the combined
65secretions during the first 24 h, and the amount of ^Zn 
- secreted was reduced by approx. 50% over the next 24 h.
The results show-that in the rat, at the dose levels 
employed in this study, approx. 5 - 10% of ^ Z n  was 
excreted in the pancreatic fluid.
*
^ Z n  was detectable in both bile and pancreatic
65fluid within the first hour after ^Zn administration.
The maximum pancreatic secretion of ^ Z n  occurred 2-4 h
after injection and then gradually diminished to a lower
level (Fig. 2.7). In oontrast, ^ Z n  content of bile
gradually increased from an initial low level and
demonstrated a diurnal rhythm, Fig. 2.8. It is clear that 
65^Zn is maximally excreted in bile during the day time 
(morning)and the excretion diminished at night time. The 
volume flow of bile is itself subject to a diurnal variation, 
with a maximum flow around midnight and a minimum flow 
around midday. Therefore more ^ Z n  is excreted per unit 
volume of bile during the day than in the night. From 
table 2-*3 it can be seen that at higher dose levels the 
bile and pancreatic secretions contained greater amounts 
of 65Zn.
-62-
Ta
bl
e 
2-
3 
Zn 
el
im
in
at
io
n 
in 
b
i
l
e
v 
an
d 
bi
le
 
an
d 
pa
nc
re
at
ic
 
fl
ui
d
•*
rH
o
LA rA co CA CD OJ CD 00 00
'd (A ■0 vD OJ 0 A - 0 00 CD- *H • • • • • I • • • •
0 O o CA O OJ O OJ CD rA
,0 i—i NT V V V" OJ OJ OJ OJ
ft
co
0*
1
0
A I WAt Vl u
*d V* V CD rA v~ V lA CN rA
A - LA O IA V CD 00 CD LA
CD V O O 1 V OJ r - CD• • • • • • • • •
0 O V V v~ r * OJ fA OJ 0
£SJ
lT\
CD
•
'
Hi*No
J> OJ CA CD CO CN O A - CN CD CN
OJ (N A - A - co O OJ lA LA V“
nd • • • • • • ♦ • • •
•H ca O O CA o CO OJ tN 0 oo
v~ v  N V OJ OJ OJ OJ OJ
.0 1—1
ft
0-
OJ
1
0o CQ
O
'd o OJ 0^ fA o A - V* 0 V
A - CA OJ VD LA LA 0 OJ 0 V
CO CA v~ 0" A - CD o A - o A -• • • • « • • • # •
0 o o V~ V V* V 0 CD CD A -
tKJ
lA
CD 1
■-C_... ' *d
•H
"^N 3
• ■ H
1—1 •P ft
0 £
> • ,* O
0 •H
rH 0- CD 0* A - CD -P A - 00 0 CN LA
hO LA VP V* O 0 0 CA OJ CN OJ OJ
O \ co 00 CA V IA 0 A - CA V IA V
CO •H o O O V 0 O O T* V* OJ
o o • • •„_• • • O • • • • •
ft ZL o o o O O 0 o o o O ov—/■ 0
ft
•d
O 0
0 1 • • - 0
+3 . 0 0
0 1—1 V- OJ IA 0* LA iH CD A - 00 CA o
PI •H •H
PQ PQ
-63-
To
ta
l 
ra
di
oa
ct
iv
ity
 
in 
sa
m
pl
e 
(c
.p
.m
.)
11,000 A  -
7,000
5,000
3,000
1,000
Time after injection of 65ZnQ2 (hours)
Fig.2.7* A typical ^ Z n  elimination in the external 
secretions of the pancreas and liver after 
i.v. 6^ZnCl2.
These results were.obtained-from two separate 
animals. Bile and pancreatic fluid (&) 
pure bile (.0 )
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65 -Fig.2.8. ^Zn levels in bile after a single intravenous
65injection of ^ZnC^*
*^Zn ( o— © ), bile volume ( e--o ).
The night period is indicated by the horizontal 
dark bars. The arrows indicate 12 noon and 
midnight. The result shown was obtained in 
one- animal. -
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2-6 Summary
In this study on the rat, the rate of elimination
of ^ZnCl2 from the body and the principal routes of
excretion of ^^Zn were investigated using sub-physiological
65doses of high specific activity ^Zn. Results obtained
from the counting of the whole body radioactivity indicated
65that the dose of ^Zn was eliminated by two processes, 
with different rates, a fairly rapid process (tg ^ = 2.5 days) 
and a much slower process (tq ^ = approx. 73 days). The 
excretion of ^ Z n  in faeces and urine accounted for the 
removal of most of the dose from the body, and after 25 
days 80% of was excreted in the faeces and approx.
2% in the urine. Using the excretion data it was again 
shown that the elimination curve could be resolved into
N
two components, one of tQ ^ « 1.3 days and the other
of tq ^ = 14- days. The increas e of— dietary z -i-nc- with
orally administered ZnSO^ produced a significant retardation
65in the faecal excretion of i.v. trace dose of ^ZnC^.
The experiment with cannulated rats provided
65information on the origin of..the faecal ^Zn. During
the first two days 1.5 - 2.8% of the dose appeared in
the bile and 6 - 10% in the combined bile and pancreatic 
65fluid. The "an content of the combined secretions 
accounted for 20 - 30% of~the faecal ^^Zn excreted in 
non-cannulated animals over two days.
65The existence of a diurnal rhythm for ^Zn excretion
in bije was discovered, the bile samples collected around
65morning containing more ^Zn than those collected around 
midnight.
C H A P T E R  3 
THE NATURE OF ZINC EXCRETED IN BILE
3-1 Introduction
The role of the liver in zinc metabolism remains
obscure. In rats, this organ contains only 4% of the total
zinc content of the body, but it localises about a third
of a trace dose of radioactive Zn. A small proportion
of *^Zn radioactivity is excreted from the liver daily
in bile, and the excretion follows a diurnal rhythm.
This suggests that the liver exercises . some control over
the biliary excretion Of zinc and therefore it was decided
65to investigate the nature of ^Zn in bile in an attempt 
to obtain information on the possible mechanisms involved.
3-2 Experimental techniques
3-2-1' Animal experimentation
_ . Male Wistar rats (approx. 220 g) were fitted 
with biliary cannulae as described in Section 2-2-3*
Twenty four hours after cannulation the rats were injected 
with approx. 20 pCi of ^ZnCl2» in the caudal vein. Bile 
samples were collected in-bulk during the period of 
0 - 24 h after ^ZnCl^ injection, in a sterilised glass 
tube packed in ice. The bile was protected from light 
during collection by wrapping the glass tube with aluminium 
foil. Prior to use the glass tube was filled with an 
atmosphere of nitrogen obtained by pouring liquid nitrogen
-6?-
into the tube. Bile collected between 0-24 h was used 
for the investigations outlined in this Chapter. Bile 
collected in this Way was a straw coloured fluid with a 
greenish tint and contained no solid matter when viewed 
unden the light microscope at a magnification of x600. 
These rats secreted 6-8 ml of bile in twenty four hours 
and the pH of bile was 8.2 - 8.4.
3-2-2 Ultrafiltration
An ultrafiltration technique similar to that of
Toribara et al. (1957) v/as used to investigate whether
65 0the ^Zn was bound to macromlecules in bile. The bile
A
samples (3 ml), loaded into Visking dialysis tubing
(Scientific Instrument Centre, LondQn) cleaned in de-
ionised water prior to use, were centrifuged in a specially
constructed ultracentrifuge tube, Fig 3*1» at 1500 g
for 30 min in sin MSE 'minor' bench centrifuge to obtain
an ultrafiltrate of approx. 0.3 ml. Accurately weighed
amounts (approx. 0.1 ml) of the original sample and the
ultrafiltrate were pipetted into counting vials and their
radioactivity determined in a gamma-ray spectrometer.
65The binding of ^Zn to macromolecules was calculated using 
the following expression:-
% binding = _ A -r —  x 100
A
where,
A = radioactivity of bile in c.p.s./g of bile 
B = radioactivity of the ultrafiltrate in c.p.s./g of 
ultrafiltrate.
-68-
Cork
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tube containing the dialysis 
tubing loaded with sample.
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Suitable controls were run to determine whether binding 
of ^ Z n  to the (cellulose material of the Visking tubing 
was involved.
3-2-3 Exhaustive dialysis.
A dialysis tank was constructed for dialysing small 
" quantities of fluid. The tank had dimensions of 16 x 13 x 12cm, 
was constructed out of perspex, and had no metallic parts.
The Visking dialysis sac containing the bile sample was 
secured to the centre fitment as shown in Fig. 3*2, and 
rotated by means of an external motor. After its use the
■ f
tank was cleaned by total immersion in EDTA, dil. HC1, dil.
NaOH, and de-ionised water.
Visking dialysis tubing, flat width 1.0 cm of
average pore size 24 $ was cleaned in de-ionised water
prior to use. Thesample was introduced into a sac made
by tying one end of the tubing. A clean glass bead was
introduced in order to stir the contents of the sac, before
tying the open end. The contents of the dialysis sac were
★
dialysed against 2 1 of the appropriate solution, for
varying lengths of time. The extent of dialysability of 
65"an was calculated as follows:-
% dialysability = c.g.s.Qf dialysed.bile  - x 100
c.p.s./g of bile before dialysis
Suitable controls were run to determine whether 
65binding of ^Zn to the Visking tubing was involved. .
* litres
-70-
3-2-4- Gel-permeation chromatography
The following materials were used:-
Chromatography column, 2,3 x 100 cm,
Sephadex G-200 gel (superfine)
Borate buffer containing 0.05M-H^B(^, 0.05M-KC1, 
l.OM-NaCl adjusted to pH 8,0 with 0.05M-Na0H.
This buffer was chosen as it has been shown to be
effective in the separation of biliary proteins by Nakayma 
and Miyake (1965). The glass column, flow adaptors and 
associated parts were thoroughly washed in weak Teepol 
solution. Possible metal contaminants were removed with
A
i
1.0% EDTA solution. These detergents were removed by repeated
washing with de-ionised water. Sephadex gels were swollen
in de-ionised water over a bpiling water bath for 5 b, and
then suspended in borate buffer. A gel column was made by
pouring the slurry upto 80 cm mark, and secured in position
with flow adaptors at both ends.. The column was equilibrated
with buffer solution for 24 h prior to use. A constant
a
upward flow was maintained by^hyarostatic pressure difference 
of 15 cm of water. The separations were carried out at 
ambient temperatures (18-20°) initially, and were repeated 
at low temperatures (5-7°)i by the passage of cold water 
through the cooling Jacket. The column was protected from 
light during chromatography. The flow rate of the column 
was 9-10 ml/h and the void volume determined with 2% (W/v) 
blue dextran was■150 ml. 1 '
A bile sample, 2.0 ml was applied at the bottom of 
the gel bed and chromatographed in an upward direction. The
-71-
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S
T
eluates were collected in clean glass tubes in volumes
of 4.5 ml. Aliquots of 1.0 ml were taken into counting 
65vials for yZn assay. The remaining samples were read 
in a spectrophotometer (Unicam SP 500), at 280 and 460 nm, 
against a borate buffer blank. A bovine serum, albumin 
(BSA) standard was run and its elution volume determined.
A new gel column was used for each experiment.
3-2-5 Thin-layer gel filtration
This technique w$s used as an adjunct to column
chromatography for more efficient separation of smaller
amounts of proteins.
Sephadex G-75 gel* 3*75 g was swollen in 50 ml of
borate buffer at pH 8.0, for two hours over a boiling
water bath and was poured on'' a 20 x 40 cm glass plate, and
drawn to a thickness of 0.04 cm. The plate was placed in
a commercial TLG apparatus (Pharmacia G.B, Ltd.). The
upper buffer reservoir was filled with 50 ml of borate
buffer^and connected to the gel bed by a 17«5 x 5 cm
Whatman 3MM filter paper wick and the continuity to the
receiving reservoir was made similarly. The gel bed was
equilibrated at an angle of 20° overnight and the plate was
lowered to a horizontal position for sample application.
of
After application^10 pi of the-test sample the plate was 
inclined at 15° and the sample was allowed to migrate 
downwards. After four hours the plate was lowered and the 
buffer wicks.disconnected. The plate was left in an oven ' 
at 40° to remove excess moisture and the proteins were 
visualised by:-
-73-
(a) Replica transfer method
A Whatman no. 1 filter paper 50 x 20 cm was unrolled 
along the length of the gel bed. The paper was removed 
from the gel and dried in an oven at 60° for 0.5 h. The 
proteins were fixed in a bath of 10% (w/v) trichloroacetic 
ac'id solution and stained with 1% (w/v) Ponceau S in 10% 
(v/v) acetic acid solution.
(b) N-chloro derivatives
After chromatography the plate was exposed to an 
atmosphere df chlorine vapour for 5 min. The excess 
chlorine was neutralised by spraying the plate with 20% 
ammonium sulphate and 5% sodium bicarbonate (w/v) in aq. 
solution. After: 15 min, an aq. solution of 1% starch 
also containing 1% potassium iodide (w/v) was sprayed over
N
the gel. Iodine formed by the N-chloro derivatives was 
-visuaPised as —b lue spots.— This --me t hod is more s ensitive 
than (a) but the test is not specific for proteins.
3-2-6 ^  Paper electrophoresis
Paper electrophoresis was carried out in a horizontal 
electrophoresis apparatus (Shandon Ltd,,, London). About 
20 jul of the bile samples were applied as a thin band on 
Whatman 3MM paper (12 x 2.5 cm), 2 cm from the cathode 
wick. The buffer solution used was O.IM-H^BO^ adjusted 
to pH 8.4- with O.IM-NaOH. The bile samples were subjected 
to electrophoresis at 20 V/cm for 1.2, and 4 h periods at 
4°. After electrophoresis the strips were dried in an 
oven at 40° in a free hanging position. The following 
spot tests were applied on individual strips:-
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(a) Proteins
Ponceau S reagent as described in Section 3-2-5«
(b) Amino acids
- Papers were sprayed with 4% (w/v) ninhydrin soln. 
in acetone (1:19), and heated at 110° for 5 min.
(c) Bilirubin
Papers were sprayed with a freshly prepared diazo 
reagent. The reagent consisted of 96% ethanol 
(10ml) added to 0.1% aq. sulphanilie acid soln.(10ml)an
0.5% NaNOg soln. (0.6ml). Sulphanilic acid was 
diazotised in the sodium nitrite soln. in HC^ .? in the 
cold.
(d) Cholesterol N ■ '
• The papers were dipped in conc. ^SO^ ~ acetic
anhydride (3:2) and flattened oh a glass plate.
(e) Glucuronic acid
The papers were dipped in 0.2% napthoresorcinol 
.in aq. H^PO^ (9%, v/v) and heated at 95° for' 5 Diin,
(f) Bile acids
The papers were sprayed with 2% (w/v) vanillin in 
ethanol, then dipped in 85% aq. PO^ and heated 
to 70°.
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(g) Lipoproteins
The papers were dipped for one hour in a saturated 
soln.of sudan black B in 55% ethanol and the 
surplus stain was removed by washing the papers with 
40% ethanol.
3-2-7 Electro-immunodiffusion
An electrophoretic apparatus suitable for two 
dimensional electrophoresis was developed. The apparatus 
( Fig.3«3 ) was made out of perspex and consists of:-
(a) Buffer tank
This is a four compartmental vessel containing 
a platinum electrode in each compartment. The four power 
terminals are connected to a switch which is used to make 
-or break the current flow and to -di-rect the current aeross pne 
pair of . electrodes at a time.
(b) Cooling platen
This is used for supporting the Agarose gel plate 
during electrophoresis and can be cooled by cold water 
circulation. In these experiments the cavity of the platen 
was filled with cold water. In the first dimension 
electrophoretic run using 24 Y/cm the gel bed tended to 
warm up and this was overcome by cooling the apparatus 
in a refrigerator before use and during electrophoresis*
A series of four platens can be stacked vertically to 
support four gel plates, which allows four uniform separations 
to be obtained simultaneously.
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“
Fig. 3«3« Two dimensional electro-immunodiffusion apparatus.
Buffer tank (A)v Cooling platen (B), Lid of the 
cooling platen (L)
The position of an Agarose gel plate on B 
and the electrode wicks are shown.
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A bed of Agarose gel was prepared by pouring 4.5 ml 
of a solution containing 3 ml of 2$ (w/v) Agarose (Paines & 
Byrne Ltd., London) and 3 ml of 0.04M-barbitone-lactate buffer 
(pH 8.4), on a 5 x 5 cm clean glass plate. After the gel 
had set the excess was prised off leaving a 1 cm strip 
along one edge of the plate. Pour ml of 1% Agarose gel 
"prepared as before was mixed with 0.2 ml of the appropriate 
antiserum (see Section 3-2-9) at 40°. This was poured onto 
the plate to reconstitute the complete bed once again. A 
well was punched in the antiserum-free Agarose gel, half 
a centimeter from one. corner on the diagonal line.
The glass plate containing the gel was placed on the 
cooling platen. Buffer wicks were cut out from Whatman 3MM 
filter paper and soaked in the barbitone-lactate buffer. Two 
layers of 1 cm wide wicks were used to connect the ends of 
the antiserum-free gel to the respective electrode compartment 
for the first dimension run, while 5 cm wide wicks were used 
for the^electrical continuity of the second dimension run.
The four compartments of the buffer tank were each filled 
with 250 ml 0.02M-barbitone-lactate buffer, pH 8.4 and the 
whole assembly was cooled to 4° one hour prior to loading 
the wells with 10 |ul of protein solution fb'r electrophoresis. 
Current was applied for 1 hr at 24 V/cm in the first dimension 
and for 8 h atAY/cm in the second dimension.
After electro-immunodiffusion the eccess antiserum 
was removed by washing the gel for 2 h in 0.9% NaCl adjusted 
to pH 8.8 with lM-NaOH. The excess saline was in turn 
removed with short rinses in de-ionised water. The Agarose
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was dried to a thin film in an oven at 60°. The preparations 
were then layered with 5 iu thick Melinex sheets (IC1 Ltd) 
and autoradiographed using Kodirex film (Kodak Ltd).
The immuno-precipitated proteins were visualised by dipping 
the Agarose plate in 1% (w/v) Ponceau S in 10% (w/v) 
acetic acid soln.
3-2-8 Immunoelectrophoresis
The electrophoretic separation of samples investiga-
out
ted by this technique was carried in the apparatus described
A
in section 3-2-7, at 4°.
The Agarose gel was made by pouring 3«0 ml of a solution 
of 2% (w/v) Agarose in 0.03M-tris-barbitone sodium barbitone 
buffer of pH 8.8 (Gelman Instrument Co., Ann Arbour, Michigan, 
U.S.A), on a 2.5 x 7*5 cm glass plate. After the gel had 
set, wells (1mm diameter) and troughs (1 x 45 mm) were cut 
using a standard punch (. Shandon Ltd., London). About 
10 pi sample of the proteins to be separated was placed 
in the wells and electrophoresed in 0.3M-tris-barbitone
sodium barbitone buffer for-0.75'h at 6 V/cm. After
o T ,
electrophresis 0.4 ml of the appreciate antiserum (see
Section 3-2-9) was placed in the trough and immuno-precipitation
allowed to occur for 14 h at 37° in a moist chamber. The
Agarose plate was washed to remove excess of antiserum,
65^Zn was located by autoradiography^and the proteins 
visualised with Eonceau S. (see Section 3-2-7).
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3-2-9 Raising of antisera
Antisera for rat. serum proteins and rat biliary 
proteins were obtained by immunisation of rabbits. Rabbits 
v/ere chosen for the raising of antisera as their antisera 
show marked precipitation lines on the Agarose gel over 
a wide range of antisera concentrations. The method used 
was as described by Campbell et al. (1970).
Two male rabbits, Dutch strain (approx. 2.5 kg)
were used. Blood serum was obtained from six normal healthy
adult rats (approx. 200 g) and the pooled serum sample was
thoroughly dispersed in Freund's complete adjuvant (Difco
Laboratories, U.S.A) in a ratio of.4:1 (serum: adjuvant).
The emulsion thus obtained was deposited in five subcutaneous
sites in the nuchal region of* rabbits and in each hind foot
pad, in amounts of 0.1 ml per site. Two weeks later, 0.25 ml
of fresh rat serum was injected.into the ear vein to boost
the immune reaction. The rabbits were bled 3 days later
to check the antibody titer. Subsequently, when antisera
s
were required the animals were booked subcutaneously with 
serum in Freund's complete adjuvant, 7 days before bleeding.
For raising antisera to rat bile three rabbits weighing 
approx. 2 kg were used. Fresh rat bile samples obtained from 
three healthy rats (approx. 200 g) were pooled and thoroughly 
dispersed in an equal volume of Freund's complete adjuvant 
and this emulsion was deposited in volumes of 0.2 ml at 
five subcutaneous sites in the nuchal region and in each
hind foot pad. Thereafter at fortnightly intervals 0.3 
ml of fresh bile samples were injected intravenously into
-80-
the ear vein for three months. The i.v. dosage of bile • 
in volumes between 0.6 - 0.75 ml produced discomfort, 
respiratory arythmia and temporary loss of gait, within 
a few minutes of injection, with recovery after about 30 min. 
If the i.v. dose was about 1.0 ml of bile, convulsions, 
severe body tremo^rs and respiratory arrest leading to 
death was observed. A dose of 0.3 ml of bile produced 
no observable discomfort or any other toxic symptoms in 
single, or multiple dosage at fortnightly intervals.
A final booster dose of bile in Freund's complete adjuvant 
was given subcutaneously seven days before collecting the 
antisera. The animals were bled 3 days after the first
i.v. dose and after three months of the initial dose to 
check the antibody titer.
s
For the determination of the antibody titer, the
-passi-ve^haemagglutinatibn-method—similar to that described---
by Campbell et al. (1970) was used. The agglutination of
tanned human group-0 red blood cells coated with pure rat
serum and pure bile, respectively, was checked using serial
P
dilutions of the approriate_antisera. Both antigen andA
the antibody solutions were heated to 50° for 30 min to 
inactivate the complement which was then absorbed with an 
equal volume of group-0 red blood cells.
A titer of 20,000"was obtained in one rabbit for 
rat serum protein antiserum. Further immunisation of this 
animal was delayed until seven days before the requirement 
of antiserum. The three rabbits immunised with bile gave a 
titer of 100 after the first i.v. dose and with further
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immunisation a titer of 5000 was obtained in one rabbit 
after three months. The animals showed signs of 
hypersensitivity towards i.v. injections of bile at this 
stage.
Two animals from the respective groups with high 
titer antisera were selected as antisera donors, and 
when antisera were required these were bled from the ear 
vein and blood serum was obtained in the usual manner. 
These antisera were used for immuno electrophoresis and 
electro-immunodiffusion without further isolation of 
purification.
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5-3 Materials
The glassware used for the collection of body-fluids 
and for the analytical techniques such as dialysis, chromato­
graphy, electrophoresis and ultrafiltration were cleansed 
by treating with the following solutions to decontaminate 
radioactivity from the previous experiments and to remove 
possible metal contaminants:-
(a) 1% EDTA - soak for 24 h
(b) 10% Chromic acid - soak 24 h
(c) 5% NaOH - boil 2 h
(d) 10% HC1 - boil 2 h
(e) De-ionised water - wash and rinse
Between each step the detergent left from the previous 
treatment was removed by rinsing in distilled water.
De-ionised water:
Glass distilled water was siphoned through a
w '
commercial deioniser, Elgastat ( Elga Products, Bucks. ), 
where the electrolyte content of the water was reduced 
by flow through an electrolyte cell and was further 
de-ionised by cation and anion exchange resins.
All the chemicals were obtained from the BDH Chemicals 
Ltd. The standard proteins for molecular weight determination 
were obtained from Koch-Light Laboratories Ltd., Colnbrook, 
Bucks.
3-4 Experimental results
3-4-1 Ultrafiltration of ^ Z n  in bile
Two studies were carried out, one at room temperature
and the other at 4° using bile samples from nine animals
65injected with 20 juCi ^ZnC^ and two types of control
solutions were used. The first solution contained 0.9%
NaCl in de-ionised water and the second an ultrafiltrate
of bile. The latter was obtained by centrifugation of
7 ml of bile in 24 2 pore size Yisking tubing kept in
large ultracentrifuge tubes (2.5 x 9*5 cm). These were
centrifuged for one hour at 4° to obtain an ultrafiltrate
of 1 ml. The ultrafiltrate of bile has a straw green
colour, probably due to bilirubin. Both saline and bile
65ultrafiltrate were separately mixed with 0.1 ml of ^ZnC^ 
to give counting rates similar to that of bile samples.
The pH of the resulting solutions was elevated from their
normal pH of 6.4 and 7»8 to the pH of bile (8.3) by the
^ 65addition of O.IM-NaOH. Duplicate ^Zn added saline con­
trols were centrifuged at the same time as bile samples.
65The 'Zxl added bile ultrafiltrate was centrifuged in
triplicate at room temperature and at 4°, on one occasion..
The ultrafiltrates of both control solutions contained
^Zn. The Counting mtes'of these were compared with their
original solutions and gave a recovery of 95 - 98% in the
ultrafiltrate. The solution left in the dialysis bag also
gave counting lates similar to that prior to ultrafiltration.
65This indicated the absence of ^Zn binding to the cellulose
material or to the glass walls of the ultracentrifuge tubes 
65at this low ^Zn concentration. Therefore this method was
used for the study with bile.
65The 'Zn in bile samples did not filter through the
24A pores of the Visking tubing i.e.^ no ^Zn was detected
in the ultrafiltrate of bile. This together with ultrafiltra- 
65 65bility of yZn in ^Zn added to bile ultrafiltrate indicated
65the absence of ^Zn binding by ultrafiltrable low molecular
weight materials in bile, under these conditions. Centrifuging
samples at room temperature or at 4° had no effect on the
65extent of ultrafiltrability of ^Zn in bile or the controls.
The results of this experiment is summarised in Table 3-1*
Table 3-1• Ultrafiltration of bile
65Zn in;- % binding at:-
.18° 4°
Mean + s.d. Mean + s.d.
Bile* 98.6 3.46 96.3 3.42
Bile ultrafiltrate** 8.62 - 5.39 -
Saline control* ,6.44" 2.65 4.48 2.01
* Six determinations at each temperature
** One determination in triplicate at each temperature
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3-4-2 The dialysability of ^ Z n  in bile
Bile samples were obtained from nine rats injected
(i.v.) with approx. -20 jaCi of ^ZnClg. These samples were
placed in 1.0ml amounts in Visking cellulose sacs and
controls were prepared similarly, with 0.9% NaCl containing 
65added ^ZnC^ of counting rates similar to that of test bile. 
Bile samples were dialysed against 2 l*of isotonic saline 
solution and the sacs were removed from the tank at 2,4,8,24 
and 48 h. The controls were dialysed similarly. The temp­
erature of the dialysis system was maintained at 4° by 
leaving the apparatus in a refrigerator. This experiment 
was repeated at ambient temperatures, 18-20°.
In another experiment, bile samples obtained from
65 "three animals dosed with "an were dialysed against 0.9%
-4
NaCl soln. which also contained 10 mM-EDTA, and the pH
of this solution was adjusted to 8.3 by the addition of
l.OM-NaOH. The temperature of the dialysis system was
maintained at 4°. At the. termination of dialysis graVime-
trically known amounts of dialysed saline controls, dialysed
bile and similar amounts of the original solutions of saline
controls and bile were placed in counting.vials and assayed 
65for ^Zn radioactivity.
The results obtained in the experiments conducted at
o 654 are shown in Big. 3*4. The ^Zn in the controls was
readily dialysed; and after 24 h of-dialysis complete 
65 -removal of ^Zn w^s achieved. The dialysis membranes of 
the sacs were removed at 24 and 48 hjknd counted for ^^Zn
* litres
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65Fig.$.4. Exhaustive dialysis of ^Zn in bile.
e— © Bile dialysed against saline, 
x— x Bile dialysed against lO^mM-EDTA.
.— . ^ Z n  added 0.9% NaCl soln. ("»control) 
dialysed against saline.
Each point is a mean of six determinations.
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65radioactivity. These contained only traces of yZn and
accounted for less than 5% of the ^ Z n  lost from the control
solutions. • It was concluded that the loss of ^ Z n  from
the sac contents was due to dialysis and not due to ^ Z n
binding to the cellulose membrane.
66
^Zn in the bile samples was not removed under
- similar conditions and the result indicated the absence
of diffusible low molecular weight ^ Z n  binding molecules
66in bile. Dialysis of ^Zn containing bile against saline
-lL CC
solution containing 10 ; mM-EDTA removed about 40% of ^Zn 
during the first 24 h and 80% over 48 h. Thus, EDTA 
effects the removal of ^^Zn from the bile at a slow, linear 
rate over the 48h period.
Dialysis at ambient temperatures gave similar
-y
results for all solutions and the rate of dialysis of 
saline controls and bile against EDTA was not markedly 
affected. In all the above experiments the dialysate 
was not assayed for ^Zn.
65-3-4-3 Gel—permeation chromatography to reveal ^Zn binding 
components in bile
The bile samples investigated here were those obtained
from the animals used in the previous studies. The suita-
■—  65
bility of the borate buffer system for containing bile
separation was checked by dialysis of this bile against the
borate buffer in the exhaustive dialysis system described
previously in section 3-4-2, and ^^Zn was not dialysable.
Two chromatographic separation^ were carried out at 18-20°
-88-
and another at 5-7°•
The column eluates were scanned at 280 nm for proteins.
and at 460 nm for biliary pigments, principally bilirubin,
65and also assayed for ^Zn content. The results of these
experiments were very similar, and the result of one
experiment is given in Fig. 5*5*
Small quantities of 280 nm u.v. absorbing materials
were eluted prior to and after the BSA standard; and the
X
major absorbance peak occured almost at a volume correspondingA
to the total volume of the gel bed (400 ml). Approx. 95%
of the *^Zn applied to the column was recovered in the eluates.
65 ©Of this 22-26% ^Zn was recoverd in the eluates containing
A
the high mol.wt. material, i.e. 150 - 550 ml. The majority 
of ^ Z n  i.e. 74 -78% was eluted with low mol. wt. material.
*N
Traces of bilirubin were detected in the high mol. wt. region 
but the majority of bilirubin appeared with low mol. wt. u.v. 
absorbing material. Column eluate was checked upto 800 ml 
(not shown in the Fig 5*5) and this region contained no ^ Z n  
or light absorbing material.
—  In a separate experiment it was found that bilirubin
interferes with the measurement of u.v. absorption of BSA
solutions at 280 nm. This interference may be present in
bile and therefore accurate quantitation of 280 nm absorbing
materials may not be possible. However, the presence of
280 nm absorbing materials could be indicated at a protein
concentration above 50 jug/ml in the presence of 70 jug/ml
bilirubin. Protein determination by the method of Lowry
(Lowry et al., 1951) on the column eluates of bile was not 
c
sucessful owing to precipitation.A
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The combined bile and pancreatic fluid collected 
together for 24- h were chromatographed similarly. This
cc
experiment showed additional ^Zn peaks eluted prior to 
65the major ^Zn peak in bile Fig. 3*6. These peaks were
all associated with material absorbing u.v. at 280 nm
65and probably represent ^Zn containing proteins in the
pancreatic fluid. . This figure also shows the presence
65of larger amounts of ^Zn in pancreatic fluid in the 
first 24- h after dosing, in comparison with bile.
\
3-4-4 Molecular weight determination of the major 
65xZn binding component in bile
65The presence of a low^mol. wt. ^Zn binding 
species in bile was identified by column chromatography 
and the mol. wt. of this component was investigated by 
thin-layer gel filtration.
Rat bile samples obtained from the animals used in 
the previous studies were divided into 0.3 ml aliquots 
in sterile glass tubes and stored at 4-°. A new sample 
was taken for each gel filtration experiment.
Chromatography of 10 jul samples of bile resolved six 
spots on Sephadex G-75 gels, and a typical chromatogram 
is shown in Fig. 3*7* The two fast moving spots had a 
migration distance similar to that of albumin and gamma­
globulin of blood serum. The remaining spots were unique
- 91-
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Fig. 3*7 A thin-layer chromatogram on Sephadex G-75 gel. 
Chromatographed rat bile, rat serum and proteins of known 
molecular weight are shown. The arrows indicate the 
’direction of buffer flow.
The bile collected during the first 3-4 days after 
cannulation shows six major protein spots typically, 
(right) after 4 to 5 days only five spots can be detected 
(centre). In this'latter sample the protein spot with 
an value similar to that of albumin is lost and the 
gamma-globulin spot becomes more prominent.
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to bile. The spot with the lowest migration distance was
65the only spot that contained ^Zn, and this was found by 
65^Zn assay of the Sephadex gel which was scraped off the
glass plate after chromatography of bile samples applied
as a band. A similar migrating spot was faintly visible
•n
in chromatographed serum but in this experiment it was not 
possible to determine whether it was identical to the 
k^Zn binding component in bile. No other ^^Zn binding 
material could be detected in bile by this method, unlike 
the column procedure, probably because of the small quantities 
used. A number of proteins (10 jag/ml ) of known mol.wt. 
were used to obtain a standard plot relating mol.wt. to 
migration distance ( Fig. 3*8.-). The mol. wt. of ^ Z n  
binding component was obtained by reference to the standard 
curve and was in the region of 10,000 + 2000.
Both replica tranfer method and N-chloro derivatives 
enabled"all the above spots to be visualised,, but the 
transfer method outlined the spots only faintly.
653-4-3 Investigation of ^Zn binding protein in bile 
using"immuno techniques
Approx. 10 (ul of bile samples were subjected to
immunoelectrophoresis and electro-immunodiffusion. Rabbit
antisera for rat bile and serum proteins were used in 
c
separate eletrophoretic plates and on occasions in the same 
immunoelectrophoretic plate in the respective troughs.
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Their cross reaction v/as checked against rat bile and 
serum.
In rat bile, three immunoreacting proteins were 
demonstrated by immunoprecipitation of electrophoresed 
bile"samples (see Fig. 3*9 & 3*10). The precipitin arc 
close to the point of application was probably a gamma­
globulin. The second precipitin arc was identified as 
albumin (i.e. albumin-like) by comparison with an electro­
phoretic plate on which serum was cros^reacted with
antiserum to serum as well as bile. The third precipitin
65arc occured only in bile and ^Zn was found in association 
with this protein. This was found by autoradiography 
of electro-immunodiffusion and immunoelectrophoretic plates 
(see Fig. 3*9)• The autoradiographs due to ^Zn, which
■s
has poor film ’fog' properties, at these low levels of
radioactivity were barely visible after 6 months of exposure
and generous over-development of the film. However, a faint
outline of biliary ^ Z n  binding protein and the absence of
Ag images corresponding to albumin and the gamma-globulin
65.was noted. No free ^Zn was detected under similar con-
65ditions, and pure <5nCl2 remained at the point of application.
Of the two methods, the electro-immunodiffusion 
produced clear well defined protein peaks. The immuno­
electrophoretic method was employed to check for the
/r r f
dissociation of ^Zn which may have occured during the 
long, second electrophoretic run of.8 h in electro­
immunodiffusion. However, in this experiment no dissociation
v/as noted. It was noticed that the majority of pigment was
65associated vzith the biliary ^Zn binding protein and therefore
-96-
iFig.3.
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9 ImmunoCreacting proteins of rat bile.
The proteins were separated by immunoelectrophoresis. 
B = bile, S ss serum, BAS = antiserum to rat bile,
SAS = antiserum to rat serum.
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Fig. captions continued ...
Biliary proteins and serum proteins immuno-
precipitated with rabbit antiserum to rat bile. 
Three :.biliary proteins and two serum proteins 
were immunoprecipitated. The fast migrating, 
weakly immunoprecipitated protein was present 
only in bile. Two anode seeking spots were 
produced by bile in addition to the precipitin 
arcs and these were coincident with the front
end (=anodic end ) of the precipitin arc of the 
65^Zn binding protein and albumin-like protein, 
respectively. These spots were stained with 
Ponceau S and nigrosine, and were not removed 
when electrophoretic plates were washed with 
0.9% NaCl soln. The biliary pigments also 
associated these spots but were removed with 
saline.
Biliary proteins and serum proteins immuno- 
precipitated with rabbit antiserum to rat serum.
Two biliary proteins have electrophoretic and 
immunogenic properties similar to serum albumin 
and a gamma-globulin.
^ Z n  binding protein of bile.
65The dotted areas contained ^Zn and the broken 
lines outline the precipitin arcs due to biliary 
proteins immunoprecipitated with rabbit antiserum 
to rat bile and serum, respectively. Note the 
reaction of identity produced by the homologous 
antibody. When ^ZnCl^ Was added to bile (1juCi/ml)
notes continued....
and subjected to immunoelectrophoresis, the 
albumin band was also labelled.
Fig. The effect of biliary drainage on the composition
of biliary proteins.
Two bile samples obtained 24 h (upper) and 96 h
(lower) after bile duct cannulation were subjected
to immunoelectrophoresis. The continued
65biliary drainage lowered the yZn binding
protein and the albumin-like protein but the
65gamma-globulin arc became more prominent. ^Zn 
binding was not studied under these conditions.
0
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Fig. 3*10 Electro-immunodiffusion of bile,
B e* bile, BAS = bile antiserum.
Ten microlitres of bile obtained from ^ Z n  dosed rats
was placed in the well and electrophoresed in the 1st
dimension )« Electrophoretically separated proteins
ti
were then electrophore^cally forced into the biliary antiserum 
bed Proteins were stained with Bonceau S. Note the
presence of three immunoreacting proteins in bile. Dotted 
areas contained ^ Z n  located by autoradiography.
it is likely that the pigment exists in association with 
this protein.
In a further experiment the ^ Z n  binding protein in
bile was separated on thin-layer Sephadex gel as described
in Section 3-4-4 and the relevant band of Sephadex gel
removed. The protein was eluted from tie gel with a &w
drops of 0.9% NaCl by centrifugation in a modified
Torib.ara tube, by placing the gel over the sintered glass
disc for centrifugation. The resulting protein solution
6
was investigated by lmmunoelctrophoresis using bile antiserum,
65A precipitin arc was produced identical to the ^Zn binding
protein observed in whole bile samples. This confirmed that 
65the ^Zn binding protein of mol. wt. approx, 10,000 was 
' . 65identical with the ^Zn lmmunoreacting protein.
N
3-4-6 Paper electrophoresis of ^ Z n -p ro te in -c o m p le x  pn 
bile
In the previous experiments it was found that
65bilirubin normally accompanied the ^Zn binding protein m
bile. This simple experiment was designed to study further
the presence of ether biliary metabolites in association 
65with ^Zn binding protein. The containing bile was electro-
A
phoretically separated on Whatman 3MM filter paper, and 
a number of compounds were identified by spot tests. The 
Whatman paper was selected as a supporting medium for 
electrophoresis because the Agarose gel and Sephadex gel 
were not stable to some of the spot reagents.
Typical electrochromograms showing the areas of colour 
obtained with the spot reagent are shown in Fig. 3*11 and
- 101-
the results are given in Table 3-2. Samples electrophoresed
for 1,2 and 4 h did not show any variation of the constituents
associated with ^ Z n  protein zone. Althouth simple paper
electrophoresis may not have separated all the components of
65bile, it is indicated that the ^Zn binding protein may also 
be associated with amino acids, simple peptides, bilirubin 
-and glucuronic acidi cholesterol and possibly other lipids.
-102-
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Fig.3.11. Electrophoretically separated biliary components.
Ten microlitres of bile was applied as a thin band 
and subjected to zone electrophoresis at 20V/cm for 1 h,. and 
spot tests done to locate the compounds shown above.. A number 
of compounds migrated with the fast moving protein band and 
the position of ^^Zn (not shown) corresponded with the fast 
moving protein band.
-103-
Table 3.2
Test for:- Results
Proteins Three bands were visible, one at the point of 
application, a second weak band in the 
central zone and a third of maximum 
migration towards the anode.
Lipoproteins Two bands, one coincident with the fast
moving protein band.
Cholesterol Two narrow bands, one with the fast 
moving protein.
Bilirubin One bilirubin band, coincident with the 
fast moving protein band.
Amino acids Two bands, one at the point of application
(neutral
ninhydrin)
and a wide band extending from the fast
moving protein band towards the anode.
Glucuronic A wide zone extending from the point of
acid application to the fast moving protein
- -■ band abutting both major protein zones.
Bile acids A wide band between the major protein
«1
zones but not concident with them,A
65Zn One centimeter strips were counted for 
65•'Zn and the majority corresponded with
fast moving protein band.
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3-5 Summary
A group of rats v/eighing approx. 200g were cannulated
for the collection of bile. These were injected with
65approx. 20 uCi of 'ZnC^ in the caudal vein. Bile samples
obtained during the first 24 h after dosing were analysed
by a number of methods to study the chemical nature of
^ Z n  in bile.
Bile samples were subjected to ultrafiltration and 
65it was found that ^Zn in bile was not ultrafiltrable.
^ZnClg added to 0.9% NaCl soln. and to an ultrafiltrate
of pure bile was completely ultrafiltrable. This experiment
65indicated that all of the ^Zn in bile was bound to
macromolecular components. Exhaustive dialysis of bile
N 65samples against 0.9% NaCl did not remove ^Zn from bile.
However, the presence of EDTA in the dialysing medium
effected the removal of ^^Zn from bile at a slow linear
rate, and about 80% of ^ Z n  was dialysed over 48 h. This
evidence suggested that ^ Z n  was strongly bound to
macromolecules of bile. In_Sephadex (G-200) chromatography 
65^Zn m  bile was eluted in association with 280 nm absorbing
65materials and the majority of .^Zn (approx. 80%) was associated 
with a biliary protein of mol. wt. 10,000. Antisera for 
rat biliary proteins and-rat serum proteins were cross­
reacted with biliary proteins and it was confirmed that 
65the ^Zn binding protein was an immunoreacting protein 
which is present in bile, and not in blood serum. In paper 
electrophoresis of bile a number of biliary constituents 
were found to associate the ^ Z n  binding protein, thus
-105-
65leading to the conclusion that ^Zn excreted in bile is 
bound to a macromolecular complex.
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C H A P T E R  4-
TISSUE DISTRIBUTION OF ^ZnCZnCip
4— 1 Introduction
A number of studies have been reported on the
65tissue distribution of ^Zn and these were reviewed m
Chapter 1. The laboratory rat has been selected in most
of these studies as a model experimental animal. Although
a vast amount of information has been obtained in this
species these initial studies were carried out with high
doses of zinc carrying the radioactive tracer.
^ Z n  with a low concentration of carrier ainc was
used in this study to permit-the investigation of tissue
distribution of zinc at physiological levels. This study
was carried out in three sections:- 
65•^ Zn distribution in major organs and tissues,
65^Zn distribution in the liver, the pancreas, the
duodenum and the prostate gland at the cellular
level,
65^Zn distribution m  subcellular organelles of 
the liver tissue.
65Previous studies on the_tissue distribution of ^ZnC^
65indicate that, in soft tissues, ^Zn dees not equilibrate
until 3- 7 days following the intravenous administration .
65of a single dose of ^ZnC^* This study was designed to
65examine the tissue distribution of • ZnC^ in the 'pre- 
equilibrium' period before y days and then upto 10 days.
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An autoradiographic investigation was carried out
on some of the more important tissues in zinc metabolism,
namely, duodenum, liver, pancreas and the prostate gland.
The times chosen for this study were 2, 24 and 72 h after
administration of ^ Z n C ^ .
As the liver has been shown to play a central role 
65m  zinc metabolism, ^Zn distribution in subcellular 
organelles of liver was investigated to obtain further 
information on the behaviour of zinc in this tissue.
108
4-2 Experimental techniques 
4-2-1 Gross tissue distribution
Wistar albino rats ( approx. 230 g) were used, and 
the intravenous dosing of. ^ZnClg and counting of tissue 
samples were carried as described in Section 2-1-4 and 
2-2-3. At selected times after dosing the animals were 
anaesthetised with ether and samples of blood (8 ml) 
taken from the heart into a heparinised syringe. The 
animals were then killed by cervical dislocation and the 
following tissues were removed as quickly as possible
Liver Heart
Pancreas Lungs
Stomach v Spleen
Duodenum Kidneys
Prostate gland Testes
Thigh muscle
Bloodr" Blood samples ( approx. 2 ml ) were centrifuged
at 600 rev/min in a bench centrifuge for 5 - 8  min. The
supernatant plasma was pipetted out and 1 g aliquots were
65taken for the assay of ^Zn. The formed elements of blood 
were washed free of plasma proteins using a quantity of
0.9% NaCl soln. equal to the volume of plasma removed.
The cells were gently dispersed in the saline and centrifuged
as before. The supernatant saline soln. was removed and 
the blood cells were washed twice more. Finally the packed 
cells were.transferred to the counting vials.
65Liver. For the assay of ytLn in the liver, tissue samples 
( approx. 1 g ) were removed from the centre of the right
-109-
anterior lobe. To establish whether the distribution 
of ^ Z n  in the liver was uniform, the distribution of ^ Z n  
in the different lobes of the liver was examined by taking 
samples (0.3 - 0.5 g) from each of the five major 
liver lobes from a group of rats. In another group of rats 
the total ^ Z n  content of the liver was estimated by 
weighing the the whole liver and assaying a representative 
sample.
Pancreas. As the pancreas in the rat is a diffuse tissue 
suspended in the omentum and its distinction from adipose 
tissue is difficult, a guide dissection was prepared to 
show the pancreatic tissue delineated from the associated 
tissue. A rat was intravenously injected with 0.1% eosin 
soln. and five minutes later was sacrificed and the pancreas 
removed from the associated viscera and placed in a bath 
of 1.0% potassium dichromate soln. The eosin stained the 
pancreatic tissue and the dichromate stained the adipose 
tissue. A thorough study of this preparation enabled the
“pancreas in ^ Z n  dosed animals to be dissected.
Pieces of pancreatic tissue lying in the duodenal loop 
(head), from the splenic end (tail) and from the mid-portion 
were removed for the assay of ^Zn.
Stomach and duodenum. These were opened up and their contents 
removed by washing under a jet of saline. The excess saline 
was removed by lightly blotting the tissue between filter 
paper.
Prostate gland. This gland was removed as a whole and 
cleaned free of adipose tissue.
Heart, Heart was opened to expose the chambers and cleaned 
with a jet of saline to remove blood. The excess saline was 
blotted off.
Other"tissues. Lungsspleen, the left kidney and the left 
testicle were removed from the carcass and assayed whole.
- All the muscles of the left thigh were removed from the 
femur.
All tissues were transferred into prev/eighed counting
vials as they were dissected out and the vials were capped
to prevent the dessication of the tissues. When all the
organs had been transferred, the bottles were reweighed- 
65and the ^Zn radioactivity assayed in the gamma-ray 
spectrometer as described in Section 2-2-3*
The tissue distribution of ^ Z n  was also studied in
a group of rats which were given an additional oral intake 
of unlabelled ZnS04 as described in Section 2-4-5.
4-2-2 Autoradiography
A group of six rats were each injected with 20jiCi 
of ^ZnCl^ and killed at selected time intervals. Samples 
( approx. 3 mm cubes ) were taken immediately from the 
median lobe of the liver, the tail of the pancreas, the 
left dorso-lateral lobe of_the prostate gland and the duodenum 
near the opening of the bile duct.
The tissue samples were frozen by immersion in 
n-hexane cooled tn -70° in a bath of solid CC^ and acetone.
The frozen tissue was removed from the n-hexane bath within 
a minute and placed on a pre-cooled microtome chuck which 
was kept in the cryostat (Slee, London), at 3^0°;
-HI-
Tissue was glued to the chuck with a thin film of Tissue 
Tek (Ames CO., U.S.A.) surrounding the tissue cube at its 
base. After 15 - 20 min the top layer of tissue cube was 
sliced off in 20su sections to expose the tissue in the 
centre. This central tissue was least exposed to n-hexane,
0 n O
Tissue Tek, sudden temprature elevation from -70 to -50
A
and moist atmosphere of the cryostat. Histological sections 
(5su thick) were cut and picked-up directly on AR.10 Stripping 
film for autoradiography (Kodak Ltd., London). The films 
were maintained between 0° to -4° for proper picking-up.
Once a section was removed the cutting area of the knife 
was thoroughly cleaned with a moist tissue paper before the 
next section was cut.
N
The films were exposed in light-tight boxes containing
silica gel for approx. 4 months at -10°♦ After exposure
the preparation was allowed to warm to room temperature
and the histological section fixed using 10% (v/v)
formaldehyde solution for 10 min. Excess formaldehyde was
removed by washing in distilled water. Photographic
development was carried out as described by the manufacturer
(Kodak Ltd.). Histological sections were stained with freshly
diluted Ehrlich's haematoxilin soln. (haematoxilin:water$
1:3) and 1% aq. eosin. "The preparations were dried in
o n
air and mountedAmicroscope slides using a drop of Euparal 
for each slide.
The autoradiographs thus prepared were examined 
under a light microscope at magnifications of x 95i x 240 
and x 600 to study the Ag grain distribution in relation
-112-
to cell types. In some studies the grain density was 
estimated by counting the grains using a graticular eyepiece. 
This was done at a higher magCnifcation, x 1000 using 
an ojll immersion lens, and the field of view within the 
area (0.178 x 0.178 mm) of the graticule will be referred 
to as a unit area.
654-2-3 Subcellular distribution of ^Zn in the liver
Eats were injected with 20pCi of ^ Z n C ^  and killed 
by cervical dislocation at selected times after dosing.
The livers were removed immediately and perfused through 
the hepatic vein with 0.23M-sucrose soln. chilled in ice. 
About 0.3 g of perfused liver was excised from tie median 
lobe for ^ Z n  assay and the'remainder was subjected to 
homogenisation and differential centrifugation.
The livers from two rats were combined and squeezed 
through an ice-cold stainless-steel mincer (pore size 0.1mm). 
The pulp was homogenised in 0.25M-sucrose (1:4 by weight), 
in a Potter Elvehjem homogeniser with 12 complete strokes. 
Preparation of the subcellular fractions was achieved 
using the differential centrifugation scheme outlined in 
Fig. 4.1.
All procedures were done between 0° and 4° using
unbuffered 0.25M-sucrose soln. The final pellets were 
s
dispelled in 0.25M-sucrose with the aid of Pasteur pipetted 
followed by mixing in a whirly mixer. Samples of each 
homogenate were taken in duplicate for ^ Z n  assay ( 1 ml) 
and protein estimation (0.2*ml).
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Protein content of the samples was estimated using 
the procedure of Lowry et al. (1951)• The whole homogenate 
was diluted 1:100, the lysosomal fraction 1:25 all 
other fractions 1:50. A standard plot was prepared using 
crystalline BSA soln. in lM-NaOH. The absorbance of 
the protein-reagent chromophore was read in a spectrophotometer 
(Unicam SP 500)at 750 nm.
-114-
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Notes for Fig.4.1.
The underlined fractions were assayed for ^Zn.
The volume in brackets indicate the volume of homogenate 
and suspended pellets equivalent to 1 g of original tissue. 
*MSE High Speed (13000) centrifuge using 8 x 25,13° angle 
head rotor.
+Spinco Ultracentrifuge (Model L) using 12 x 12, No. 40 
rotor.
h
Resuspended in 2.4M-sucrose using two slow strokes in
ground glass homogeniser with a loose-fitting pestle.
2 v Resuspended in 0.25M-sucrose.
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4-3 Materials
The autoradiographic film, Stripping film AR.10 
was obtained from Kodak Ltd., London and the photographic 
chemicals from Johnson Ltd., London. Histochemicals 
were obtained from R.A.Lamb, London.
-117-
4-4 Experimental results
4-4-1 Tissue distribution
Male rats were injected intravenously with 20viCi 
^ZnCl'2» killed at selected times and the tissues and blood 
assayed for ^Zn. The distribution of ^^Zn was studied 
_over three different time periods:-
Short term - from 10 to 40 min after injection 
Medium term - from 1 to 6 h after injection 
Long term - from 1 to 10 days after injection.
The experimental design was:-
Short term
Time of killing (min) 10 20 40
Ho. of animals 5 "5 5
Medium term
Time of killing (h) 1 2. 3 4 6
No. of animals 4 4 3 4 4
Lbng term
Time of killing (days) 1 3 4 5 6 9 10
No. of animals 3 3 3 3  3 3 3  3
The ^ Z n  in the blood and tissues was expressed as a 
percentage of the injected dose per gram wet weight of 
tissue.
Plasma. The disappearance of ^ Z n  from the plasma over the 
first 6 h is shown in Pig.4,2. Analysis of the plasma clearance
from 0-24 h
curve^ indicated the presence of two components with half-iives 
of 0.85 h and 4.4 h, respectively. The experimental point
-118-
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Fig.4,2. The analysed plasma clearance curve.
For the evaluation of the slower process 
the clearance curve was considered up td 
24 hours ( not shown in the figure ). 
mean + S.D. for 5 animals
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determined for two hours was anomalous and was
significantly different (p— 0.01) from the anticipated point
65of the curve. ^Zn was still detectable in the plasma up to 
10 days after injection and the long term values are given 
in fable 4-1.
Table 4-1 Long term plasma clearance of ^ Z n
Time of withdrawal of blood 
after ^ Z n  injection (days)
1 '
He an + 
0.068
s.d
0.007
2 0.029 0.008
4 0.012 0.008
5
N
0.017 0.003
6 0.018 0.002
9 0.012 0.003
10 0.006 0.002
Values are means + s.d. for three rats.
65Liver The concentration of ^Zn in the different lobes
of the liver was investigated in a group of 8 rats,
intravenously injected with 20pCi of ^Zn'Clg. Five rats
were killed 2 h after the injection and the others after 
6524 h, and the ^Zn assays were carried out on liver 
samples taken from the five lobes. 6^Zn assay results are 
shown in Table 4-2. These results indicated fairly similar 
^ Z n  concentrations in the five lobes. Therefore a tissue 
sample from any one lobe could be assayed to estimate the
-120-
65^Zn in blood plasma 
(% of dose/g)
65•'Zn concentration in the liver*
Table 4-2 ^^Zn distribution in different lobes of rat liver
Liver lobe ^ Z n  ( % dose/g ) at: -
2 h 24 h
Mean hI s.d. Mean + s.d.
Posterior right lobe 2*1? 0.58 1.41 0.32
Anterior right lobe 2.08 0.59 1.39 0.28
Median lobe 2.14 0.56 1.28 0.26
Left lobe 2.35 0.62 1.28 0.24
Caudate lobe 2.12 0.75 1.29 0.28
No. of rats 5 N 3
In another experiment a group of rats were injected (i*v*)
with 2QpCi of ^ZnCl^* The livers were removed at 0*33* 2,
6, 24 and 48 h after injection and weighed whole* A sample
(0*3 g) was taken from the anterior right lobe for ^Zn. assay*
65Zn content of the v/hole livers are sho^n in Table 4-3* It
can be seen that more than a third of the tracerdose entered
the liver initially but the hmount fell rapidly to approx#15%
65at 6 h. from 6 to 48 h ■ Zn content in the liver f e n  
slowly. '
65
In another experiment, the uptake and clearance of Zn 
in the liver was examined on a wider time scale from 10 min 
to 10 days* Liver samples were obtained from rats used 
in the gross tissue distribution studies, where other tissue 
samples were analysed too. These rats were dosed normally
-121-
65and killed at selected times after dosing. •'Zn assays
were performed on liver samples obtained from the right
65anterior lobe (0.5 g) and ^Zn concentrations expressed
as a percentage of the injected dose. The results are
given in Tables 1 and 2 given in the Appendix.
65The 'Zn concentration curve of the liver is presented
in Fig. 4.3. The curve - shows an uptake portion and a
clearance portion demarcated by a peak concentration level.
65The maximum 'Zn concentrations were achieved rather rapidly,
i.e., before one hour. Once the peak concentrations were 
reached ^ Z n  was a-t first released from the liver rather 
rapidly, but the clearance rate was slower from 6 h to 3 days, 
and became extremely slow from 4 to 10 days.
■" T ' " . ' . . . . . .    J Z 1 -  3  L U - U - U   -  —
Table 4-3 'Zn concentration in the whole liver
Time after injection 
(hours)
65Liver 'Zn content 
(total % of dose)
No. of animals
Mean + s.d.
- 0.35 40.27 3.22 5
~  2 22.79 4.13 5
6 15.67 3*48 4
24 15.58 2.67 3
48 13.78 2.82 3
65Pancreas Small tissue samples from the pancreas of the 'Zn 
dosed rats were obtained from the head, mid-portion and 
tail of the pancreas and were pooled for ^ Z n  assay.
-122*.
32
©
o
I 2 3 4  5 6 9 IO2  4  6
Hours Days
65
Fig,4.3• Za concentration in the rat liver after a
65single i.v. dose of -'ZnCl^.~     ^ -
Points and bars are means + s.d.
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In the pancreas, the concentration of ^ Z n  increased up to
2 h, to reach a peak level (Fig.4,4). From 6 - 72 h 
65the ^Zn concentrations decreased at a rate higher than
the period following this, i.e. 3 - 10 days. Using these
65assay values the total loss of ^Zn from the pancreas was 
calculated, and this amounted to 2 — 3% of the dose for
than
the period from 2 - 24 h and lessA1% from 24 - 48 hours.
3
2
Days after injectiooHours
65Fig. 4.4 ^Zn concentration in the rat pancreas after 
a single i.v. dose of ZnCl^
Points and bars are means i  s.d.
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Kidney The ^ Z n  in the left kidney was assayed and the
^Zn concentration, calculated as a percentage of the
injected dose, is presented graphically (see Fig* 4.5)*
65
The'kidney.showed a rapid uptake of ^Zn earlier than
a
two hours and showed gradual clearance through the course
A
of the study.
•H
•H
D a y sH o UR sLA
65 •Fig. 4.5 ^Zn concentrations in the kidney following a
• 65
single i.v. dose of ^Zn Cl,-,.
Points and bars are means + s.d.
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Duodenum A portion of.the duodenum was removed from the ■ 
^ Z n  dosed rats and the ^ Z n  content expressed as a 
precentage of the injected dose as shown in Fig. 4.6.
The duodenum showed fluctuating ^ Z n  levels during the
first 6 h after injection with maximum concentrations
e 65
achived around 2 h. The clearance of ^Zn during 1-10 days
occurred rather slowly, in a manner similar to that of the
liver, pancreas andfkidney.-
8T
-8
A
8
2
2  4  6
Hours
//
/u
Days
9  I O
Fig. 4.6.
65Zn concentrations in the duodenum after a
65single i.v. dose of ^ZnClp. 
Points and bars.are mean + s.d.
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65xZn concentrations in the liver, pancreas and 
kidney showed variations among the individual animals during
the period 10 min to 6 h. From 1 to 10 days these tissues
and particularly the duodenunij throughout the course of
65the study, showed smaller individual variations in ^Zn 
levels*
The spleen, lungs, stomach, heart and thigh muscle 
were obtained from the same animals and the ^ Z n  levels 
are expressed as a percentage of the injected dose as 
shown in Fig.4.
Spleen ^ Z n  concentrations in this organ increased at 
a slower rate and then showed a slow clearance.
65Stomach ^Zn concentration in the stomach remained 
almost steady during 10 min to 4- - 5 days, and the 
clearance was extremely slow.
65Lungs The lungs showed an initial clearance of ^Zn 
up to"one hour followed by a slow increase up to 2^ h 
which then decreased slowly.
65Heart Heart contained lower xZn levels than the lungs
65but otherwise behaved similarly to lungs in ^Zn uptake 
and clearance.
Thigh muscle Muscle showed slowly increasing ^ Z n  levels 
over the 10 days following injection.
*^Zn was assayed in the prostate gland, left testicle and 
blood cells of the same animals used for the other tissue 
assays and the results are shown in Fig.4.8.
65Prostate gland This showed an increase in ^Zn up to 24 h
-129-
followed by a slow clearance.
Blood cells These showed an intial decrease followed by
65an approx, constant level of ^Zn over 10 days.
65Testes Testes slowly accumulated ^Zn for at least 6 
days and showed a decrease afterwards.
The effect of additional oral ZnS0/; on the tissue
65distribution of i.v. ^ZnClo*
A group of six rats were force-fed with 2.0 mg of
non-radioactive ZnSO^^^O daily for 30 days. Three
control rats were given de-ionised water by gastric
intubation. On the 31st day all rats were injected with 
6520|uCi of ^ZnC^, intravenously. Twenty four hours
65later these were killed and ^Zn levels in plasma and
tissues were assayed. The results are presented in
Table 4-4. Daily ZnSO^ feeding resulted in increased 
65^Zn levels in the kidney, liven,muscle, pancreas and
duodenum while significantly lower levels were found in the
spleen.and the prostate gland* . Plasma and stomach
65^contained similar ^Zn leveljs to that of controls.
4-4-2 ^^Zn localisation in pancreas, liver, duodenum and 
prostate gland ^
65Six rats were injected with 20?aCi of ^ZnC^ 
in the caudal vein and killed in groups of two at 2, 24 
and 48 h after injection. Histological sections of the 
liver, pancreas, duodenum and prostate gland were 
autoradiographed. Identical tissues obtained from a 
control rat demonstrated that chemical fogging was not
-130-
involved and the grain count obtained with these tissues 
were considered as the background levels.
The autoradiographs of the pancreatic tissues were 
examined at a magnification of x 600. At the three time 
intervals, 2, 24 and 48 h,Ag grains were located over the 
thin connective tissue capsule that surrounds the pancreas 
and over the interlobular septa that demarcate each lobule. 
In contrast, the tissue enclosed within the connective 
tissue capsule contained more Ag grains. Grains were 
counted over the islets of Langerhans (endocrine tissue) 
and over the acinar tissue (exocrine tissue) at a 
magnification of x 1000. Grain counts were made over the 
control autoradiographs similarly. The results of this 
experiment are shown in Table 4-5*
-131-
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Eig,4.9. ^^Zn localisation in the basal region of
acinar cells of rat pancreas•
C •= centroacinar cell, D = lumen of the acinus.
A diagrammatic representation of a pancreatic
acinus. The pancreas was obtained 2 h after 
£* £“ 3 -
i.v. injection and^5ju thick histological
section was autoradiographed. Black dots
represent Ag grains due to ^Zn.
( viewed at a magnification of x 600 )
- 133-
if
Fig. 4.10. ^^Zn in the granular cytoplasm of acinar cells
of rat pancreas.
A = acinar cell, N = nucleus •
A diagrammatic representation of an acinus.
The pancreatic tissue was obtained 24 h after 
65i.v. ^ZnCl^ Injection. Black dots represent 
Ag grain pattern in acinar cell autoradiographs. 
( viewed at a magnification of x 600 )
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Table 4-5 Silver grain counts in the autoradiographs of 
Pancreas
Time after injection Grains per unit area over:-
(hours) Islet tissue Acinar tissue
Mean + s .d. Mean ± s .d.
2 68 12 (27) 77 14 (27)
24 38 8 (32) 35 12 (32)
48 24 8 (35) 20 8 (35)
Control 4 2 ( 9 ) 3 2 ( 9)
Total number of areas counted are shown in brackets.
. N
These results indicated a lowering of the grain count
over the islets as well as the exocrine tissues from 2 to 48 h.
The islet and acinar tissues contained similar grain
densities at a given time interval.
A difference was noticed in the manner in which Ag
grains were distributed within the component cells of the
endocrine and exocrine tissue. In the exocrine tissue 
652 h after ^Zn injection, a large number of acini frequently 
65showed ^Zn localisation in the cytoplasm in the basal
portion of the acinar cell' (Pig. 4.9) and at 24 h most of 
65the ^Zn was found to cluster in the central and apical
areas of acinar cells in all acini (^ig. 4.10). The
65distribution of ^Zn in the islet tissue appeared uniform 
and no specific localisation within the cell could be
-135-
observed.
Liver The autoradiographs prepared from liver sections 
were examined at x 600 magnification, and numerous silver
grains were found in the blood vessels, the cells and the
- 65sinusoids. At the time intervals of 2, 24- and 4-8 h, ^Zn
appeared to be uniformly distributed in the whole histolo­
gical section of the liver.
Duodenum A small portion of the duodenum proximal to
opening of the bile duct v/as obtained 2, 24- and 4-8 h after 
65^Zn injection. Autoradiographs of tissue sections revealed
65the presence of ^Zn in all types of cell at all three time
65intervals. Autoradiographs obtained 2 h after ^Zn injection 
showed that the tissues between the serosa and muscularis 
mucosa contained a smaller number of grains in comparison
N
with the tissue between the muscularis mucosa and the duodenal
lumen. Clusters of grains were visible at the base of
crypts of Lieberkuhn near the muscularis mucosa (Pig. 4-.11
and 4-.12). The end of the crypt near the lumen of the
duodenum was less radioactive. Also the crypts cut transver-
65sely at a point above the basal region did not show the ^Zn 
concentration noticeable in the basal portion of the longitu­
dinally cut crypts confirming that the ^ Z n  localisation 
occurred in the basal region of the crypts and not along 
its length. The villi at 2 h showed a uniform grain 
distribution and contained a lower grain density than 
the basal crypts. The localisation of ^ Z n  seen 
in the basal crypts at 2 h had disappeared by 24- h.
At 24- and 4-8 h more grains in the form of streaks running
-136-
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in a longitudal section, were localised over the centre of 
the villi in the lamina propria (Fig. 4.13a). At this 
time, localised clusters of silver grains were also 
noticeable in the duodenal lumen, in the spaces between 
the villi. These clusters were more concentrated near 
the goblet cells, and some goblet cells showed the presence 
of clusters of Ag grains within them (Fig. 4, 13b') and at 
the luminar end of the cells.
a
Prostate Thin histological sections of the dorso-laterl
65prostate gland were autoradiographed to study the ^Zn
distribution, 2, 24 and 48 h after injection of ^Zn.
65These autoradiographs showed the presence of 'Zn in the
connective tissue capsule at the periphery of the gland,
the fibromuscular stroma consisting of connective tissue
and smooth muscle and the interstitial tissue with capillaries,
These structures contained fewer Ag grains in comparison
with the glandular follicles, some of which showed massive
concentration of ^ Z n  within the follicular lumen (Fig.4,14)
The epithelial cells lining the glandular cavity
were heavily labelled particularly at 24 h (Fig. 4.13)
Often-. the secretion and concretions of the secretion also
contained ^^Zn in high amounts at all times studied (Fig. 4.16).
The autoradiographs showed marked differences in grain density
in different areas of the-same~~ section with some follicles 
a
containingAlarge number of grains and others in their 
immediate neighbourhood containing only a few grains.
-144-
654-4-3 Zn distribution in subcellular fractions of the
liver
Sixteen rats were injected intravenously with 
6520juCi ^ZnCl2» These were killed in groups of four at
0.3, 2, 24, and 48 h after dosing, the livers were homogenised
and subcellular fractions prepared.
65The ^Zn content in 1.0 g of unhomogenised liver 
was compared with that in l.Og of 100% whole homogenate.
The results were as follows
Time after ^ Z n  
injection (h)
Homogenate 
Liver 65Zn
6^7n-- —  x 100
Mean + s .d.
0.5 N 114 4.24
2.0 107 6.82
24.0 98.7 4.44
48.0 92.5 4.82
65Initially more Zn was recovered, in the whole homogenate
in comparison with the unhomogenised liver and the figures
progressively decreased with time. This difference may be 
65due to ^Zn in the connective tissue which did not pass
through the mincer. In view-of this all subsequent results
65have been related to the ^Zn content of the whole homogenate.
^ Z n  content in the subcellular fractions was calculated
65as a percentage of the xZn content m  the total homogenate
and the results are shown in Fig. 4.17. The majority of 
65^Zn was present m  the cytosol and decreased in order m
-145-
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the microsomal, nuclear, mitochondrial and lysosomal
fractions. The lysosomal fraction (not shown in the
65figure) contained the smallest amount of ^Zn (i.e. 1-2%).
Although in this study the microsomal fraction contained
similar amounts of protein to that of nuclear and mitochondrial
65fractions the former contained more ^Zn than the latter
65two fractions. The ^Zn recovered in the subcellular. 
fractions amounted to 91 - 95% of total homogenate content 
at the time intervals studied. The protein recovery was 
approx 95% in this experiment.
In the tissue distribution study it was seen that
65 ' 65after ^Zn injection, the ^Zn content of the liver decreased
from 0.5 to 48 h. This decreasing radioactivity was also
shown by the total homogenate and the subcellular fractions
except the microsomal fraction in this study. In contrast
65the microsomal fraction showed an increase in the ^Zn 
content around 2 h, which then decreased after 24 h.
Samples of the cytosol obtained at 0.5*2,24 and 48h
dr e
were crorna.tographed on Sephadx G-200 under identical conditions
A/ r A
to those described for bile (see section 5-2-4). The
eluate was monitored at 280 nm for protein content and assayed 
65for ^Zn. All samples showed an essentially similar elution 
pattern and the results for the 24 h samples are shown in 
Pig. 4.18. Approx. 95% of the' radioactivity was recovered 
from the column in association with high mol. wt. material.
The majority of the ^ Z n  was associated with material of mol. wt.
0
less than albumin but grater than 10,000. However, it was 
to 6SU
not possibleAcorrelate^with any discrete 280 nm absorption peaks.
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65In the region in which the ^Zn biliary complex was
eluted3n the study on bile, i.e. at an elution volume
of 420 ml, approx. 2% of the ^ Z n  in the cytosol was
65eluted as a distinct peak. A smaller peak of Zn was 
noted at 440 ml.
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4-5 Summary
65The tissue distribution of ^Zn was investigated
3l ' ' 65onAtime-course basis after intravenous injection of 'ZnC]^
in ratSo Hollowing the dosing ^ Z n  was detectable in blood
65plasma and all soft tissues assayed for ^Zn for a period
65of 10 days. The ^Zn concentrations occurred in decreasing
order in the pancreas, liver, kidney, duodenum, spleen,
stomach, lung, heart, prostate gland, testes, thigh muscle
and the formed elements of blood, during the first 24 h 
65after ^Zn injection. Each tissue had a characteristic
65
Zn concentration curve and those for the liver and
pancreas in particular showed an uptake phase and a clearance
65phase demarcated by a peak concentration level. The ^Zn
uptake in the kidneys, liver, pancreas and duodenum was
rapid in comparison with the spleen, stomach, lung, and
heart and the prostate gland. However, after 1-2 days 
65the ^Zn levels in all of these tissues decreased and
at 10 days they all contained approx. the same amount of 
65^Zn per gram wet weight. The testes, voluntary muscle
and the formed elements of blood slowly accumulated ^Zn.
This study revealed that each of the soft tissues had a
characteristic turnover of ^Zn. Additional oral ZnSO^
feeding resulted in changes in the normal tissue distribution
65of a trace dose of ^Zn.
65^Zn distribution in the pancreas, liver, duodenum 
and prostate gland was investigated by autoradiography. In 
the pancreas, both exocrine and endocrine tissue contained
^Zn, 2-48 h after infection. The acinar cells showed
65higher levels of ^Zn in the cytoplasm at the base of
the cells, 2 h after ^ Z n  injection and at 24 h and 48 h
more ^ Z n  was localised in the cytoplasm, in the central
and apical areas. In the duodenum ''Zn was detected in
the Paneth cells of the crypts of Lieberkuhn and in the
lumen of the crypts^ 2 h after dosing. At 24 and 48 h 
6 *)Zn was localised along the centre of the lamina propria of
villi, in the goblet cells and in duodenal lumen near
the goblet cells. In the dorso-lateral prostate of sexually
65mature ra-bs there was § great variation in the ^Zn distri­
bution in glandular follicles with some showing a heavy 
65^Zn localisation within the epithelial cells of the
6 5
secretory units and follicular lumen. In the liver tissue - Zn 
was uniformly distributed in polygonal cells and Kupffer 
cells.
65^Zn distribution in the subcellular fractions of 
65the liver of ^Zn dosed rats was investigated. All subcellular
65fractions contained -'Zn with the highest amount in the 
cytosol followed by the microsomal fraction. The cytosol 
showed a gradual clearance of ^ Z n  after the injection,
however, the microsomal fraction showed an increase in
6^ wthe ^Zn content around 2 h folloed by a decrease.
—  A u
—  6 5The liver cytosol obtained from ^Zn dosed rats was
chromatographed on Sephadex gel and it was found that approx. 9056
of ^ Z n  was associated with 280 nm u.v. absorbing material
of mol. wt. 10,000 to 60,000.
These studies clearly indicated the ubiquitous
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65distribution of i.v. injected ^Zn in the soft tissues^in.. 
different types of cells and subcellular organelles of the 
liver.
152-
C H A P T E R  3 
D1SCUSSIQH
Simple experiments were conducted in rats using 
^Zn^+ containing a known amount of carrier zinc, and 
the behaviour of the zinc dose v/as monitored by assaying 
the ^ Z n  radioactivity. In the absence of evidence to 
the contrary, it v/as assumed that the radioactive atoms 
of zinc were not discriminated by the body mechanisms 
from the natural non-radioactive dietary zinc isotopes 
(^qZn, |gzn, ^Zn). It was also assumed that the conditions 
under v/hich the animal experiments were conducted would not 
alter the zinc metabolism in the test animals to a degree 
greatly different from that of normals. However the test 
conditions have been clearly^defined in order that the 
experiments could be repeated and the interpretations 
re-evaluated when the body mechanisms are better understood.
The test dose of zinc (0.2 fig) used in these experiments
in rats represented a small quantity of zinc in comparison
with the normal, daily dietary intake (approx. 400 (ug).
Assuming the blood volume of test rats to be approx. 7% of
body weight, the normal zinc content in the blood
4 fig zinc/ml, and the plasma zinc to be 12% of blood zinc,
it can be calculated that the total dose given intravenously
v/as approx. 2% of the plasma zinc and approx. 0.3% of the
total blood zinc. Therefore the total dose represents a
very small increase in the plasma zinc level', and it can be
referred to as a sub-physiological dose. The intravenous
65administration of ^Zn in sub-physiological amounts can be 
expected to result in its incorporation into the normal
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metabolic pattern of endogenous zinc. Therefore the 
following discussion refers to normal physiological and 
biochemical aspects of zinc metabolism in the rat.
The whole body counting showed that the zinc in the 
body is removed by at least two rate processes described by 
two exponential components (tq ^=2.5 days and tQ ^=73 days).
Of these the rapid component operates immediately after 
zinc dosing. In the study of Ballou and Thompson (1961) 
using high doses of zinc they obtained a substantially 
larger value for this initial process (tQ days) and 
when considered with the present study this may indicate 
that the body has a limited capacity to excrete zinc.
The elimination of zinc from the body is brought about
by excretion in faeces and urine, and this has been shown 
by various workers using zinc assays on faeces and urine 
of normal animals, and on test animals injected with ^ Z n  
containing high amounts of carrier zinc. The present experi­
mental results with .trace amounts of zinc are in good
agreement with these findings. The major route of zinc
66excretion is the faeces, although ^Zn was detectable in 
urine at all times at approx* one hundredth of the amount 
detected in faeces. Although cnly small amounts of ^ Z n  
were excreted in the urine in this study, a comparison with 
the findings of Mclsaac (1955) shows that the urinary excretion 
of 6^Zn is significantly higher after the intravenous 
administration of comparatively high doses of zinc. Mechanisms 
that regulate zinc excretion may operate in the gastro-intestinal 
tract and the kidney to control the quantities of zinc excreted
under normal.conditions. Increased urinary excretion of -
zinc may occur when systemic zinc levels are high., as
after-intravenous administration, and the capacity of
the gastro-intestinal tract for the elimination of zinc
is saturated.
In the present investigations, the amount of ^ Z n
recovered in faeces and urine was greater than the whole
body loss as calculated from whole body counting studies.
The lack of correlation between the body content of ^^Zn
and the excretion data is attributed to the errors inherent
in the counting of the whole body radioactivity due to
changes in geometry associated with tissue redistribution
of ^Zn. When whole body clearance of ^^Zn was estimated 
65using faecal ^Zn excretion, the tQ ^ values obtained were
considerably lower than those obtained by whole body counting.
It is considered that the values obtained from the excretion
data more accurately represent the tQ ^ of the rate processes
involved (tQ 1.3 days and t^ 14 days).
65Faecal excretion of ^Zn was significantly retarded
in test animals treated orally with non-toxic doses of
non-radioactive zinc as ZnSO^. Evidence is available from the
studies of Miller et al.(1970) "in cattle, that increased dietary
zinc brings about a decreased absorption of an oral tracer dose 
65of ^Zn, yet results in increased stable zinc levels m  tissues*
The decreased absorption in Miller*s study may have been due to 
65dilution of ^Zn by stable zinc, resulting in decreased -
65 .absorption of ^Zn. However, the increased tissue deposition
a
indicted that the total zinc absorption from the gut was
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increased and tissue accumulation resulted. Similarly in
intubation of ZnSO^ in the present study, although the
fraction of zinc absorbed may have decreased, there may
have been an increase in the total amount of zinc absorbed
with a concomitant rise in tissue zinc levels. This would
lead to the lowering of the specific activity of tissue ^Zn,
65which could result in the decreased ^Zn excretion seen in 
this experiment, where a sub-physiological dose was used 
intravenously. With regard to zinc absorption and excretion, 
homeostatic mechanisms have been postulated by Cotzias et al. 
(1962). These mechanisms were- observed with high levels of 
test doses of zinc and hence the present result obtained with" A
a sub-physiological dose do not contradict the Existence of 
such mechanisms.
It is also possible that the ZnSO^ intubation may have
stimulated the synthesis of a protein such as the liver zinc
binding protein, described by Davies et al.(1972)* They
demonstrated the synthesis of this protein in rats after a
single intraperitoneal injection of ZnSO^. The daily
dosing of rats with ZnSO^ in the present studies coixld have
maintained the concentration of this protein in high amounts
65sufficient for the binding _of the tracer dose of ^Zn, which 
may have retarded its excretion .
Although analytical grade ZnSO^^I^O was used in the 
present experiment, the ZnSO^ had an assay value of 0.001% 
for Cd (quoted by the manufacturer), and therefore in this 
experiment the animals might have received upto 0.02[ug Cd per 
day by intubation. It is known that trace amounts of Cd
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have a retarding effect on the faecal excretion of ^ Z n  in
mice (Cotzias et al., 1962), due to the synthesis of
metallothionein (Shaikh & Lucis, 1970). The occurrence of
metallothionein in mammalian liver and renal cortex under
normal conditions, due to life-long accumulation of Cd in
these tissues, was shown by Shaikh and Lucis (1972). This
protein also contains zinc in addition to Cd and can also
bind zinc (Pulido et al.,1966). Thus the presence of Cd in
test ZnSO^ soln. used in this study may also have resulted
65m  the retarded -^ Zn excretion due to the synthesis of
metallothionein in the test animals. Rats in this experiment
excreted normal quantities of ^ Z n  in the urine and therefore 
£
the increased non-radioactive zinc levels in the body failed to 
66alter ''Zn levels in urine. This also may be due either to
65protein binding of ^Zn or to lowering of the specific activity 
of the ^Zn. '
The investigation of ^^Zn in the exocrine secretions
of the pancreas and liver showed that the secretions contributed
nearly 30% of the total faecal ^Zn. j_s therefore possible
that the other 70% of the faecal ^ Z n  was excreted by the
gastro-intestinal tract itself. The pancreatic fluid contained 
65more ^Zn than bile and in„this~ respect these results compared
favourably with the findings on the dog (Montgomery et al., 1943)• 
65^Zn excretion m  pancreatic fluid occurred within one hour of
^ Z n C ^  injection, and increased to maximum levels (in parallel 
65with the Zn levels, in the pancreas) and then declined rapidly.
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65The pattern of yZn excretionjin bile was more complex
and also constituted an important source of faecal zinc. ^ Z n
levels"in bile showed fluctuations in a rhythmic manner with
the maximum levels in the morning and the minimum levels in
65the night. This variation in ^Zn level was not directly
related to the dietary intake of stable zinc. The onset of
lowering of the radioactivity in bile began before the food
was offered to the animals. Therefore it is likely that the
65diurnal variation in levels in bile is a true biological
phenomenon occurring in the liver. The diurnal variation in 
65biliary ^Zn excretion may reflect,
(a) The anabolism and ^ catabolism of zinc 
containing compounds in the liver,
(b) The excretion of zinc containing 
compounds in bile.
65' The bile obtained from ^Zn dosed rats v/as investigated 
65for ^Zn containing compounds. The techniques employed 
were essentially those used for the study of proteins, and 
the separation of the biliary components was attempted in a 
manner to affect minimally the chemical nature of the compounds.
The ultrafiltration experiment demonstrated the absence 
65 65of free ionic ^Zn or ^Zn bound to small molecules which
could be removed with the ultrafiltrate. It is possible that 
65 •the ^Zn could be held in mixed ligand complexes, in which 
65the ^Zn is bound to low mol. wt. compounds which in turn 
are bound to macromolecules. If these were present, the 
association was not disrupted by thermal agitation at tempera­
tures of 4-29°. Therefore the result of this experiment
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clearly showed that zinc in bile does not exist as free ionic .
zinc normally. The findings of exhaustive dialysis of bile
agreed with this result and indicated that ^ Z n  in bile is
in a strongly bound form which could, however, be removed by
EDTA at a slow linear rate. The number of binding sites for 
65^Zn cannot be estimated in this system, but the linear removal 
may indicate a single binding site or a number of binding sites 
of similar affinity.
65In Sephadex chromatography, ^Zn m  bile was eluted
with 280nm absorbing material. The majority (75%) of the ^ Z n
eluted from the column just prior to the total bed volume of
65the gel, but the ^Zn peak appeared just before the 280nm
absorbing peak (i.e. the peak-positions did not coincide)
65suggesting that ^Zn was bound to compounds of mol.wt. greater
than 5000, present in the low mol. wt. peak. The compounds
in this 280nm peak were not resolved well owing to the wider
fractionation range of the Sephadex G-200 gel (5000-200,000).
The majority of the bile pigments were also found in this low
mol. wt. region. Here the bile pigments peak corresponded
65well with the 280nm peak but not the Z^n- peak. Hence it 
is evident that the trace amounts of zinc in bile are not 
exclusively bound to pigment molecules, although, it has 
been observed by Barrowman et al.(1973) that- ^ Z n  can 
bind to bilirubin in bile when higher zinc doses are administered 
to rats. In the .present study approx. 25% of the *^Zn in the 
column eluates corresponded with other biliary, macromolecules, 
some of which may have been proteins of blood serum normally 
present in bile. It is known that human bile
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contains a number of zinc metalloenzymes such as lactate
dehydrogenase and alkaline phosphatase in trace amounts.
These may be present in rat bile also, and their labelling 
65with ^Zn would account for some of the labelled 
macromolecules seen in Sephadex column eluates.
The Sephadex column method was not suitable for the
65mol. wt. determination of the major ^Zn binding component 
in bile as it was considered that the elution of the low 
mol. wt. 280 nm absorbing peak was retarded in this system 
due to column contraction. The column contraction may have 
been due to the aromatic substances, including pyrroles, in 
bile which have a high affinity for the Sephadex gel. For 
this reason a thin layer gel filtration system was used for 
the mol. wt. determination. Here, owing to the high sensitivity 
of the detection method, small quantities of bile could be 
used for chromatography. According to this method the major 
^ Z n  binding component of- bile had a mol. wt. of approx. 10,000. 
It is possible that some retarded migration of this fraction 
may have still occurred, but to a lesser degree.
The immuno technique confirmed the results of the 
Sephadex experiments showing that the major ^ Z n  binding 
component in bile is a protein. It does not conrain a serum 
analogue with similar antigenic properties,showing that the 
low mol.wt. zinc binding protein is present only in bile.
In the paper electrophoretic study, where the biliary components
• a ‘
were subjected to smaller degree of separation, a number of
A
other compounds such as amino acids, glucuronic acid, bilirubin 
and cholesterol were also found to be associated with or 
had the same electrophoretic mobility as this
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protein. If these compounds are truly associated with this
protein then it may serve as a carrier protein for other biliary
metabolites as well as zinc. A number of preliminary experiments
using ethanol at 4° to precipitate biliary protein brought
65about the dissociation of some of the ^Zn. A possible
65explanation of this is that ^Zn in bile is held in a mixed 
ligand protein complex, rather than bound to protein alone, 
and the precipitation of the protein moiety led to the dissocia­
tion of this complex.
65The presence of a low mol. wt. Zn binding protein 
in rat bile has been shown recently by Barrowman et al.(1973)< 
but the presence of a macromolecular complex in rat bile does 
not appear to be reported. However, in human hepatic and 
gall-bladder bile Bouchier and Cooperband (196?) have shown 
the presence of a macromolecular complex of mol. wt. 11,000
■r
to 20,000 which is composed of cholesterol (14%), phospholipids 
(16%), bile salts (66%), bile pigments (3%) and protein (0.5%).
The functions of this protein may be several, involving 
solubilisation, transport and detoxication of hepatic metabolites.: 
The present studies have shown that this protein also binds 
zinc, and therefore it may serve to transport zinc in bile.
The complexing of zinc with this protein may be fortuitous 
but on the other hand, it may be a function of the liver cell 
to incorporate zinc into a protein complex for excretion.
It appears that the incorporation of zinc into this 
macromolecular complex facilitates zinc excretion from the 
liver cell to the external environment. It has not yet been
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established whether the level of zinc-biliary-protein
in bile varies diurnally, although some components of
this protein complex such as cholesterol and lipids
are known to vary diurnally. However, since all the 
65yZn m  bile has been shown to be protein bound, it is 
likely that the level of the biliary protein itself also 
varies diurnally.
Just as the physiology of the pancreas and the liver
differ with regards to zinc excretion, so the chemical form
of zinc in their secretions differ, also. When pancreatic
65fluid obtained from ^Zn dosed rats was subjected to gel
chromatographjj/similar to bile, ^ Z n  was eluted in association
with proteins of mol. wt. 33»000 - 36,000. It is known
that the pancreas elaborates carboxypeptidase (mol. wt.
6534-,000) and the ^Zn was probably eluted with this protein.
65Therefore ^Zn in the blood is taken up by the exocrine
pancreas, rapidly incorporated into carboxypeptidase and
secreted in the exocrine secretions.
' 65
The turnover of ^Zn in ainumber of soft tissues
was investigated on a time-course basis, after the intravenous 
65injection of ^ZnC^. Three aspects of the tissue 
distribution can be considered
(a) ^ Z n  concentration in tissues,
65(b) time taken to reach the maximum yZn levels,
(c) ^ Z n  clearance.
The pancreas, liver, kidney and'duodenum constituted one 
group (group A) and contained the highest ^ Z n  concentration
over 24- h. The spleen, stomach, lungs and cardiac muscle
formed another group (group B) and these contained intermediate 
65^Zn levels over 24- h. Blood cells, voluntary muscle, testes
and the prostate gland formed the third group (group C) and
65these contained the lowest ^Zn levels over 24- h. This tissue 
classification, based on the result of the sub-physiological 
zinc dose, compares well with the tissue classification 
(see Introduction) formulated on the basis of the results 
of other workers using ^ Z n  containing high amounts of 
stable carrier zinc. However the present result does not 
correlate with the tissue content of endogenous zinc, possibly 
because of tissue differences in the rate of turnover of zinc.
Significant differences of tissue ^ Z n  levels were
shown by individual animals from 10 min to 6 h. These
differences were most pronounced in the pancreas, liver
65and kidney, the organs with the highest ^Zn concentrations.
e
These differences may be attributed to anaesthesia-induced
blood flow variations. The double exposure to ether vapour
of the animals killed within a short time after injection
of ^ Z n  may have caused profound variations in the amount
of ^ Z n  transported to these tissues. Also the injection
of ^ZnClg may have been traumatic, and the rats may have
reacted differently to the 0.1M-HC1 in the injection. In
the absence of individual variations in the animals killed
later £i.e. 1-10 days) it is reasonable to attribute the
initial differences to the factors mentioned above.
* 65Group A tissues each had a characteristic yZn
concentration curve. Although the peak concentrations .
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of ^ Z n  in pancreas, liver and kidneys were reached at
65different times after injection, the ^Zn was rapidly
cleared from these tissues, and this may well be related
to their function regarding zinc metabolism. The pancreas
65showed a maximum ^Zn level around 2 h and the maximum 
- 65
"£n secretion in pancreatic Juice corresponded with this
65peak. The total amount of ^Zn in the whole organ at 2 h
(approx. 3% of dose) decreased to 1% at 24- h. An amount of 
65"£n (3-4-% of dose) greater than the decrease in tissue
content, was recovered in the pancreatic fluid, within 24- h
65in cannulated rats injected with a similar dose of ^Zn.
65Therefore the pancreas extracted -^ Zn from the blood for 
secretion into the duodenum, s
65In the liver the lowering of ^Zn content from the
peak value at 20 min (approx. 40% of dose) to the value at
24 h (15% of dose) was not entirely due to ^ Z n  secretion
in bile"over this period, which was about 1-2% of the dose.
65However, the lowering of hepatic ^Zn content from 24-48 h
65could be -attributed to biliary ^Zn secretion alone since
65the decrease in liver content of ^Zn corresponded to the
65amount in bile. Therefore the majority of ^Zn present in
the liver initially, returns ta the blood stream within a
short time after injection and this may be responsible for
65the slight increase in the plasma ^Zn level observed at 2 h.
Also at 2 h a slight increase of ^ Z n  levels in the duodenum,
pancreas and stomach were observed and this may in turn be
due to the increase in plasma ^Zn. Thus the major fraction 
65of Zn in the liver may finally be excreted by these tissues^
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as it was found that more than 80% of the total dose 
administered' was excreted in the faeces in 25 days. It is 
therefore likely that the liver serves an important function 
in zinc distribution, probably by two independent pathways, 
one of which results in biliary excretion of zinc, and the 
- other which results in its elimination from the liver into 
the blood stream.
65In the kidneys the peak level of was reached
soon after injection of ^ZnCl^ and was pr0bably
related to the blood flow to this organ. The kidneys contained
approx. 7% of dose at 6 h, and decreased to 5*5% at 24- h.
However, only a small quantity (less than 0.5% of dose) of 
65•^ Zn was recovered in the urine. As with the liver, the
65kidneys appear to release the major proportion of their ^Zn 
into the blood stream and only a small percentage is excreted 
in the urine.
65The initial uptake and clearance of ^Zn from the
duodenum was different from the pancreas, liver and kidneys.
65 "The fluctuations in ^Zn levels observed in the duodenum
65may be due to the elimination of ^Zn in the duodenal secretions
65and reabsorption of ^Zn from the duodenal lumen.
The testes, prostate gland, voluntary muscle and the
65formed elements of blood contained the lowest •'Zn levels
of the tissues studied. Testes, blood cells and muscle
contained a low ^ Z n  level initially, and accumulated ^ Z n
over a considerable period of time. Lactate dehydrogenase
and malate dehydrogenase are zinc metalloenzymes present in
65skeletal muscle but it is not clear whether xZn accumulation
65in muscle is entirely due to the incorporation of ^Zn
into these enzymes. In the testes endogenous zinc content
has been found to increase during the maturation of the
testes (Parizek et al., 1966) and also zinc is present in
65high amounts in spermatozoa and seminal plasma. ^Zn
accumulation in the testes in the present study is consistent
65with this data. The initial levels of ^Zn in the formed
65elements of blood may be due to an initial diffusion of ^Zn
into the erythrocytes but the later slow rise may be due to 
65^Zn incorporation into newly formed erythrocytes and
leucocytes. Erythrocytes have been shown to contain the zinc
metalloenzyme carbonic anhydrase and the leucocytes
65zinc-containing alkaline phosphatase, and ^Zn accumulation
s
in the formed elements may be related to the incorporation 
65of ^Zn into these enzymes.
The ZnSO^ dosing by gastric intubation significantly 
increased the 24 h ^ Z n  concentration (due to i.v. injection) 
in the liver, kidney, pancreas and duodenum. This result 
is in agreement with the findings of Miller et al.(1970)» 
who found that feeding of added dietary non-radioactive zinc 
as ZnS0^(600 p.p.m.) caused an increase in the ^ Z n
concentration in similar tissues in cattle. The increased
65 • -^Zn levels found m  tissues in the present study may be
65due to the retarded faecal excretion of ^Zn. The
65suggestions made to explain the decreased ^Zn excretion 
in ZnSO^ treated rats ( see pp. 155-157) are also consistent 
with this finding. Tissues with a slow zinc turnover, such 
as the spleen and prostate gland, contained significantly
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65lower ^Zn concentrations m  contrast to the tissues 
with a higher zinc turnover. This may be due to:-
(a) a decrease in the available ^ Z n  due to
65an increased affinity for ^Zn in other 
tissues such as the liver, kidney, pancreas 
and duodenum,
(b) an absence in the spleen and prostate gland
of the synthesis of the postulated zinc binding 
protein,
(c) a higher level of accumulated stable zinc 
in the prostate gland, caused by long term
intubation of ZnSO^ which may have prevented
' 65the normal uptake of ^Zn.
The ZnSO^ intubation did not affect the 24 h ^ Z n  levels 
in plasma significantly, suggesting that the plasma turnover 
of zinc is not affected by increased ingestion of zinc.
65-—  The cellular localisation of ^Zn in the pancreas,
duodenum, liver and prostate gland was studied in an attempt
to obtain further information on the behaviour of zinc in
these tissues. The tail portion of the pancreas, which usually
contains more islets of Lahgerhans, was examined to see
65whether there was a differential concentration of -'Zn in
comparison with the exocrine tissue. ' However, both these
65tissues contained a similar concentration of ^Zn. This 
finding with the sub-physiological dose of zinc was different 
from the result obtained in the rat by Mclsaac (1955)? using
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a higher dose of zinc(500 jug). Mclsaac found more ^ Z n
in the exocrine tissue initially, which later decreased
below^that of the endocrine tissue, and this result agrees
65with the known ^Zn loss in the exocrine secretions.
The present study, however, shows that the normal
turnover of zinc in exocrine and endocrine tissue is similar.
It-was also noted that within the islet of Langerhans no
65preferential localisation of ^Zn in e i t h e r o r  p cells
65is found. The initial ^Zn localisation observed in the
basal region of the acinar cells and the later ^ Z n  localisation -
65in the apical region may indicate the transport of ^Zn
from the periphery of the acinus towards the central ductule
that drains the acinus. This" may represent the passage of 
65■^ Zn through the acinar cell prior to secretion in the
pancreatic, fluid. The cytoplasm at the basal region of the
acinar cell is basophilic, owing to the presence of cytoplasmic
RNA, involved in protein synthesis. Pancreatic carboxypep-
tidase may be synthesised in this region of the cell, and the
65localisation of ^Zn may therefore be related to its
dincorporation in carboxypeptidase. SynthesiseA proteins
accumulate,, in the zymogen granules which are present in
abundance in the apical region- of the acinar cell and
65therefore the presence of Zn in this apical region
65may be related to the accumulation of ^Zn-carboxypeptidase.
It is known that the duodenum is an important site
65for the excretion of zinc and ^Zn has been recovered in 
the duodenal juice of dogs after intravenous administration
-168-
of ^ZnCl2 (Montgomery et al., 194-3), "but ^ Z n  localisation-
at the cellular level in the duodenum has not been reported
previously. The present study revealed that the Paneth
cells of the crypts of LieberkiiHn and goblet cells of villi
65contained more ^Zn than surrounding tissue* Therefore it 
is suggested that the zinc is excreted into the duodenum 
at two different sites, maely the crypt of Liberklihn and villi,
A
65and the high ^Zn content in the Paneth and goblet cells
is related to the zinc excretion from these cells. The
maximum zinc concentration in these cells occurred at different 
. 6 5times after ^Zn injection, the Paneth cells showing an
initial high concentration and the goblet cells a later
Sihigh concentration. The apperance of ^Zn in the duodenal
lumen in close proximity to both Paneth and goblet cells
suggests that these cells are responsible for the excretion 
65of ^Zn. It was also noted that the epithelial cells
65contained trace amounts of ^Zn. It is not clear whether
65 'this ■ Zn originated from the blood or whether it was due
65to absorption of yZn from the duodenal lumen. However 
the epithelium of the small intestine is shed frequently, 
and in rats it is renewed every txvo to three days, hence 
there may be a very slow loss of ^ Z n  in this way.
Paneth cells are known to contain high amounts of 
endogenous zinc (Ham, 1969), and the present study revealed 
that they are also capable of a high turnover of zinc.
Paneth cells are known to have features of enzyme secreting 
cells (Bloom & Fawcett, 1962). but their precise function, 
and the composition of their secretion does not appear to be
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known. The goblet cells unlike the Paneth cells did not 
65 -contain ^Zn initially but at later times these as well
65as their secretions contained ^Zn. Goblet cells elaborate
glycoproteins, but it not known whether these contain zinc.
Zinc is required for protein synthesis, so it is possible 
65that high ^Zn in the goblet cells could be related to 
glycoprotein synthesis.
The ^ Z n  concentration at localised spots in the
centre of the lamina propria of villi appeared to be due to
65the presence of xZn in the lacteal, rather than in the
blood capillaries. This may be due to the reabsorption of 
65, ^Zn from the duodenal lumen in association with lipid 
substances. N
In the rat prostate gland the dorso-lateral portion
65is known concentrate more ^Zn than the ventral
65lobes. Therefore the distribution of ^Zn in the
dorso-lateral portion was studied by autoradiography.
65^Zn autoradiographs resembled those of the thyroid gland,
131obtained with  ^I , in that there was a great variability
in the amount of radioactivity in different secretory units
65with some showing heavy localisation of ^Zn within the
epithelium lining the glandular cavities and their exudates.
65The presence of high amounts of ^Zn in some follicles
65and the virtual absence of ^Zn in other follicles may be
related to the functional state of the different follicles
65or due to the storage of •'Zn labelled secretions in the 
follicular lumen. The nature* of zinc in prostatic secretions
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is not known. Although the epithelial cells are known to 
- . ahe rich m  acid phosphatse, zinc has not been shorn to be 
related to its structure or function, and in an in vitro 
system it has been shown that addition of zinc to leucocyte 
acid phosphatase decreases the activity of the enzyme 
(Dechatlet et al., 1971)*
The centrifugational analysis showed that all
65subcellular fractions of rat liver contained ^Zn in
different amounts with higher quantities in the cytosol
and the microsomal fraction. However, stable endogenous zinc
has been found in higher amounts in the cytosol and nuclei
(Vallee, 1962). As the subcellular fractions were prepared
65at various times after _Zn injection, the relative clearance
rates in the various subcellular fractions were revealed.
In the nuclear and mitochondrial fractions, fairly constant
^ Z n  levels of total homogenate) were maintained suggesting
a turnover of zinc in these organelles the same as observed
65for the whole liver. The cytosol percentage content of ^Zn
decreased slightly over the 48 h period, whereas the microsomal
fraction showed a peak at 2 h which then decreased more
rapidly, than the cytosol content. This suggests that the 
65^Zn was retained to some extent by the microsomal fraction
65or at least was not cleared at the same rate as the ^Zn 
loss from the whole liver.
The cellular macromolecules that are likely to form
65^Zn protein complexes and metalloproteins were cited in 
Chapter 1. Although these may account in part for the presence
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65of -'Zn in the subcellular fractions, the present
knowledge of zinc interaction at the cellular level is
undoubtedly too incomplete to offer a satisfactory
6 5explanation. The ubiquitous distribution of ^Zn within 
the liver cell may be due to its interaction with the 
membranes of cell organelles as well as its association 
with several soluble proteins in the cell sap.
6 5The turnover of •'Zn m  the microsomal fraction 
and cytosol can be interpreted as being at least partly due 
to the synthesis of zinc binding proteins, such as the known 
metalloenzymes and the zinc biliary protein complex, thus 
resulting in the intracellular redistribution and excretion 
of 65Zn. N
In Sephadex chromatography of rat liver cytosol,
65vZn was found to associate with a variety of cytoplasmic
proteins of different mol. wt. In recent years two
metalloproteins of zinc have been isolated from the liver
cell cytoplasm. These are hepatocuprein isolated from
human liver (Carrico & Deutsch, 1970) and metallothionein
isolated from the liver cell sap of a number of experimental
animals and man (Shaikh & Lucis, 1970) and these have mol. wts.
of 33,000 and 10,300 respectively. Similar proteins and
6 5  .and other proteins may account m  part for the ^Zn binding 
seen in the present experiments.
Pancreas and prostate gland scanning
The experiments discussed in this thesis give some 
imformation on the behaviour of a sub-physiological tracer dose
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of zinc such as that used in scanning and the results
of these experiments can be used to a certain extent to
\
assess whether radionuclides of zinc (as ZnC^) are
suitable for scanning of the pancreas and prostate gland,
The results of the present experiments may also be of
use in the interpretation of the results obtained with
the use of radionuclides of zinc in scanning, For the
clear delineation of the pancreas and the prostate
glqn4 the most important requirement is that the radioactivity 
. ' t h e
in.these tissues , due toAradionuclide of zinc must be
sufficiently high so as to fulfil the requirement of
radioactivity detection with a minimum contribution
from the surrounding tissues*"The present investigations
clearly indicated that apart from the pancreas, a number of
tissues such as the liver, duodenum and kidneys are
important for zinc metabolism, taking an active part in 
65^Zn concentration, incorporation into macromolecules and 
excretion. The size of the liver, and the anatomical 
position of the pancreas in relation to the liver and 
duodenum become most critical as these would show high 
amounts of radioactivity. In order that the pancreas is 
better visualised by scanning, -it must retain its radioactivity 
while the neighbouring tissues must show a clearance.
However, the excretion of zinc is pronounced in the pancreas 
and less in the liver. The initial zinc secretion from 
the pancreas prevents the maintenance of zinc concentration 
within the gland. The radioactivity in the duodenum due to 
its own secretions and pancreatic fluid would present difficulties
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in delineating the head of the pancreas and tumours 
present in this part of the pancreas. It was believed 
that radionuclides of zinc would be of use in scanning for 
tumours of the pancreas such as the insulin secreting tumours 
of the islets, which are difficult to locate even at 
the operation (Fonkalsurd et al., 196&). But in the 
autoradiographic study it was seen that there was no 
preferential localisation of zinc in the islets of Langerhans 
in comparison v/ith the exocrine pancreas or in the pcells 
in comparison with the ctcells and therefore it seems unlikely 
that the insulin secreting tumours can be visualised with 
the use of radioactive zinc.
s
The initial zinc levelv m  the protate gland was low,
A
and the ratio of zinc between the prostatic tissue and blood 
was low, from 0-6 h after injection. Therefore this may 
hinder the external visualisation of the gland, initially. 
Although there is a long term accumulation of zinc in the 
prostate gland, owing to the accumulation of zinc in muscle 
and the excretion of zinc in the faeces^the radioactivity 
in the neighbourhood of the prostate gland rises. This 
again may present problems in the scanning of the gland at 
later times after injection of radionuclides of zinc.
The autoradiographic investigations on the rat and human 
(human results not reported in the thesis) prostate gland 
showed a non-uniform zinc distribution in different areas 
of the gland, probably related to the functional state.
Zinc was located in this study within the lumen of secretory 
units? perhaps stored with the secretions, rather than over
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cellular areas. Owing to the lack of a uniform distribution 
it may be difficult to outline the normal gland. In the 
human, the carcinomatous prostate gland has been shown to 
have a low uptake in the affected areas, and in view of the 
absence of a relatively high concentration in all normal 
tissue, these tumours may not be visualised with radioactive 
zinc.
Although the above discussion refers to the behaviour
r\
of ionic zinc (Zn +), its metabolism may differ when the 
chemical nature of zinc is altered and such radio-Zn- 
preparations may be worth testing.
Oral ZnSCbj therapy:-
An experiment was conducted to study the excretion 
and tissue distribution of a sub-physiological tracer dose 
of intravenously administered zinc in rats given an 
equivalent of a therapeutic dose of ZnSO^^E^O ( given 
orally,in humans ) for 30 days. During this period of 
ZnSO^ intubation the test rats did not show any symptoms 
of zinc toxicity. However the' endogenous test zinc was 
excreted more slowly and the zinc dose was retained longer 
in the major organs of zinc metabolism. While it is 
clear that the continued ZnSO^ treatment caused a slower 
turnover of zinc in the body, the reason for the increased 
tissue retention of zinc was not investigated. But in view 
of the recent findings of ZnSO^-induction of zinc binding 
protein synthesis it was suggested that the decreased turnover 
could be due to the synthesis of zinc binding proteins in the 
liver, pancreas, duodenum, and kidneys.
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C H A P T E R  6
TISSUE DISTRIBUTION AND EXCRETION OF ftALUUM
6-1 Introduction
In recent years compounds of gallium have been 
Used in diagnostic medicine in the United Kingdom.
Gallium has been studied with regard to its behaviour in 
the vertebrate body including its toxicology 
and this has been reviewed in Chapter 1. The availability 
of this element in carrier-free form as ^ G a  has permitted 
the study of its tissue distribution and blood transport 
reported in this Chapter.
^ G a  is a moderately short-lived radionuclide of 
Uq ^«3*24 days, and it decays to stable ^ Z n  by electron 
capture. The electron capture process results in the 
release of the following gamma-ray quanta:-
Energy
(MeV)
- —
Abundance
w
0.093 40
0.184 - — -  24
0.296 22
0.388 7
By Lederer et al. (1967)
The gamma-rays, particularly, the 0.184 and 0.296 
MeV with a total percentage abundance of 46% are suitable
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for the assay of ^ G a  in biological samples, by scintillation 
counting. The Auger electrons, 0.1 to 9*5 keV have been
fry
shown satisfactory for micro-assay of 'Ga at subcellular 
level by autoradiography of thin histological sections.
(Swartzendruber et al., 1971)*
6-2 Experimental techniques 
6-2-1 Animal experimentation
Normal Wistar albino rats (approx. 200g) were used 
for metabolic studies and as blood donors for protein 
binding studies.' These as well as tumour bearing animals 
were housed and maintained during the pre-experimental and 
experimental periods as described in Section 2-1-1.
Wistar rats transplanted with two types of tumours, 
RIB5 and SSB1 were used. RIB5 tumour is a benzpyrene- 
induced fibrosarcoma maintained by successive subcutaneous 
transplantations. These grew to reach a mean diameter of 
9 to 10 mm two weeks post transplantation. Over the size 
ranges used it had an average volume doubling time of about 
a day. RIB5 is an anaplastic tumour with no differentiated 
cells (Denekamp, 1968). The tumour cells infiltrate the 
underlying muscle and skin in the immediate neighbourhood 
and develop multifocal necrosis at a very early stage of 
growth.
SSB1 tumour originated as a spontaneous fibrosarcoma 
in a Wistar rat and has been maintained by successive 
transplantations in rats. It is a well differentiated tumour 
with a doubling time of 3*5 -days. This is a relatively slow
growing tumour, and takes approx. a month to reach'9 to
10 mm post transplantation.
RIB3 tumours were transplanted subcutaneously in 
the flank of Wistar rats (160g) with the usual trochar 
technique. SSB1 tumours were grown by implanting 2 to 
3 mm cubes of tumour, subcutaneously, in recipient Wistar 
rats (150g).
The normal and tumour bearing rats were injected 
in the caudal vein (see Section 2-1-4) with approx. 9&Ci 
of ^ G a  citrate.
6-2-2 Whole body counting, excretion and gross tissue 
distribution
A group of 13 normal rats were injected with 9pCi
of ^ G a  citrate per animal and the dose received by each
animal was obtained by whole body counting (see Section
2-4-2). At regular 24 h intervals after dosing?the rats
were sacrificed in groups of three each day for tissue
distribution studies^ and prior to killing the amount of
^ G a  left in the body was estimated by whole body counting.
Immediately after death tissues were removed from
65the carcass. Tissues similar to those taken for the ^Zn 
study were prepared in a manner similar to the description 
in Section 4-2-1, and these included;- 
Blood Lungs
Liver Thigh muscle
Duodenum Kidney
Spleen Testes
In addition to these tissues, the whole brain and a represen­
tative sample of skin with hair and the left femur were taken.
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The brain was exposed by a median scissor cut of the cranial
capsule and parting the bony plates to either side. The
brain was lifted off with a spatula and transferred to a
counting vial. The skin with hair was taken from the back
of the animal. To obtain the femur, skin and muscles were
teased from the left thigh. The bone was cut in two pieces
and the marrow was removed with a jet of saline.
67Tissue distribution of Ga was also studied in a 
group of 15 rats bearing 9 - 10 mm SSB1 tumour. These were 
dosed with 9pCi of ^ G a  citrate. Tissues for ^ G a  assay 
included tissue^mentioned above and the tumour.
In the case of spleen, left kidney, lungs, femur,
brain and left testicle, the whole tissue was assayed.
* s
For blood plasma, liver (tissue cube from the anterior
lobe), duodenum, thigh muscle and skin, a.i g sample was assayed.
Tumour was bisected and the halves placed in two counting vials.
All tissues were packed in the bottom of counting vials so
that the change of tissue volumes was minimal. Radioactivity
due to ^ G a  was assayed in a gamma-ray spectrometer(see
Section 2-2-3) and the counting rates were corrected for
radioactive decay, and background counting rates.
In another experiment six rats, two normal, two RIB5
tumour bearing and two SSB1 tumour bearing rats were injected
with 9jaCi of ^ G a  citrate. These were housed in metabolism
cages and samples of faeces and urine collected <hily for 
673 days. 'Ga in urine and faeces was assayed by gamma-ray 
spectrometry.
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676-2-3 Ga distribution in transplanted tumours
The rats bearing RIB5 tumour and SSB1 tumour were 
intravenously injected with 10juCi of ^ G a  citrate, when 
the tumours reached a diameter of 3 - 13 mm. The rats 
were killed at 2 h and 1,2,3*4 and 3 days after ^ G a  injection. 
The tumours were quickly removed, frozen in n-hexane, and 
20ju thick histological sections cut across the tumour, in a 
cryostat and picked up on pre-cooled (approx. 0°) microscope 
cover glasses. The tissue containing cover glass was secured 
on to a 5ju thick Melinex sheet (ICI Ltd.)* and Eodirex 
films/were exposed to the tissue at 4° for 4 days. Fogging 
of the film due to biological material was prevented by 
the interlayer of Melinex between tissue and film. The 
film was processed and the photographic image analysed 
in relation to the histological section.
6-2-4 ^ Ga localisation in tumour cell
A group of 3 rats bearing RIB3 tumours, approx.
10 mm diameter were injected with 10juCi of ^ G a  citrate :,l%-
in the caudal vein. Twenty four hqrs later the rats were 
killed and the tumour removed. Approx. 5f* thick sections 
were autoradiographed according to the method described 
in Section 4-2-2. The length of exposure was 3 to 7 days.
676-2-5 Investigation of 'Ga binding serum proteins
^ G a  protein binding was studied with blood samples 
obtained from normal rats and patients with confirmed
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malignant disease. Both species received a similar dose 
equivalent (0.045 fuCi/g body weight) of carrier-free 
^ G a  citrate. Th^patients were injected with approx. 2mCi 
of ^ G a  citrate in the antecubital vein. The total 
volume of the injectate was about 2 ml and was forced into 
the vein as a bolus. The rats were injected in the tail 
vein with 9juCi of ^ G a  citrate. Blood samples were obtained 
3, 24 and 72 h after injection, from rats by cardiac 
puncture and in humans from the antecubital vein in the other 
arm. Blood samples were allowed to clot in sterile tubes at 
37° and the resulting sera were taken for the following 
investigations:- '
Ultrafiltration (see Section 3-2-2)
Exhaustive dialysis (see Section 3-2-3)
Zone electrophoresis 
Electro-immunodiffusion
The zone^ electrophoresis technique used was as follows:-
Electrophoresis was conducted in a horizontal apparatus 
using Cellulose Acetate Membranes (CAM) as a supporting medium. 
Three buffer solns. were used in separate experiments and the 
operating conditions for the respective buffers are shown in 
the Table 6-5. Approx. 10 jul of-serum was applied over the 
CAM strip soaked in the appropriate buffer soln., and subjected 
to electrophoresis for 2 h. ^ G a  citrate (10 jul) with a 
counting rate similar to sera was also subjected to electrophore­
sis as a control in a parallel strip. At the end of the run the 
strip was dried in a horizontal position in air and cut into 
0.5 cm pieces across the length of the strip for ^ G a  assay.
The parallel strip was stained with Ponceau S for proteins.
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The stained strips were either scanned in a chromoscanner 
(Joyce Lobel, London) or visually checked for protein zones.
Sera obtained from* normal rats and cancer patients at 3 h 
hnd 24- h after injection of ^ G a  citrate were investigated 
by this method.
Blood sera obtained 3 h after 'gallium citrate injection 
in cancer patients were also investigated by the method of
electro-immunodiffusion. This method was described 
previously in Section 3-2-7, and the conditions were similar 
except that the gel was prepared in 0.04-K-tris-barbitone 
sodium barbitone buffer, and the electrode buffer was the 
same buffer shin, at half strength. Ten fill of serum was 
placed in the sample well, within a minimum time after collection 
and the proteins were separated in the first dimension by 
electrophoresis at 24V/cm for 45 min. The separated proteins 
were forced into the second dimension gel bed impregnated 
with a mul^yalent antiserum for normal human serum proteins 
at 8V/cm for 8 h. The electrophoresis was conducted at 4°.
At the end of the run excess antiserum was washed out with 
0.9% NaCl soIn. and ^ G a  located by autoradiography using 
the AR.50 autoradiographic film (Kodak ltd.)*
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6-3 Materials
k^Ga was produced in the MRC cyclotron by the nuclear 
reaction:-
||cu + gHe — > fiGa + 2n
(Sylvester & Thakur, 1970)
The radioactive surface of the irradiated Cu target was
etched with HNO^ and the resulting soln. was boiled down;-
with conc. HC1# The residue was taken up in HC1 and metal
contaminants were removed by cation exchange chromatography.
^ G a  free from the major chemical impurity Cu and the
65radioactive impurity, ^Zn, was obtained in 10 ml of 3-5M-HC1. 
This soln. was evaporated to dryness and ^ G a  was taken up 
in a suitable volume of 3*8% sodium citrate soln. The doses 
were prepared from this stock soln. by dilution with 3«8%' 
sodium citrate soln. so that 9pCi was contained in 0.2 ml 
for injection into rats and 2.0mCi in 2.0 ml for injection
into patients. The amount of gallium in the respective
-12 -10 injections was 2 x 10 and 4 x 10 jumol.
Kabbit antisera for human serum proteins were obtained 
from Hoechst Pharmaceuticals Ltd., Brentford, Middx, and 
Cellulose Acetate Membranes for zone electrophoresis was 
purchased from Hawksley & Son Ltd., Lancing, Sussex.
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6-4 Experimental results
6-4-1 Whole body counting
A group of 15 normal rats and 15 tumour bearing
67rats were injected with 9pCi of 'Ga citrate and the 
radioactivity was counted in the whole body counter. The 
amount of ^ G a  injected was assumed to be equal to 100% and 
the ^ G a  remaining in the body was expressed as a percentage 
of the initial counting rate. In this experiment both 
tumour bearing and normal rats retained similar amounts 
of ^Ga, hence the results are considered together and are 
shown .in Table 6r1.
Table 6-1 ^ G a  retention in the rat
Time after injection 
(days)
67 ^Amount of 'Ga retained 
(% of initial dose)
Mean + s.d.
0 100
1 85.62 3.8
2 —  80.62 4.1
3 76.87 4.0
4 77.74 3.9
5 69.79 4.7
Mean + s.d. for 6 rats.
These results show that the tracer dose was rather slowly 
removed from the body.
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6-4-2 67Ga excretion in faeces and urine
Six rats injected (i.v.) with approx. 9iuCi of
67Ga^citrate were housed in metabolism cages. Urine and
faeces samples were collected and assayed for ^Ga. (The
two normal rats and the four tumour bearing rats excreted
similar amounts of ^ G a  and the results were considered
together (Table 6-2). During the first two days more 
67'Ga was excreted in urine than in the faeces
but after two days only small amounts were excreted in
67urine and more 'Ga was recovered in the faeces. The 
67amount of 'Ga recovered in faeces and urine accounted for
67
all the loss of 'Ga seen in whole body counting.
Table 6-2 ^ Ga excretion in faeces and urine (cumulative)
Time after injection 
(days)
67Ga radioactivity (% of dose)
Urine Faeces
Mean + s.d. Mean + s.d.
1 9.57 2.4 4.66 ~ 0.97
2 12.84 3.3 7.62 1.04
3 14.03 3.6 9.98 1.28
4 14.36 3.7 11.59 1.44
5 -15.03 3.6 15.17 1.88
Mean + s.d. for 6 rats.
67,6-4-5 Tissue distribution of 'Ga
The rats in Section 6-4-1 were killed daily ,
3 from the normal group and 3 from the tumour bearing group,
-186-
A number of tissues were removed from the carcass immediately
after death-and the ^ G a  assayed. The results are given
in Table 6-3* The tissues of tumour bearing rats contained
6 7similar amounts of 'Ga to that contained in the tissues
of normal rats, hence the results of the two groups are
67
_ considered together. 'Ga was cleared extremely slowly
from blood plasma during 2 - 5  days and the concentration was 
almost identical to that of whole blood. When blood cells 
recovered in the preparation of plasma were washed free of 
plasma proteins and counted for ^ G a  , these contained 
similar amounts of ^ G a  to that in the plasma from which they 
were separated, The highest concentration of gallium was 
found in the liver, spleen and kidney at 24 h but the ^ G a  
in the kidney cleared rapidly. The femur,, lungs, skin and 
testes contained lower concentrations than the above tissues 
but higher concentrations than muscle, duodenum and brain.
On a unit weight basis, brain contained the smallest amount 
of 67Ga.
6 7~—  The uptake and loss of- 'Ga in the various tissues 
showed differences. The kidney, liver and spleen showed 
a relatively rapid clearance (Fig.6.1), while the skeletal 
muscle?doudenum and lungs maintained fairly constant levels 
of ^ G a  during the 5 days. Of the other tissues, the testes
4
and brain (Fig.6.2) and also the femur (Table 643) accumulated 
6?Ga.
67The SSB1 tumour contained a higher concentration of 'Ga 
than body tissues, and showed a tendency to accumulate initially 
and retain ^ G a  (table 6-4). This is also evideht from the
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Fig.6.
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Time after—  i njection Cday£
4 5
67Ga clearance in the liver ( n ) kidney ( . M  
and spleen (m) after in.iection (i.v.),.gX 
^ G a  citrate in the rat.
A mean for six rats is given.
-189-
2 3 4 5
Time after injection Cdays)
^ G a  accumulation in the testes (n) and brain (H) 
of the rat after a single intravenous dose of 
^ G a  citrate.
A mean of six animals is given.
go
constant ratio for 'Ga between tumour and plasma from 
3 to 5 days (Table 6-4).
67Table 6-4 'Ga concentration in SSB1 tumour
Time after injection ^ G a  concentration Tumour/Plasma
(days) (% injected dose/g) (range)
Mean + s.d.
1 v 0.4937 0.0437 3.8 - 4;4
2 0.6397 0.0588 10.2 - 12.3
3 0.7081 0.0573 19.8 - 24.6
4 0.6755 0.0827 20.2 - 23.4
5 0.6426 0.0808 20.4 - 23.3
Mean.and s.d. for three SSB1 tumours per time interval.
6-4-4 ^Gallium distribution in experimental tumours by 
gross autoradiography
—  Rats bearing 5-13 mm diameter RIB5 and SSB1 tumours
6 7we re injected with 10jnCi of Ga citrate. Animals were killed 
at 2 h and 1 - 5  days after injection. Approx. 20jti thick 
histological sections were autoradiographed and the areas 
of ^ G a  localisation were studied.
The regional ^ G a  distribution in RIB5 tumours varied 
according to the'size of the tumour. At 2 h, 5 - 7 mm 
tumours contained ^ G a  throughout the entire cross section 
of the tumour*, however , the blood vessels’ present at the 
periphery of the tumour contained more radioactivity than
-191-
/ x 23
<g>
Fig.6.3* ^ G a  distribution in experimental rat tumours.
N= areas of necrosis 
—  BV= blood vessels-
These sketches were drawn combining the histological 
section and the autoradiographic image due to ^Ga. 
The darker shade represents areas of increased 
*^Ga radioactivity*
(a) Approx* 5mm diameter RIB5 tumour.
Note radioactivity in the periphery of the tumour
near blood vessels and in the central zone(between
necrotic and vital zones) 24 h after ^ G a  citrate
injection. ,
Fig. captions continued...
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(b) Approx. 8mm diameter RIB5 tumour.
67Note 'Ga localisation in the peripheral zone
(vital) and the absence of radioactivity in the central
6 7zone (necrotic) 24 h after Ga citrate injection.
(c) About 12mm diameter RIB5 tumour.
67'Ga localised as a thin band on the periphery 
67of the tumour, 72 h after Ga citrate injection. Note 
that the major area of the tumour is free of radioactivity.
(d) SSB1 tumour
approx. 9 tumour showing ^ G a
localisation in the vital areas of the tumour. 120 h after 
67'Ga citrate infection.
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other areas of the tumour. At 24 h these tumours consistently 
showed a ring of radioactivity a few mm inner to the peripheral 
ring of blood vessels (Fig.6.3*s0* With larger tumours 
(10 - 13 mm), 2 h after injection the majority of radioactivity 
was again located as a narrow band in the periphery of the 
tumour with the central areas being completely free of ^ G a  
(Fig.6.3*b). The pattern of ^ G a  distribution did not differ 
with time ih these larger tumours and at all times the 
majority of radioactivity was located in the periphery of 
the tumour. The slow growing SSB1 tumour resembled the small 
RIB5 tumour with regards to ^ G a  distribution. Both RIB5 
and SSB1 showed the absence of radioactivity in the 
areas of necrosis, which in the latter tumour is usually 
less(Fig. 6.3*c & d).
6-4-3 ^ G a  Uptake by the RIB3 tumour
Approx. 5n thick histological sections of 10 - 15 mm
RIB5 tumours obtained 24 h after ^ G a  injection were
autoradiographed, and these showed very little radioactivity
67within the blood vessels. - More 'Ga was associated with 
the cellular areas of the tumour.(Fig 6.4). The Ag grain 
density in the necrotic areas ' was lower than in the vital 
zone of the tumour. However, groups of cells scattered in 
the necrotic zone often showed abundant Ag grains. In 
the peripheral zone more grains were associated with groups 
of cells with darkly staining nuclei containing granular 
cytoplasm (Fig.6.5)• Other cells in their neighbourhood 
with faintly outlined non-granular cytoplasm contained few 
Ag grains. In certain areas where the tumour cells infiltrated
-194-
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the abdominal muscle the lack of excess ^ G a  in the 
muscle and its presence in the tumour cells was noted (Pig*
6 .6).
- 67'Ga localisation was mainly cytoplasmic, but occasionally 
some nuclei showed heavy ^ G a  labelling. The results of 
- this experiment indicated that ^ G a  concentrated predominantly
i
in the cytoplasm of RIB5 tumour cell that appeared to be 
viable.
676-4—6 Ultrafiltration of 'Ga in serum
Blood sera obtained 3i 24 and 72 h after ^ G a
injection in patients and rats were investigated by this
,, method, Three ml fractions of serum samples were centrifuged
at 2000g for 0.5 h at 4°. ^ G a  citrate diluted with 0.9%
UaCl soln. was used as controls. In a separate experiment
^ G a  binding by pure human serum albumin (HSA) was investigated.
A 4% (w/v) soln of HSA was mixed with ^ G a  citrate. The
radioactivity in this soln. was I.OjuCi ^Ga/ml and the citrate
concentration was 0.1mM. These were typical in vivo
concentrations of ^ G a  and the citrate expected in man 
6 7following 'Ga citrate injection. The mixture of HSA and 
^ G a  citrate was incubated with gentle agitation for 3 h at 57° 
prior to ultrafiltration._ The- results obtained for ^ G a  
binding in sera and control solutions are shown in Table 
6-5.
The controls gave a binding of 15%» and this is probably
due to ^ G a  binding by the cellulose membrane, and the other .
figures were not corrected for this blank value. In sera
6 7the percentage binding of Ga was increased from 5 - 72 h
- 197-
- 198-
67after injection. The binding of 'Ga by rat and human 
sera were similar. The lower binding figure of HSA (35%) - 
may indicate that non-albumin proteins in serum probably 
played an important role in ^ G a  binding.
Table 6-5 ^ Ga binding in blood serum
Sample % binding
Rat
*
serum Human
* #
serum
Mean + s.d. Mean + s.d.
serum 3 h 87 4.7 84 6.9
serum 24 h 98 5.3 97 3.5
serum 72 h 97 N 3.2 99 2.0
Human serum albumin 35* 2o4
67'Ga controls 'J Cj* * * + 2.2
* Sera of three rate per time interval
* *
Sera from ten patients
*** Mean of ten samples
+ Mean of six samples
6-4-7 Exhaustive dialysis of 6^Ga in serum
Serum samples obtained from rats and cancer patients
3, 24 and 72 h after ^ G a  citrate injection were subjected to
exhaustive dialysis. Visking cellulose bags containing 1 ml
of serum were dialysed against 2 litres of sterile 0.9% NaCl
solution at pH 7*2 . Dialysis was continued for 24 h at 4 
In another study using sera from different subjects and 3 rats
-199-
crn
injected with 'Ga citrate the effect? of phosphate ions
69on the dialysability of 'Ga was examined by the dialysis 
of the sera against a phosphate buffer, 6 x 10~^mM, in
0.9% NaCl soln. at pH 7*4-. ^ G a  citrate containing saline 
solutions were dialysed as controls. The results of a 
- typical dialysis experiment are shown below:-
Dialysing medium % binding
Controls Rat serum Human serum
Mean + s.d. Mean + s.d.
Saline 2 39 3-5 33 2.2
Phosphate buffer 0
N
4 1.0 2 0.4
Mean value of 12 human serum samples and 6 rat serum samples
in each buffer solution are presented. Dialysis removed the 
67'Ga in the control solutions and no radioactivity was found
in association with the cellulose membranes. All sera retained
about a third of ^ G a  after 24 h of dialysis and this fraction
could be removed,by further dialysis for 6 h against phosphate
buffer. Sera dialysed against the phosphate buffer lost the
^ G a  completely in 24 h. fihe dialysability of ^ G a  in rat sera
was slightly less than that of-human sera. In both species
67similar amounts of - Ga were removed from sera obtained at
3, 24 and 72 h after injection. It was not possible to check the
6 7
accuracy of the above figures by counting the dialysate for 'Ga 
owing to its dilution in a large volume of buffer.
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6-4—8 Zone electrophoresis of 'Ga binding proteins in 
serum
Serum samples obtained from cancer patients and normal 
rats , 3 and 24 h after ^ G a  citrate injection were investigated 
by this' method and the electrophoretic mobility of ^ G a  in 
serum was compared with that of ^ G a  in ^ G a  citrate.
In the phosphate buffer (pH 7*8) the majority (Approx.
65%) of ^ G a  remained at the point of application when ^ G a  
citrate was subjected to electrophoresis, whilst a smaller 
fraction migrated towards the anode. ^ G a  in both sera at 
both time, intervals migrated with proteins in the albumin, 
oc and p-globulin zones (Pig.6.7)*
In the citrate-phosphate buffer (pH 7*8), ^ G a  of the 
controls migrated towards the anode and the sera migrated as 
a wider zone from oC-globulin to beyond albumin at a rate 
slower than the ^ G a  of the controls (Pig.6.8) • In addition 
to the major ^ G a  peak, a small peak was detected in the " 
p>-globulin zone.
In the barbitone buffer (pH 8.4) ^ G a  of ^ G a  citrate
and ^GaCl^ showed an anodic migration. ^GaCl^ transformed
from an electrically neutral species into an anode seeking
67species (Pig.6.9). 'Gallium in all sera migrated with albumin 
c( and p-globulin zones when^serum was subjected to 
electrophoresis for one hour (Pig.6.10), and when electrophoresis 
was continued for six hours, the majority of ^ G a  migrated 
beyond the albumin zone leaving a small peak in the 
p>-globulin zone (Pig.6.11).
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o
X © ©
C A M  length CcnrD
67Fig.6.7. Electrophoretic migration of 'Ga in phosphate 
buffer.
^ G a  citrate (---)„
^ G a  in blood serum (-— )
( see text for experimental details )
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© ©
0 fi 0C2 oC, 4l3
C A M  length Ccm)
Fig.6.8. Electrophoretic mobility of ^ G a  in citrate-phosphate 
buffer.
^ G a  citrate (---)
67Ga in blood serum ' (---)
( see text for details )
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67Fig*6.9• Anodic migration of~ rGa chloride in zone
electrophoresis in barbitone buffer.
67Ga chloride was subjected to electrophoresis 
for 0.5, 1> 1.5 h. Note the gradual transformation 
of the electrically neutral species to an ionic 
species. ^ G a  of gallium citrate also behaves 
as an anode seeking species under similar conditions.
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Fig.6. "10. A typical electrophoretic separation of ^ G a  in 
^ G a  serum in barbitone buffer.
Sen pi of a serum sample obtained from a patient 
6724 h after 'Ga citrate injection was subjected 
to zone electrophoresis in barbitone buffer, pH 
8.4, at 10V/cm and 0.5 mA/cm, for one hour.
^ G  a radioactivity (— -)
A parallel strip stained for proteins with Ponceau S 
•is shown.
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Sera dialysed for 24 h against saline (see Section 6-4-7) 
were subjected to electrophoresis, these contained 'Ga in 
the ^-globulin zone only,
These investigations revealed that the electrophoretic 
migration of ^Ga, when ^ G a  serum was subjected to electro­
phoresis was different from that of free ^ G a  citrate and
67 .the presence of serum constituents delayed 'Ga migration
in citrate-phosphate and barbitone buffers and accelerated
^ G a  migration in phosphate buffer. Sera obtained from rats
67and cancer patients showed a similarity in 'Ga migration 
and no differences were detected between 3 and 24 h samples.
6-4-9 Identification of ^ G a  binding proteins by electro- 
immunodiffusion .
s
Blood serum samples obtained from cancer patients 
3 h after ^ G a  injection were investigated by this technique 
using rabbit antiserum to normal human serum. ^ G a  in 
these preparations was located by autoradiography and 
protein peaks made visible with Ponceau S. ^ G a  citrate 
controls were investigated similarly.
^ G a  in ^ G a  citrate migrated to the very edge of the
gel near the respective anodes leaving the major area of the
gel free of radioactivity. Blood sera showed at least 30
67distinct protein peaks. 'Ga was detected with two protein 
peaks by autoradiography ( see Pig,6.12) and these proteins 
were identified on the basis of their position as transferrin 
and haptoglobin. Monospecific antisera for transferrin and 
haptoglobin were incorporated separately into the second
-207-
dimension gel bed and the sera were investigated by
electro-immunodiffusion and autoradiography. Transferrin
67and haptoglobin peaks immunoprecipitated contained 'Ga 
and the two ^ G a  labelled protein peaks immunoprecipitated 
with multivalent antiserum occupied similar positions on 
the gel plate. Serum samples obtained from 12 patients 
consistently showed ^ G a  labelling to transferrin and 
haptoglobin.
67Fig.6.12. 'Ga binding proteins in human blood revealed
by electro-immunodiffusion and autoradiography. 
Transferrin = slim peak 
Haptoglobin = flat peak
-208-
6-5 Summary
cry
A tracer dose of 'Ga citrate was used to study the 
mode of transport of this element in blood of humans and 
the rat, and its tissue distribution and excretion in the 
rat. Ultrafiltration of blood sera indicated ^ G a  
binding to non-ultrafiltrable components in serum. ^ G a  
protein associations were dissociated to a greater extent
by exhaustive dialysis and zone electrophoresis. Both
67methods showed the presence of a smaller fraction of 'Ga 
strongly bound to proteins. These strongly bound ^ G a  
protein molecules in human blood were found to be transferrin 
and haptoglobin.
After intravenous injection of ^ G a  citrate in rats
^ G a  was released from the body rather slowly. ^ G a  was
excreted in the urine as well as in faeces but faecal excretion 
67 ^of 'Ga occured later than its pronounced excretion in
the urine. A number of soft tissues and bone were assayed
for ^ G a  and of these, the kidneys, liver and spleen showed
the highest concentration. Skeletal muscle, duodenum and
lungs contained an intermediate concentration while testes,
brain and bone contained the lowest concentration. During
671 -5 days after 'Ga citrate injection most tissues showed
a clearance, and in contrast bone, testes and the brain 
67accumulated 'Ga .
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6-6 Discussion
It is now known that gallium is present in the body
in trace amounts, but its function if any is not known.
Gallium has been little studied in relation to its behaviour
in the body, and some of these studies were reviewed in
Chapter 1. The present investigations, using carrier-free
tracer doses of the radionuclide of gallium ( ^ G a  citrate)7
in the rat permit some explanations on the blood transport,
tissue turnover and excretion of this trace element.
Following the intravenous administration of ^Ga,
it was slowly removed from the body, and this is in agreement
72with the findings of other workers using carrier-free ' Ga 
and ^Ga. The slow removal of ^ G a  was brought about by 
its slow excretion in the urine and faeces. Initially 
more ^ G a  was excreted in the urine than in the faeces, 
but at later times the faecal excretion v/as greater than 
the urinary excretion.
The slow removal of gallium from the body may be due
to its retention in the tissues and body fluids. The study
of tissue distribution of ^ G a  resulted in the following
tissue classification related to the ^ G a  levels in tissues 
67and the 'Ga clearance and accumulation in tissues3-
(a) ^ G a  levels in tissues:-
1.. High levels - kidney, liver and spleen
2. Intermediate levels lungs, skin, testes and 
bone (femur)
3* Low levels muscle, duodenum, brain, 
blood and blood plasma.
(b) ^ G a  clearance or accumulation:-
1. Rapid clearance - kidney, liver and spleen
" ’ 2. Fairly constant - lungs, muscle, duodenum
levels and skin
3. Accumulation - bone (femur), testes and
brain.
The fairly constant levels of gallium in soft tissues
such as the lungs, muscle, duodenum and skin, and gallium
accumulation in the testes, brain and bone would explain the
slow removal of gallium from the body. The rapid clearance
of ^ G a  from -fcke kidney and liver may be due to the excretion
67in urine and faeces. When  ^'Ga levels in these tissues were 
67lowered, the 'Ga excretion in faeces and urine was lowered. 
67'Ga distributes in similar amounts in the blood plasma and 
the formed elements of blood, in which it is associated with 
the erythrocytes. It is claimed from the study of Belozerov 
(1963) that gallium associates with the erythrocyte membrane 
of human erythrocytes. But in the present study 'Ga
was recovered in the erythrocyte cytoplasm where it may be 
bound to haemoglobin. In plasma, ^ G a  clearance was rather 
slow, and small amounts were detected up to 3 days* This 
may be due to plasma protein binding.
^ G a  (as gallium citrate) behaved as a negatively 
charged species in zone electrophoresis at physiological 
pH. Similar experiments with ^ G a  chloride also showed 
that gallium migrated as negatively charged species.
Therefore the gallium in gallium citrate used in the present
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3+investigations could not have been Ga^ , but it may have
3+been a complex of citrate, or a hydrated form of Ga •
It is known that GaCl^ is readily hydrolysed in aqueous 
solution:-
GaCl, + 3H20 — » Ga<OH)5 + 3HC1
The gallium hydroxide may ionise in order that an anion 
is formed as follows
Ga(OH)5 = H^GaO^ ^  H + H2GaO~
67This would account for the ''Ga of gallium chloride migrating 
as a negatively charged species at physiological pH*
Group 3 elements form chelate complexes with dicarboxylic
acids, such as tartaric acid* and tricarboxylic acids such as
citric acid (Cotton & V/ilkinson, 1962). Pattanaik and Pani
(1961) reported that aluminium citrate behaves as a dibasic
acid above pH 3*1 and therefore aluminium citrate would be
negatively charged at physiological pH. It is possible that
the ^ G a  citrate used in the present investigations was a
gallium citrate complex, having" ionisable carboxyl groups.
67The observed anodic migration of 'Ga in gallium citrate 
at the physiological pH may be due to the net negative charge 
of the ionised carboxyl groups of the citrate complex.
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The protein binding of ^ G a  in rat blood and human
blood were similar, and the binding proteins in human blood
of serum proteins, principally albumin , transferrin and
dose levels, and it is not clear why gallium binds to 
albumin and haptoglobin in addition to transferrin, eve 
the dose level of gallium in the present study was extremely 
low. The fraction of gallium undialysable in saline was
resembles iron which can be removed from its binding site 
on the transferrin molecule by phosphate (Schade et al.,
1954)• Gallium binds rather strongly to haptoglobin 
which is not normally a metal binding globulin. This 
binding could be due to gallium bound to haemoglobin 
which is then bound by haptoglobin. Haptoglobin has a high 
affinity for globin, whether free or in the form of haemoglobin 
and with these haptoglobin forms very stable complexes (Nyman, 
1959). The labelling of erythrocytes with gallium was ' 
seen to be due to gallium localised in t&e erythrocyte
cytoplasm. This may have been, due to gallium binding to 
haemoglobin. The high concentration of gallium in the 
spleen may reflect erythrocyte destruction in the spleen 
thus releasing haemoglobin bound gallium into the blood 
stream which will be bound to haptoglobin. The haptoglobin- 
haemoglobin complex so formed will be rapidly removed from 
the blood, mainly by the liver following the normal
were identified. ^ G a  was found to associate with a number
3+ 3+haptoglobin. Trivalent metal ions such as Fe^ , Cr^ and 
5+In^ were found to bind exclusively to transferrin at low
easily removed by phosphate and in this respect gallium
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pathway 6f haemoglobin degradation. In this way gallium 
could finally be excreted in bile and this would account 
for the delayed excretion of gallium in the faeces. 
Although no attempts were made in the present study to 
examine whether ^ G a  was excreted in bile it has been 
reported that human bile contains ^ G a  when it is injected 
for tumour scanning (Nelson et al., 1972),
The majority of ^ G a  was associated with plasma
proteins, an ultrafiltrable fraction was found in plasma
and this fraction progressively decreased with time. This
fraction may represent free gallium citrate or gallium
associated with other low mol. wt. ultrafiltrable components
of plasma. The existence of free gallium citrate o£ low 
67mol. wt. rGa labelled material could account for the 
gallium excretion in urine initially, which later decreased 
when the ultrafiltrable fraction of ^ G a  in plasma decreased. 
Therefore gallium excretion in urine appears to be related 
to the nature of the gallium in blood plasma. Although 
gallium albumin association are weaker, it is suggested that 
this fraction does not directly contribute towards renal 
excretion of gallium for the reason that more than a third 
of the gallium was foundjto be associated with albumin 
at 72 h after injection, as much as at 3 h.
Gallium deposition in two experimental tumours 
was examined and in these solid tumours it was found • 
that the gallium deposition was related to the degree 
of vascularity. The peripheral vascularised areas 
contained more gallium in comparison with the necrotic
- 2 1 4 -  .
areas which are poorly vascularised. In this respect 
gallium distribution resembled remarkably well the 
distribution of blood-borne vital dyes to various tumour 
regions in benzpyrene-induced solid tumours (similar to 
the RIB5 tumour used in this study), v/here the well 
vascularised young and small tumours showed a uniform 
distribution of the dye and the older 
tumours concentrated the dye in the vital zones (Goldacre 
& Sylven, 1962). Unlike the vital dyes which were removed 
from the tumour within 24 h, gallium remained within the 
tumour up to 72 h and . was found to be intracellular.
The presence of gallium in high concentration in the tumour 
cell in comparison with the extracellular medium may mean 
an increased affinity of the tumour cell for gallium.
Swartzendruber et al.(1971) have shown gallium localisation 
in lysosomes in tumour cells, and lysosomes bring about 
intracellular digestion of high mol. wt. material ingested 
from the extracellular environment. It is possible that 
gallium protein complexes are taken into the tumour by 
phagocytosis and the gallium retained within the cell 
after digestion of the proteins. However high 'Ga 
concentrations in the SSH1 tumour were reached within 
24 h and further uptake in the tumour was low.
During this period the plasma contained ultrafiltrable 
gallium and therefore it is also possible that the 
ultrafiltrable fraction was responsible for gallium locali­
sation in the tumour. The tumour cell, owing to its rapid 
turnover and to the pathological degeneration of its
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organelles, would show extensive lysosomal activity and 
in this instance gallium localisation in the autophagic 
vacuoles would still be consitent with the findings of 
Shartzendruber et al. (1971)* It may be possible that the 
initial rapid uptake of gallium was due to low mol. 
wt. ultrafiltrable components and the later slow uptake 
was due to the gallium albumin fraction.
Assuming that the findings of the tissue distribution 
and the gallium uptake in the experimental tumours of 
rats can be extrapolated to the behavior of gallium 
in the human body and malignant tissue in humans, certain 
comments can be made on the use of ^ G a  citrate as a 
tumour scanning agent.
Gallium citrate is suitable as a tumour localising
agent, in‘that the initial high concentration in most
soft tissue is lowered in two to three days while tumour
radioactivity levels are maintained thus enabling better
visualisation of the tumour._ However the initial high
concentration in the liver, kidneys and the spleen and the
presence of gallium in urine and faeces may mean that
tumours present in these organs and the organs of excretion
may not be prominent in scanning, owing to the extraneous
radioactivity in the non-tumour area. However sequential
scanning procedures may permit visualisation
in
of tumours in these organs andAtheir neighbourhood, due to 
the rapid turnover of gallium in the normal tissue.
As the apess of gallium to the tumour tissue is 
related to the degree of vascularity of the tumour and 
to the degree of cellular activity and necrosis of the
tumour gallium citrate is suitable for the imaging of
those tumours with good vascularity and cellular activity.
67The failure to visualise tumours with 'Ga citrate may
therefore be related to the age of the tumour, its
morphology and cytology. Therefore the absence of a 
67„positive 'Ga citrate scan m  a patient with suspected 
cancer is no guarantee against the absence of a tumour.
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following-a single i.v. injection of ^ZnCl .^
Tissue Time after injection
Minutes 
10 20 40
Hours
1 2 4 6
Blood cells 0.442 0.232 0.169 0.146 0.137 0.121 0.122
+ s.d. .141 .102 .083 .074 .076 .066 .041
Testes 0.093 0.097 0.099 0.137 0.149 0.145 0.151
+ s.d. .002 .002 .003 .002 .005 .002 .003
Heart 0.749 0.573 0.479 0.436 0.558 0.486 0.461
+ s.d. .039 .063 .072 .077 .132 .102 .082
Lung 0.746 0.597 0.569 0.481 0.773 0.659 0.607
+ s.d. -137 .122 .142 o093 .217 .206 .176
Muscle 0.191 0.148 0.130 0.126 0.123 0.142 0.097
± s.d. .013 .009 .007 .001 .012 .015 .024
Spleen ' 0.998 1.230 1.201 1.332 1.422 1.114 1.056
+ s.d. .047 .133 .103 .101 .097 .082 .073
Stomach. - 0.746 0.650 0.734 0.706 0.845 0.789 .0.615
--+ s.d. .037 .033 .043 .043 .057 .123 .072
Duodenum 1.670 1.613 1.345 1.921 1.634 1.125
+ s.d. .053 .032 .008 .047 .051 .053 .093
Prostate 0.291 0.270 0.299- 0.195 0.349 0.428 0.269
+ s.d. .022 .024 .035 .063 .037 .132 .06 7
Liver 2.834 3.257 2.568 1.829 2.063 1.672 1.369
± s.d. .460 .136 .729 .433 .594 .836 .334
ancreas ‘1.833 2.296 2.711 2.919 3.666 2.659 2.056
± s.d. .235 .643 .886 .493 .421 .645 .388
. of rats 3 5 5
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4 4 4 4
following a single i.v, injection of ^ Z n C ^ .
issue Time after injection (days)
1 2 3 4 5 6 9 10
lood cells 
+ s.d.
0.208
.006
0.207
.004
0.178
.006
0.114
.034
O.174
.003
0.217
.047
0.136
.002
0.106
o003
estes
+ s.d.
0.299
.004
0.3 57 
.009
0.378
.011
0.266 
.052
0.428
.024
0.472
.033
0.383
.062
0.286
.057
eart
± s*d*
0.663
.037
0.537
.053
0.414
.042
0.253
.044
0.325
.021
0.190 
.0 77
0.210
.014
0.170
.006
ung
+ s.d.
0.724
.099
0.696
.082
0.504
.042
0.295
.040
0.365
.027
0.263
.014
0.210
.009
0.199
.006
uscle 0.181 0.231 0.206 0.162 0.200 0.144 0.179 0.128
+ s.d. .004 .007 .006 .033 .003 .013 .022 .053
pleen 1.043 0.735 0.501 0.313 0.333 0.275 0.222 0.142
+ s.d. .063 .063. .032 .041 .047 .023 .017 .032
tomach. -0.671 0.583 0.524 0.324 0.484 0.346 0.297 0.277
+ s.d. . .067 .052 .043 .042 .073 .042 .021 .023
uodenum - 0.940 0.730 0.617 0.298 0.361 0.348 0.215 0.165
s.d. .033 .039 .040 .042 .044 .033 .033 .007
rostate 0.414 0.351 0.372 0.179 0.236 0.160 0.118 0.104
± .090 .057 .099 ’ .143 .093 .073 .052 >033
idney 1.081 0.654 0.479_ 0.340 0.371 0.255 0.233 0.178
+ s.d. .121 .041 .090 .012 .010 .012 .013 .009
iver
± s><i*
1.391
.284
1.148 
• .156
0.800
.074
0.516
.039
0.637
.132
0.472 
• 066
0.462
.062
0.307
.062
ancreas 1.039 0.854 0.525 0.342 0.459 0.377 0.318 0.218
+ s.d. .063 .174 .045 .044 .142 .039 .038 .055
o. of rats 3 3 3
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SUMMARY
W hen carrier free gallium -67 is adm inistered i.v . in  c itra te  fo rm  fo r  tu m o u r 
scanning, ra d io a c tiv ity  rem ain ing in  serum a fte r three hours, H  cannot be rem oved b y  
u ltra f iltra tio n . N early  a th ird  o f serum 67Ga remains undialysable and indicates the  
fo rm a tion  o f strong p ro te in -G a  complexes. B y  a cross e lectro-im m uno-d iffusion 
technique these prote ins were iden tified  as trans fe rrin  and haptog lob in . Gam ma g lo­
bu lins do n o t show any detectable in te ractions a t th is  dose level.
INTRODUCTION
In  recent c lin ica l-tr ia ls  rad ioactive  67Ga has been shown to  localise in  a w ide 
v a rie ty  o f so ft tissue tum ours, inc lud ing  some deposits w h ich  escaped detection  b y  
o ther c lin ica l methods1-3. These studies also reveal a h igh  success ra te  in  detecting  
certa in  types o f tum ours. I t  appears th a t if- th e  up take  o f 67Ga in  tum ours  can be 
augmented, i t  can p la y  a useful c lin ica l ro le as a diagnostic agent. A  system atic survey 
in to  the  mode o f transpo rt and the  mechanism responsible fo r  ce llu la r up take  of 
ga llium  appears to  be essential in  order to  a tte m p t such m anipu la tions.
Th is  paper reports the  aspect o f plasma p ro te in  ga llium  in te ractions, and we 
consider th a t i t  m ig h t be o f value in  investiga ting  fu r th e r the  behaviour o f ga llium  in  
the  body. ,
METHODS AND RESULTS
Carrier free 67Ga in  c itra te  fo rm  was prepared in  the  M .R.C. C yclo tron  a t the  
H am m ersm ith  Hospital-4. The patien ts were in jec ted  w ith  2.5 m C i o f 67G a-c itra te  in ­
travenously as a bolus fo r tu m o u r scanning3. B lood samples w ith d ra w n  a t 3, 24 and 
72 h a fte r g a lliu m  in jec tion  were allowed to  c lo t in  sterile  tubes a t 370 and serum was
Clin. Chim. Acta, 3 9  (1 9 7 2) 4 0 1 - 4 0 6
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taken fo r the  fo llow ing  studies. R a d io a c tiv ity  o f the samples and the preparations 
was counted in  an au tom atic  Gam ma-Spectrometer (Nuclear Enterprises L td .).
( i )  U ltra  filtra tio n  o f serum samples obtained at 3 ,24  and 72 h to investigate prote in  
binding. Three m l fractions o f serum were poured in to  V isk ing  cellulose tu b in g  (Scienti­
fic  In s tru m e n t Centre, London), cleaned in  deionised w ate r p rio r to  use. Th is p la c e d * m 
a sm all To riba ra  tube5 and centrifuged a t 2000 g fo r 0.5 h  a t 4 0 and a know n q u a n tity  
o f u ltra f iltra te  was counted fo r ra d io a c tiv ity . 67G a-citrate d ilu ted  w ith  0.9%  saline 
was used as a contro l.
In  a separate experim ent, b ind ing  b y  pure hum an serum a lbum in  was in ­
vestigated b y  m ix in g  a 4 %  so lu tion o f H SA  (L is te r In s titu te , London) w ith  67Ga- 
c itra te , m a in ta in ing  a specific a c t iv ity  o f 1 ^ wCi/ml a t a c itra te  concentration o f 0.1 m M  
(in  vivo concentration fo liow ing  in jec tion ). The m ix tu re  was incubated w ith  gentle agi­
ta tio n  a t 370 fo r 3 h p rio r to  u ltra f iltra tio n . The %  b ind ing  was calculated as fo llow s:
 Af
%  B in d in g  =  —   X io o
AS
As =  R a d io a c tiv ity /m l serum ; A f  =  R a d io a c tiv ity /m l u ltra filtra te .
Since free 67Ga (in saline controls) can be rem oved b y  u ltra f iltra tio n , th is  tech­
nique can be used to  investigate  the degree o f b ind ing  o f g a llium  b y  molecules re ta ined 
b y  the membrane. Results o f a ty p ic a l experim ent (Table I)  show an increasing degree
T A B L E T > ; .
G A L L IU M  B IN D IN G 'B Y  B L O O D  S E R A  A S D E T E R M IN E D  B Y  U L T R A F IL T R A T IO N  A T 4 °
Sample % binding
3 h  serum 85 ± 6.7*
24 h  serum 97 i 3-2
72 h  serum 99 4- 1.9
HSA 35 ± 2.4
Controls 15 ± 2.2
* M ean of six  de term inations ±  S.D.
of b ind ing  to  serum prote ins a t the  tim e  in te rva ls  studied. The b ind ing  figure fo r pure 
H S A  (35%) indicates th a t nonalbum in proteins in  serum p la y  an im p o rta n t ro le in  
ga llium  b ind ing . Controls fa iled  to  give the an tic ipated  figure o f zero ow ing to  b ind ing  
o f ga llium  to  the cellulose membrane b u t the o ther figures were n o t corrected in  view  
o f th is  (average, 15%  b ind ing  o f the contro l). U ltra fi lt ra t io n  a t 40 and 370 gave s im ila r 
results.,
(2 ) Exhaustive dia lysis o f 3, 24, and 72 h serum samples. F o r dialysis V isk ing  
bags conta in ing  1 m l fractions of serum were secured in  a Feinstein type  ro ta ry  
d ia lyser6 conta in ing  2 1 o f 0 .9%  sodium chloride so lu tion a t p H  7.2 (A llen &  H anburys 
L td ., London). D ia lys is  was continued fo r 24 h a t 4 0.
In  another s tudy  the effect of P 0 43- was exam ined b y  dia lysis against a 0.06 M 
phpsphate bu ffe r; p H  7.4 a t 40. 67Ga in  saline solutions were used as controls.
• R a d io a c tiv itv /m l o f dialysed serum
. . %  B ind ing  — — — ----- - .-----—— - . -— — X io o
' R a d io a c tiv ity /m l p rio r to  d ialysis
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Whereas the  contro ls showed a complete loss o f a c tiv ity , a ll serum samples re­
ta ined  approx. 30%  o f 67Ga (Table I I ) .  T h is  fra c tio n  cannot be rem oved b y  prolonga­
tio n  o f d ia lysis u p to  72 h. PC^3- b rough t about a complete loss o f 67Ga fro m  serum.
T A B L E  I I
B IN D IN G  O F GALLIUM B Y  SERUM  PR O T EIN S AS S EEN  IN  D IA LY SIS AT 40
D ialysing medium %  binding
Saline 29.8 ±  2.5
Pho sp h ate  buffer 2 ±  0.4
Control 0
(3) Cellulose acetate membrane electrophoresis; study with 3 h and 24 h serum 
samples. Zone electrophoresis o f serum samples and ga llium  c itra te  was conducted on 
cellulose acetate membrane (CAM) in  a re frige ra to r a t 40. A  tr is -ba rb itone  sodium  
barb itone bu ffe r a t p H  8.4, ion ic  s treng th  0.05 was used. A pp rox . 20 V /c m  s tr ip  
leng th  p o ten tia l was applied fo r  0.5 h  to  6.0 h. A t  the  end o f the  separation membranes 
were d ried  in  a ho rizon ta l position  in  a ir  and cu t in to  0.5 cm  pieces across the  leng th  
fo r ra d io a c tiv ity  counting. P ara lle l s trips were stained w ith  Ponceau-S and scanned 
fo r proteins.
67Ga under the  experim enta l conditions behaves as an anode-seeking species. 
F o r convenience a 2 h  separation is shown (Fig. 1). A fte r  a 6 h  separation no rad io -
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Fig. 1. Zone electrophoresis of 67G a c itra te . D u ra tio n  o f  electrophoresis 2 h . W h atm an  No. i.C—} 
paper, — CAM. E q u a l am ounts of 67G a-citrate  were applied a t  th e  origin. W h atm an  p ap er shows 
adsorp tion  and  re ta rd ed  m igration  of 67Ga. H ence CAM w as chosen for electrophoresis as a  sup ­
po rtin g  m edium .
a c tiv ity  could be detected on a 20 cm  long CAM s tr ip . However, when serum con­
ta in in g  67Ga is electrophoresed, a s ign ifican t delay in  67Ga m ig ra tion  is no ted  (F ig. 2) 
and free 67Ga in  con tro l s trips always m igra ted  beyond the  pre-a lbum in  zone. W hen 
electrophoresis was continued fo r longer than  one hour 67Ga in  the  a lbum in  zone and 
some 67Ga in  g lobu lin  zones can be dissociated leaving some ra d io a c tiv ity  in  the  /? 
g lobu lin  zone (F ig. 3). In  fa c t dialysed sera show a 67Ga peak on ly  a t the  f-zone.
(4) Visualisation of strongly bound gallium-protein complexes by cross-electro­
immunodiffusion technique. The technique o f C larke and Freeman7 was used w ith  
some m odifica tions in  order to  effect speedier separation to  ob ta in  sa tis fac to ry  au to­
radiographs.
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Fig. 2. CAM electrophoresis of 3 h  serum . D u ra tio n  of electrophoresis 1 h. —  Pro te in , — R adio­
ac tiv ity . 24 h  se ra  gave an  iden tical p a tte rn  for 67Ga.
Fig. 3. CAM electrophoresis of 3 h  serum . D u ra tion  of electrophoresis 6 h -  (P rotein ,—R adioactiv ity . 
24 h  sera  gave an  iden tical p a tte rn  for 67Ga.
A  bed o f I %  agarose gel was prepared b y  p ou ring  a m ix tu re  conta in ing  3 m l o f 
2%  agarose (Paines and B yrne  L td . London) and 3 m l o f 0.04 M barb itone bu ffe r on 
a 5 x  5 cm  clean glass p la te . A  hole was punched h a lf a centim eter fro m  one corner on 
the d iagonal line. Ten /A o f 3 h serum was added to  the hole soon a fte r collection and 
electrophoresed aT 24 V /c m  in  0.02 M  barb itone bu ffe r a t 4 0 in  a re frigera tor. A fte r  
45 m m  excess gel was rem oved leaving  a i-c m  w ide s tr ip  con ta in ing  the proteins. F ou r 
m l o f 1%  gel prepared as before, conta in ing  0.2 m l o f an tiserum  (Hoechst Pharm a­
ceutical, London) was poured to  complete the  gel-bed once again. Once the gel had 
set a po te n tia l o f 8 V /c m  was applied a t r ig h t angles to  the  firs t separation fo r 8 h.
Fig. 4. Cross-electro-im m unodiffusion au to rad iog raph  of 3I1 serum . O, -  Origin, <- 1st dim ension, 
t  |  2nd dim ension, H p t, hap tog lob in , Tr, transferrin .
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The excess antiserum  rem ain ing  in  the  p la te  was rem oved b y  4 successive washes in  
saline a t 370 and the  saline was rem oved b y  washing in  w arm  de-ionised w ater over a 
to ta l period of 2 h. The agar bed was then dried  to  a th in  f i lm  under a curren t o f w arm  
air. R a d io a c tiv ity  was located b y  autoradiography,on K odak  A .R .50 film . A fte r  three 
days o f exposure, film s were developed fo r 10 m in  in  K o d a k  D-19 developer. Ponceau- 
S was used to  s ta in  proteins.
G a llium -c itra te  contro ls were electrophoresed s im ila rly .
Free 67Ga in  controls m oved to  the  ve ry  edge o f the gel tow ards the  respective 
anodes. A l l  serum samples taken a t 3 h  show tw o  d is tin c tly  labelled peaks (Fig. 4). 
These peaks were iden tified  under s im ila r conditions using specific antisera as trans­
fe rrin  and haptog lob in .
DISCUSSION
H a rtm a n  and Hayes8 w o rk ing  w ith  an in vitro system  dem onstrated th a t 67Ga 
b ind ing  components in  serum are proteins. These w orkers ind ica te  th a t 67G a-prete in 
in te ractions a t low  67Ga levels were re la tive ly  insensitive to  p H  changes when the  p H  
was greater than  6.5.
O ur s tu d y  was designed to  evaluate the nature o f th is  b ind ing  and to  id e n tify  
the  67Ga-proteins complexes in  serum, when carrier free 67Ga is adm inistered i.V. in  
quantities n o rm a lly  used fo r c lin ica l scanning.
The u ltra f iltra tio n  da ta  shows th a t 67Ga in  the b lood rem ains associated w ith  
serum proteins. O f th is  nearly  70%  appears to  be loosely associated w ith  a lbum in  and 
some globulins. T h is  fra c tio n  can be easily rem oved b y  dia lysis o r zone electrophoresis. 
The undialysable fra c tio n  can be dissociated b y  P 0 4®~. In  th is  respect 67Ga resembles 
iron  w h ich  can be rem oved fro m  its  b ind ing  site in  tra n s fe rr in 9 b y  P 0 43~. In  add ition  
to  transfe rrin , a haptog lob in  peak can also be visualised b y  im m uno-e lectrophore tic  
autorad iography. O ther tr iv a le n t m eta l ions Fe, In , Cr, are know n to  b ind  exclus ive ly  
to  trans fe rrin  a t low  dose levels10*11, b u t ga llium  differs from  these in  th a t i t  possesses 
a non-specific p ro te in  b in d in g  a b ility .
CONCLUSION
The fac t th a t strong associations between 67Ga and trans fe rr in  ex is t (s im ilar 
to  Fe) does n o t ju s t ify  the  assumption th a t 67Ga tra n sp o rt is exc lus ive ly  b rough t 
about b y  th is  pro te in . W hether bo th  a lbum in  and tra n s fe rr in  serve as 67Ga carrier 
pro te ins to  sites o f c lin ica l in te rest remains to  be elucidated.
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Investigations with Radioactive Zinc Regarding 
its Usefulness for Pancreatic Scanning
S. Gunasekera and M. A. Chaudhri
S um m ary
In order to assess the usefulness o f short-lived zinc isotopes like 62Zn (9.3 h) and 69mZn (13.9 h) 
for pancreatic scanning, we have studied the distribution o f carrier-free 65Zn (in a chloride form) 
in various organs o f rats from 10 min to 10 days after intravenous injection. A  maximum ratio of 
only about 1.5 between the uptake (% dose/g) in the pancreas to that in the liver was obtained 
at 2 hours after the injection. Attempts to enhance this ratio by starving the rats, injecting them 
with Tolbutamide and Diazoxide and feeding a high protein diet failed. However, when starved rats 
were treated with Diazoxide only and injected with a mixture (complex) o f 65ZnCl2 and Alpha- 
amino-iso butyric-acid the pancreatic uptake went up by a factor o f five (6.5%/g) at 20 hours after 
injection. The pancreas to liver ratio o f as much as almost 3 : 1 was obtained at 24 hours. This 
concentration ratio combined with a fairly low blood background at that time (less than 0.1%/g) 
may be good enough for pancreatic scanning using the well-known double-isotope and computer- 
subtraction techniques.
The main advantage o f 62Zn and 69mZn would perhaps lie in the fact that for the same count 
rate over the pancreas the radiation dose to the patient would be much smaller than with 75Se 
Selenomethionine (5 rads to kidneys for 62Zn as compared to 15 rads for 75Se). Moreover, the gamma 
energies from 62Zn and 69mZn (510 and 440 keV respectively) being similar to the one from 198Au 
(410 keV) would make these isotopes much better partners in dual-isotope subtraction technique 
than 75Se.
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LABP 21-111 APPARATUS AND DEVICES
Ultrafiltration for concentration and 
desalting of proteins in solution
by S. W. Gunasekera
M.R.C. Cyclotron Unit, Hammersmith Hospital, 
Ducane Road, London W12, U.K.
The technique o f u ltrafiltra tion by centrifugation is commonly 
employed to investigate plasma protein interactions w ith 
ultrafiltrable substances. The presence or absence o f inter­
actions and the degree o f association can be determined as 
described by Toribara et al (1957). In  this laboratory the 
technique has been used fo r the study o f trace element 
association w ith proteins in blood, bile and other protein 
solutions and fo r checking the efficiency o f labelling o f proteins 
w ith radio-nuclides. In  addition, the centrifuge tube des­
cribed here is used satisfactorily fo r concentrating macro­
molecules in solution p rio r to electrophoresis and column 
chromatography and as a container fo r Sephadex gel in 
centrifuge desalting.
Materials and methods
Centrifuge tubes are made from  filter tubes w ith a disc 
diameter of 10 mm, porosity No. 1, length 15 cm (Scientific 
Supply Co. Ltd., London). These are sealed o ff and rounded 
at one end 3 cm below the disc. A  small hole was made 1 cm 
below the disc to  introduce a polythene tube o f external 
diameter 2 mm. This is secured in position by sealing w ith a 
few layers o f Parafilm (Gallenkamp Ltd., London) and 
warming in  an oven at 45 °C fo r 10 minutes. The other end 
o f the polythene tube is passed through a cork. Visking 
cellulose tubing o f flat width 10 mm (Scientific Instrument 
Centre Ltd., London) containing 1-3 m l o f the sample is 
placed over the disc. The free ends are bent over and the cork 
is placed as shown in Figure 1. I f  necessary a battery o f loaded 
centrifuge tubes can be gassed by connecting the polythene 
tubes crosswise to introduce the desired atmosphere.
The speed and duration o f centrifugation must be deter­
mined by tria l, as factors such as viscosity o f the liqu id often 
come into effect. .In the author’s experience w ith a MSE 
‘m inor’ centrifuge (MSE, London) fitted w ith a swing-out 
head, loaded w ith six centrifuge tubes, and centrifuged at
3,000 r.p.m. (approximate RCF value 1,500 g) an ultrafiltrate 
o f 10% o f the volume o f serum is obtained in 30 minutes. 
The speed o f the centrifuge must be increased very slowly to 
prevent the rupture o f the cellulose membrane. The u ltra­
filtrate is withdrawn by unplugging the polythene tube at the 
Parafilm seal.
The same set up is used fo r concentrating macromolecules. 
Maximum speeds available in the centrifuge, longer spinning 
times and, i f  necessary, repetition o f this step by transferring 
the solution into clean Visking tubing, enable concentration 
o f the solution to desired levels. Alternatively high molecular 
weight substances are added (up to 3 m l) to ultra-centrifuge 
tubes packed w ith 1 g o f dry Sephadex G .25 (coarse) and 
after 10 minutes o f slow centrifugation (600 r.p.m.) followed 
by centrifugation at 3,700 r.p.m. (approximate RCF value 
2,350 g) a concentrate o f the material collects in the lower 
compartment w ith in  15 minutes.
This centrifuge tube packed w ith 1 g o f dry Sephadex G .25
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(coarse) can also be used fo r the separation o f proteins from  a 
solution containing inorganic salts and protein preservatives. 
S im ilarly i t  can be used fo r checking the efficiency o f radio 
active labelling o f macromolecules. Sephadex gel previously 
swollen in water is poured in to  the centrifuge tube and 
centrifuged to  remove excess water remaining outside the gel. 
The sample, 1/10 to 1/5 the volume o f the swollen gel capacity 
o f the tube, is introduced on top o f the gel bed and allowed 
to permeate while at rest. A fte r equilibration fo r about 10 
minutes desalted proteins are obtained by centrifugation at
1,000 g.
The extent o f desalting, concentration and recovery o f the 
substance o f interest depends upon parameters such as the 
centrifugal force applied, viscosity and the amount o f sample 
(Emneus, (1968)), and therefore optimum operating condi­
tions must be determined beforehand.
M iniaturisation o f the u ltra filtra tion tube fo r use in the 
small ‘bench’ or ‘jun io r’ centrifuge enables the technique o f 
u ltrafiltra tion to  be performed in  a laboratory not normally 
equipped w ith a high-speed centrifuge, or when working w ith 
small volumes in any laboratory.
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